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ABSTRACT 
The active metabolite of vitamin D3, 1, 25 dihydroxyvitamin D (1,25(OH)2D) is 
produced in the skin following exposure to UVR. UVR also produces DNA damage in 
the form of premutagenic cyclobutane pyrimidine dimers (the majority of which are 
thymine dimers) and 8oxodG, and also causes immunosuppression. UVR-induced 
DNA lesions and immunosuppression eventually lead to photocarcinogenesis. It has 
previously been shown that 1,25(OH)2D reduces direct DNA damage in a process 
that requires the non-genomic actions of ligand binding to the vitamin D receptor, 
including the opening of chloride channels. Mice with an ablated vitamin D receptor 
gene are more susceptible to photocarcinogenesis, however mice that do not 
contain the gene required to hydroxylate 25-hydroxyvitamin D to active 1,25(OH)2D 
do not show greater susceptibility to produce UVR-induced skin tumours, 
suggesting the possibility of other photoprotective 1,25(OH)2D-like molecules 
present in the skin. Recently an alternate vitamin D metabolism pathway has been 
found in the skin involving CYP11A1 that produces 20-hydroxyvitamin D (20(OH)D), 
a vitamin D-like molecule that can bind to the VDR without producing the genomic 
effects of 1,25(OH)2D. Furthermore, previous reports show that tetrahydrocurcumin 
(THC), a metabolite of the spice curcumin, is an effective anti-oxidant at micromolar 
concentrations, but may potentially have 1,25(OH)2D-like photoprotective effects at 
nanomolar concentrations.  
 
The current study tested whether 20(OH)D and THC would reduce UVR-induced 
DNA damage in primary human keratinocytes and Skh:Hr1 mice, and inflammatory 
oedema and immune suppression in Skh:Hr1 mice. Furthermore, the mechanism of 
photoprotection of 1,25(OH)2D and 20(OH)D was tested using DIDS, a chloride 
channel inhibitor, shown to inhibit vitamin D non-genomic actions, as well as an 
inhibitor of Wnt, a procarcinogenic signalling protein.. Photoprotection with  
1,25(OH)2D  was also assessed using Skh:Hr1 mice and oestrogen receptor-β knock 
out  (ERβKO) mice, to examine whether firstly UVR-induced immunosuppression 
differed between males and females, and secondly whether the photoprotective 
effects of 1,25(OH)2D and 20(OH)D were affected by gender. 
 
20(OH)D and THC were as photoprotective as 1,25(OH)2D against UVR-induced DNA 
damage in both primary human keratinocytes (8oxodG and thymine dimers) and 
Skh:Hr1 mouse skin (thymine dimers), 3 hours following UVR exposure. In primary 
human keratinocytes, use of DIDS reversed the protective effect of both 1,25(OH)2D 
and 20(OH)D against thymine dimers The Wnt inhibitor alone was protective 
against UVR-induced thymine dimers, and did not cause reversal of the 
photoprotection by 1,25(OH)2D and 20(OH)D. 20(OH)D was as effective as 
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1,25(OH)2D in reducing UVR-induced skin inflammation and immunosuppression in 
Skh:Hr1 mice. UVR-induced immunosuppression and DNA damage was greater in 
males than females, and at high doses 1,25(OH)2D caused immunosuppression on 
its own. ERβKO mice were more susceptible to UVR-induced immunosuppression 
than wild type controls and the photoprotective effect of 1,25(OH)2D and 20(OH)D 
was reduced.  
 
This study showed for the first time that 20(OH)D is photoprotective against UVR-
induced DNA damage, inflammation and immunosuppression, in the same non-
genomic way as 1,25(OH)2D. Furthermore, the results show 1,25(OH)2D mediated 
photoprotection is more pronounced in the presence of a functional ERβ, 
suggesting a potential interaction between ERβ and the actions of VDR ligands.  
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1 INTRODUCTION 
1.1 SKIN 
 Structure and function of the skin 1.1.1
As the largest organ of the adult human body, the skin is the body’s first line of 
defence from stressors such as ultraviolet radiation (UVR) in the external 
environment. Making up 6% of total body weight with a thickness fluctuating 
between 1.5 and 4.0mm in different areas of the body, it consists of two layers, an 
external epithelium called the epidermis and an internal connective tissue called 
the dermis (Tobin, 2006), as shown in figure 1.1. There is an additional layer 
underlying the dermis known as the hypodermis connecting the skin underlying 
organs of the body. Each layer is made up of different cell types which have unique 
properties allowing for the holistic protective abilities of the skin. 
 
Figure ‎1.1 Structure of the whole human skin (Kumar and Clarke, 2012). 
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 Epidermis 1.1.2
The epidermis consists of a specialised architecture of different cell types. As a 
protective epithelium, the epidermis is stratified; it has a stratum of four stacked 
layers of keratinocytes in a variety of morphologies, the most abundant cell type 
within the epidermis (~90%), as can be seen in figure 1.2. The remaining 10% of 
epidermis is made up of Langerhans cells, melanocytes and granstein cells which are 
dispersed amongst the four layers of keratinocytes (Kanitakis, 2002). From the 
bottom to top, these continuous layers of epidermal cells are known as the stratum 
basale, stratum spinosum, stratum granulosum and stratum corneum.  
 
Figure ‎1.2 Structure of the epidermis (Marieb and Hoehn, 2012). 
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1.1.2.1 Keratinocytes 
Basal layer keratinocytes are cubical in structure and lie anchored to the basement 
membrane which itself is connected to the vascularised dermis. These cells derive 
from mitotic divisions of stem cells and express proliferation antigens, which ensure 
constant renewal and growth. Newly divided basal keratinocytes undergo 
morphological differentiation and push older cells away from blood supply towards 
the superficial stratum corneum. Lack of oxygen and nutrients results in 
degeneration of the nucleus.  At the stratum granulosum, keratinocytes develop 
protein rich keratin filaments and lamellar lipid filaments giving them a “grainy” 
appearance. In the process of self-directed destruction, the nucleus is digested and 
the cytoplasm is expelled. Keratin filaments form a tight cross-linked cytoskeletal 
structure covalently bonded with lipids resulting in cells with a flattened hexagonal 
cornified cell envelope which ultimately forms the impermeable stratum corneum 
(Baroni et al., 2012).  This process of proliferation and desquamation gives 
keratinocytes a short life span of 25-45 days (Baroni et al., 2012). The rate of 
keratinocyte differentiation is largely dependent on application of pressure and 
friction, thus the soles of the feet contain thicker layers of cells than the eyelids or 
forehead (Baroni et al., 2012). 
 
Additionally, it is well established that keratinocytes self-mediate growth and 
proliferation, and play a role in the skin immune response by the production of 
regulatory chemokines, cytokines, namely interleukins (IL) IL-1, -6, -7, -8, -10, -12, -
15, -20 and tumour necrosis factor- (TNF-), growth factors such as epidermal 
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growth factor (EGF), and interferons (IFN) IFN-, -, and - (Williams and Kupper, 
1996, Christensen and Haase, 2012). Whilst some mediators are released 
constitutively to a small extent in intact skin, production is stimulated following 
changes to the cutaneous environment, such as physical insult or irritant exposure 
(Corsini and Galli, 2000, Lippens et al., 2005) supporting the theory that the skin 
contains links between the multifactorial humoral immune system and cell-
mediated immune system (Williams and Kupper, 1996). 
1.1.2.2 Melanocytes 
Melanocytes are distributed evenly amongst the basal layer of the epidermis and 
synthesise melanin, the most expressed pigment of the skin (Kanitakis, 2002). The 
production of melanin occurs within membrane bound melanosomes, as a result of 
the enzymatic activity of tyrosinase. Melanin granules reach neighbouring 
keratinocytes via transport along the melanocyte’s dendritic processes and seek to 
accumulate on keratinocyte nuclei to protect from ultraviolet radiation (UVR) 
(Tobin, 2006).  
 
Melanin pigmentation varies greatly amongst racial and ethnic origin, and it has 
been reported than there is an inverse relationship between melanin content in the 
skin and UVR- induced DNA damage (Tadokoro et al., 2003). Interestingly, albino 
epidermis contains melanocytes deficient in tyrosinase. Lack of tyrosinase-induced 
melanin production is manifest in the characteristic “white” skin highly prone to 
damage by UVR exposure.  
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1.1.2.3 Langerhans cells 
These cells originate from haemopoietic stem cells of the bone marrow and migrate 
to the stratum spinosum of the epidermis. Also known as epidermal dendritic cells 
for their capacity to form a network through their dendrites, Langerhans cells 
remove and process invading antigens to present them to helper T-cells which then 
initiate a cell mediated immune response (Kanitakis, 2002). This part of the barrier 
protection of the skin is highly affected by exposure to UVR. UVR exposure initiates 
DNA damage of the Langerhans cell, altering antigen presenting functionality and 
ultimately suppression of local and systemic immune responses. 
1.1.2.4 Merkel cells 
Merkel cells are located in the basal layer of the epidermis and derive from the 
neural crest. These mechanoreceptors form synaptic junctions with free nerve 
endings arising from the dermis (Kanitakis, 2002). 
 Dermis 1.1.3
Beneath the basement membrane of the epidermis, lies a highly vascularised elastic 
connective tissue known as the dermis. It consists of dermal proteins, primarily 
collagens and elastins, fibroblasts, nerve endings, blood vessels and immune cells 
such as macrophages and mast cells. Most importantly, the dermis functions to 
support the epidermis with its elastic properties, and supply via its vascular 
network, oxygen and nutrients to the epidermis (Tobin, 2006). Like the epidermis, 
thickness of the dermis is highly dependent on pressure and anatomical location 
(Kanitakis, 2002). 
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1.1.3.1 Fibroblasts 
The most abundant cell type in the dermis is the spindle-shaped fibroblast. 
 Hypodermis  1.1.4
This is the deepest layer of the skin and consists primarily of adipocytes, or “fatty 
cells”.  Ultimately, whilst the hypodermis provides a connection between the skin 
and underlying aponeuroses, it also provides insulation, protection from injury and 
a site for nutrient storage (Kanitakis, 2002).  
 Parallels in human and murine epidermal structure 1.1.5
Epidermal structure of the skin is generally uniform across mammalian species. In 
particular, humans and mice show similar hallmarks of keratinocyte mediated 
barrier formation and protection (Jane et al., 2005). Taking advantage of these 
similarities by using in vivo murine models of biological reactions of the skin has 
been hugely beneficial in understanding possible mechanisms of skin cancer 
formation in human skin, where in vivo models are not so readily available. 
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1.2 ULTRAVIOLET RADIATION (UVR) 
 Sources and types of UVR 1.2.1
Making up around 5% of terrestrial sunlight, UVR spans the electromagnetic 
spectrum between wavelengths of 100-400nm (Diffey, 2002, Pfeifer and 
Besaratinia, 2012). Due to the high variation in biological effects of wavelengths in 
the UV portion, UVR is further subdivided into three components increasing in 
energy; UV-A (320-400nm), UVB (280-320nm) and UVC (100-280nm) (Diffey, 2002). 
Stratospheric ozone filters out higher energy wavelengths below 290nm. However, 
since the 1970’s evidence has arisen suggesting that the ozone layer is depleting, 
especially above Australia, leading to increased surface UVR levels (Makin, 2011). 
 
UVR wavelength is inversely proportional to energy, however energy of the 
wavelength is directly proportional to its potential to cause DNA damage 
(Muthusamy and Piva, 2010). As shown in figure 1.3, UV-B wavelengths that reach 
the earth penetrate the depth of the epidermis and are known to cause direct 
damage to cellular DNA. On the other hand, long length UV-A radiation penetrates 
deeper into the dermis, altering metabolic mechanisms which ultimately result in 
indirect DNA damage. In the laboratory setting, UV-C wavelengths are absorbed by 
DNA 100 fold more readily than wavelengths of the UV-B range between 290 and 
305nm (Besaratinia et al., 2011). 
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Figure ‎1.3 UVR penetrates different layers of the skin depending on the 
wavelength (modified from (D’Orazio et al., 2013)) 
 Photoresponse to acute UVR exposure 1.2.2
1.2.2.1 Erythema (sunburn) 
One of the more familiar skin reactions following exposure to acute doses of UVR in 
fair skin is the appearance of redness and erythema (inflammation) of the skin, 
characteristic of the common “sunburn” (Matsumura and Ananthswamy (2004). 
Erythema is a delayed biphasic photoresponse occurring around 2 to 48 hours after 
UVR exposure and may persist for several days, depending on the dose of 
wavelength of the spectral light. Irradiation from the UV-B kind causes faint 
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inflammation, which subsides more rapidly than its UV-A counterpart, which 
induces blister formation and extends the duration of its effect (Warin, 1978a).  
 
It has been postulated that the mechanism of action of UV radiation on the 
formation of erythema is via prostaglandin (PG) activation in the skin and in dermal 
blood vessels increasing vasodilation (Warin, 1978a, Clydesdale et al., 2001).  
1.2.2.2 Cornification 
In addition to the rapid onset of UVR-induced skin inflammation, another skin 
photoresponse to an acute UVR exposure is the hyperplasia and cornification of the 
epidermis, in particular, the stratum corneum (Lippens et al., 2009, de Winter et al., 
2001). From around 2 hour to 48 hours following insult, keratinocytes undergo an 
amplified process of cornification whereby suprabasal cells form the keratinic 
filament networks and become corneocytes. Basal keratinocytes differentiate at a 
more rapid rate to replace the resulting in hyperplasia of the epidermis. 
Cornification and hyperplasia eventuate into a thickening of the epidermis, 
evidently occurring as a form of photoprotection to decrease the diffusion of UVR 
reaching vulnerable cell layers in subsequent exposures (de Winter et al., 2001). 
Eventually the cornified cells are shed, commonly known as “peeling” (de Winter et 
al., 2001). 
1.2.2.3 Melanogenesis 
Along with defensive epidermal thickening, the skin stimulates melanin synthesis to 
protect against the damaging effects of UVR. Melanin production following UV 
radiation exposure is biphasic, with an initial immediate pigment darkening (IPD) 
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occurring within minutes of UVR exposure, and a delayed tanning response seen 2-3 
days later (Park et al., 2009, Kadekaro et al., 2003). The IPD response is induced 
primarily by UV-A portion, resulting in oxidation and redistribution of pre-existing 
melanin, forming nuclear caps over threatened keratinocytes (Matsumura and 
Ananthaswamy, 2004, Kadekaro et al., 2003). During the DT photoresponse to UV-B, 
melanocytes increase in number and activity, increase dendritic spread, with an 
additional increase in tyrosinase mRNA activity, producing suprabasal amounts of 
melanin (Matsumura and Ananthaswamy, 2004). Increased presence of melanin 
granules results in hyperpigmentation of the epidermis, known commonly as a 
“tan”. Melanin is chromophoric, absorbing and scattering UV light and acts a 
rudimental, natural “sunscreen” for the skin (Kadekaro et al., 2003). 
 
 UVR-induced DNA damage 1.2.3
UVR is known to induce DNA damage via both direct and indirect insults to DNA 
conformation. DNA absorption of UVR leads to direct changes in nucleobase 
formation, resulting in cyclobutadipyrimidines or cyclobutane pyrimidine dimers 
(CPDs), and pyrimidine (6-4) pyrimidone photoproducts (Matsumura and 
Ananthaswamy, 2002, Cadet et al., 2005).  Moreover, the primary DNA damage 
from UV-A radiation eventuates via oxidative stress to form the 8-oxo-7,8-dihydro-
2’-deoxyguanosine (8-oxodG) DNA lesion (Pattison and Davies, 2006).   
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1.2.3.1 Direct DNA damage 
DNA damage resulting from the absorption of UVR occurs at the site of two 
adjacent pyrimidines at the 5-6 carbon (C5-C6) double bond, generally between 
tandem cytosines or thymines (Brash, 1997). If the photoexcitation of the bond 
opens completely, the double bonds form a stable four membered cyclobutane ring 
with a neighbouring pyrimidine (e.g. T<>T thymine dimer), known as a CPD 
(Matsumura and Ananthaswamy, 2002, Ravanat et al., 2001). CPD formation is 
shown in figure 1.4. On the other hand, if the C5 bond opens and undergoes 
orientation rearrangement, this may form a single bond between the C5-C6 double 
bond of the 5’-end pyrimidine and the C4 group of the 3’-end pyrimidine, a 6-4PP  
(Ravanat et al., 2001, Brash, 1997). CPDs are the most prevalent DNA photoproduct 
from UV-B irradiation, produced several times more often than 6-4PPs (Ravanat et 
al., 2001, Matsumura and Ananthaswamy, 2002).  
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Figure ‎1.4 Formation of UVR-induced DNA photoproducts (Matsumura and 
Ananthaswamy, 2002). 
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Frequency in appearance of these DNA lesions is dependent on wavelength, most 
prevalent after exposure to high-energy wavelengths in the UV-C and lower portion 
of UV-B range. However, CPDs are also formed following the longer wavelengths at 
the border of the UV-B/UV-A spectrum, albeit at a decreased amount. Location of 
the CPD is an indication of the type of UVR exposure received (Pfeifer and 
Besaratinia, 2012). UV-A generated CPDs are found in the basal layer of the 
epidermis, whilst CPDs formed in the suprabasal layers are an offspring of UV-B or 
UV-C radiation (Halliday and Cadet, 2012).   
 
Unrepaired DNA lesions become incorporated into DNA sequences by the DNA 
polymerase substitution of an adenine nucleobase opposite the unrecognisable 
photoproduct (Brash, 1997). Generally, 6-4PPs are more readily repaired compared 
to their CPD counterpart and are often less mutagenic (Matsumura and 
Ananthaswamy, 2002). 
 
1.2.3.2 Indirect DNA damage 
In addition to its direct absorption by DNA, UVR facilitates DNA damage by the 
generation of a myriad of reactive oxygen species (ROS) such as singlet oxygen, 
superoxide anions and hydrogen peroxide (H2O2) (Cadet et al., 2005). In addition, it 
is well established that UVR increases nitrative products, nitric oxide (NO) (Villiotou 
and Deliconstantinos, 1995). These products may then undergo further reactions to 
form hydroxyl anions and peroxynitrate, which are, along with singlet oxygen, 
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implicit in the main mechanisms of formation of oxidative and nitrative DNA base 
lesions (Jena, 2012, Cadet et al., 2003). Oxidative stress occurs naturally in skin, 
however there is evidence for an association with a UVR-induced increase in 
concentrations of ROS and nitrogen associated products and increased prevalence 
of DNA damage (Pattison and Davies, 2006, Pfeifer and Besaratinia, 2012). 
 
Guanine exhibits the lowest ionisation potential of the DNA purines, and is 
frequently oxidised and nitrated forming mutagenic guanine centred base lesions, 
the most lethal and reactive of which is 8oxodG, shown in figure 1.5 (Ravanat et al., 
2001, Jena and Mishra, 2012). Formation of 8oxodG is through two pathways 
mediated by hydroxyl radicals or singlet oxygen, respectively. The former requires 
one electron oxidation of guanine, creating a guanine radical cation (G•+), which 
reacts with water molecules to form a second reducing radical, 8-hydroxy-7,8-
dihydroguanyl (G-OH•).  Oxidation of G-OH• forms the 8-oxodG. The latter pathway 
involves singlet oxygen mediated cycloaddition of which may then undergo 
significant ring openings to make pairings with tandem bases and become privy to 
the cellular DNA sequence, ultimately leading to mutations and carcinogenesis (Jena 
and Mishra, 2012). Development of the 8-oxodG lesion is a hallmark of UVR induced 
oxidative stress and the most frequent form of DNA damage by UV-A (Pfeifer and 
Besaratinia, 2012, Cadet et al., 2003). 
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Figure ‎1.5 Formation of the 8-oxo-7,8-dihydroguanine from the guanine moiety 
(modified from (Ravanat et al., 2001)) 
 
Until recently, the general consensus was that all CPDs are a result of direct UVR 
absorption by DNA, however studies from our laboratory by Gordon Thomson et al 
(2012) have shown that a small proportion of these lesions are produced by the 
indirect metabolic effects of UVR. Using both the classic monoclonal antibody 
immunohistochemical staining comet assay technique, it was shown that inhibitors 
of metabolism, such as low temperature (4C) and sodium azide, reduced the 
presence of CPDs in UVR-exposed keratinocytes (Gordon-Thomson et al., 2012). 
Moreover, inhibitors of the nitric oxide synthase pathway attenuated CPD 
formation following UVR, whilst peroxynitrite donors caused an accumulation of 
CPDs in unirradiated keratinocytes.  
 DNA damage repair 1.2.4
Cells exposed to UVR show an upregulation of p53 tumour suppressor gene activity. 
The p53 gene encodes for a phosphoprotein which plays a role in cell cycle arrest, 
allowing for increased time for DNA repair and where this is not possible, the 
induction of apoptotic pathways. Before cells can synthesise DNA in the S-phase of 
the cell cycle growth is arrested in the G1 phase where lesions are recognised and 
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removed via mechanisms involved in DNA damage repair (DDR) (Melnikova and 
Ananthaswamy, 2005). Amongst the base excision repair (BER) and mismatch repair 
(MMR) methods of repair, nucleotide excision repair (NER) is the main repair 
complex associated with direct UVR-induced DNA photoproducts, notably, CPDs 
and 6-4PPs (Friedberg, 2001). There are two sub pathways of NER, transcription-
coupled NER (TC-NER) which directly removes lesions from the transcribed strand of 
the gene of interest, and the slower, less efficient global genome NER (GG-NER), 
removing the lesion from the untranscribed chromatin of the whole gene 
(Hanawalt, 2002). 
 
The mechanism of action of the NER is a five step process which begins at 
recognition of the damage by the XPC-HHR23B protein complex in GG-NER, or by 
elongating RNA polymerase II in TC-NER (de Laat et al., 1999). Following 
identification, the pathways follow identical steps in purging the lesion. DNA is 
locally unwound at the site of damage, following which ~30 nucleotides surrounding 
and including the damaged DNA are incised XPF/ERCC1 (excision repair cross-
complement gene1) and XPG endonucleases, at the 5’ and 3’ ends respectively 
(Shivji et al., 1995). Damaged DNA is removed and de novo synthesis of DNA ligase 
is formed to replace the excised lesion and allow for safe transcription of the gene 
(Matsumura and Ananthaswamy, 2002). 
 
Several diseases associated with a faulty NER complex elucidate its vital importance 
in preventing mutagenesis. Xeroderma pigmentosum (XP) results from a defect in 
the any one of the eight XP enzymes and associated genes affecting both 
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subpathways of NER. Phenotypes of the autosomal recessive disease show 
hypersensitivity to light and predisposition to amplified formation of squamous and 
basal cell carcinomas and malignant melanomas (Lehmann, 2003). In a similar vein, 
Cockayne syndrome (CS) is manifest when there is a mutation in the TC-NER 
associated RNA polymerase recognition signal proteins CS-A and CS-B. CS patients 
lose the ability to recover from UVR exposure and display increased sensitivity to 
UVR evident with a severe rubor rash, and developmental and neurological 
retardation (de Laat et al., 1999). 
 
Oxidative damage lesions resulting from UVR such as 8oxodG are not repaired by 
NER, rather they are excised and removed by the actions of BER (Melnikova and 
Ananthaswamy, 2005). In this instance, increase DNA single strand breaks are 
recognised and cleaved by a DNA glycosylase, which releases separates the N-
glycosyl bond between the damaged base and the backbone of the helix. An abasic 
(apurinic/apyrimidinic (AP)) site is formed and recognised by either an AP 
endonuclease or AP lyase which cleave and remove the site completely. DNA 
polymerase  catalyses the release of deoxyribophosphate (dRP) from the one base 
gap site, which aids in polymerisation of new DNA to fill in the gap, using XRCC1 as a 
scaffold, whilst also ensuring complete removal of the AP site (Robertson et al., 
2009). DNA ligase 3 then forms a nucleotide patch to fill in the DNA strand (Rastogi 
et al., 2010). 
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 Apoptosis 1.2.5
When DNA damage cannot be repaired, pre-programmed cellular UV responses are 
initiated to remove the damaged cells and prevent transcription of malignancies in 
daughter cells, instead forming the apoptotic “sunburn cell” (Lippens et al., 2009, 
Kulms and Schwarz, 2000). Apoptosis is a complex process involving several 
signalling pathways which ultimately lead to the activation of caspases, a hallmark 
of programmed cell death. Following UVR exposure, apoptotic pathways may be 
activated by direct UVB radiation, or in a p53 way manner from extensive DNA 
damage or via indirect reactive oxygen species (ROS) generation (Melnikova and 
Ananthaswamy, 2005, Van Laethem et al., 2009).  
 
There are two procaspase apoptotic pathways, extrinsic (death receptor (DR) 
associated) initiated by a foreign ligand, and intrinsic (mitochochondria) induced by 
self-induced intracellular cascades. The intrinsic pathway is initiated following UVB 
activation of p38 mitogen activated protein kinase (MAPK) signalling. The MAPK 
signaling cascade includes three distinct stages of protein kinase activation; a 
mitogen-activated extracellular signal-regulated kinase kinase kinase (MEKK), which 
activates a mitogen-activated extracellular signal-regulated kinase kinase (MEK) 
which can subsequently activate a MAPK. MAPKs include c-jun-N-terminal kinase 
(JNK), extracellular signal-regulated kinase and p38 MAPK. These kinases are widely 
located in keratinocytes and are targeted by various extracellular stimuli, including 
UVR (Assefa et al., 2005) as shown in figure 1.6. P38 MAPK causes the translocation 
of Bax, a proapoptotic protein, from the cytoplasm to the mitochondria 
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(Muthusamy and Piva, 2010, Van Laethem et al., 2009).  Bax makes the 
mitochondria permeable, releasing cytochrome c and oxygen free radicals  (Van 
Laethem et al., 2009, Kulms and Schwarz, 2002).  Expression of apoptosis activating 
factor 1 (APAF-1) increases which together with cytochrome c forms the 
apoptosome, recruiting procaspase 9 and 3, leading to the final executioner caspase 
cascade. Mitochondrial induced apoptosis is heavily regulated by anti- and pro-
apoptotic Bcl family proteins (Van Laethem et al., 2005). Additionally, ROS 
generated by UVR contributes to the activation of p38 MAPK (Van Laethem et al., 
2009). 
 
Apoptosis initiated by unrepairable DNA damage occurs via p53 induced 
upregulation of cytochrome c release from the mitochondria and interaction with 
Bcl proteins which in turn regulate subsequent caspase pathways. Death receptors 
are part of the tumour necrosis factor (TNF) superfamily, including TNF-receptor 1, 
Fas, and TNF-Related Apoptosis-Inducing Ligand receptors 1 and 2 (TRAIL1/2), are 
located on the cell surface membrane. DRs are activated following exposure to UVB 
by either a UVB-induced receptor cluster formation on the cell membrane, allowing 
ligand-independent signal transduction or via their natural ligands, released from 
the DNA damaged cell (Van Laethem et al., 2009, Kulms and Schwarz, 2000). 
Subsequent signalling pathways involving Jun N-terminal kinase (JNK) lead to the 
activation of caspase 3 (Kulms and Schwarz, 2002). Like p38 MAPK, UVR-activated 
JNK can translocate to the nucleus of the cell to initiate transcription of target genes 
resulting apoptosis (Assefa et al., 2005, De Haes et al., 2003, Bode and Dong, 2003). 
Whilst both intrinsic and extrinsic pathways contribute to the induction of 
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executioner caspases, it has been suggested that UVB-induced apoptosis is 
mediated mainly by the intrinsic pathway (Kulms and Schwarz, 2002, Van Laethem 
et al., 2009) 
 
Figure ‎1.6 Signalling pathways activated by UVR that contribute to apoptosis 
(Muthusamy and Piva, 2010). 
 
There are several cellular signalling proteins involved in protection against 
apoptosis. The phosphatidylinositol 3-kinase/Akt (PI3K/Akt) pathway is activated 
through the MAPK pathway during apoptotic signalling, acting as a balance to 
prevent apoptosis by inhibition of mitochondrial cytochrome c release and blocking 
the recruitment of procaspase 9 and 3 allowing progression of the cell cycle 
(Muthusamy and Piva, 2010, Wang et al., 2003). Extracellular signal regulated 
kinase (ERK) isoforms are also antiapoptotic by inhibiting the activity of executioner 
caspase 3. The PI3K/Akt pathway is also basally active at a low level in epidermal 
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keratinocytes and ERK and Akt are upregulated by UVR (Peus et al., 1999, Wang et 
al., 2003, Wan et al., 2001). Both ERK and Akt help maintain epidermal cell 
proliferation and cellular survival in response to extracellular insults (Diker-Cohen et 
al., 2006). Akt is known to inhibit glycogen synthase kinase-3 (GSK-3), which then 
frees -catenin to induce transcription of proto-oncogenes involved in cell growth 
(Cross et al., 1995). The significance of this lies in the fact that this may be a 
pathway for the development of cancerous cells and the progression to 
photocarcinogenesis. However, the potency of ERK in preventing apoptosis 
following UVB may be decreased due to its tendency to be down-regulated 
(Melnikova and Ananthaswamy, 2005). Similarly, activation of JNK by UVR, has been 
shown to inactivate ERK and Akt, suggesting that the apoptotic pathway dominates 
survival if UVR dosage is sufficient (Wang et al., 2012b). 
 
“Sunburn” cells exhibit the general morphology of apoptotic cells. Appearing firstly 
in the proliferative basal layer, sunburn cells exhibit pyknotic nuclei and membrane 
blebbing. Caspases use keratin and actin filaments as cleavage substrates, which 
results in cytoskeletal changes that differentiate sunburn cells from cornified cells 
(Lippens et al., 2005). 
 Immunosuppression 1.2.6
UVR diminishes the power of the body’s immune response, allowing malignant DNA 
damaged cells to evade normal immunological elimination, leading to the formation 
of cancerous tumours. Immunosuppression following UVR exposure is often 
measured using the delayed-type hypersensitivity (DHR) or contact hypersensitivity 
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(CHS) tests (Rangwala and Tsai, 2011). In both tests, immune responses to a 
presenting antigen are significantly depressed, both locally, sites previously exposed 
to UVR, and systemically, non-irradiated sites (Murphy, 2009). It has been 
postulated that this may be due to disabled T cell-mediated immunity (Reeve, 
2002). 
 
UVR causes immunosuppression via a number of different pathways. Firstly, DNA 
damage is a potent stimulator of immune suppression. Cells containing CPDs unable 
to be repaired by NER decrease the reaction to CHS (de Gruijl, 2008, Kripke et al., 
1992). Secondly, Langerhans cells, the main antigen presenting cells of the 
epidermis, are vulnerable to distinct changes in their morphology and functionality 
following even slight UVB exposure. UVB radiation reduces the expression of cell 
surface markers and damages well established dendritic networks, ultimately 
depleting Langerhans cell numbers, reducing their antigen presenting capabilities 
(Aubin, 2003, Murphy, 2009). Lastly, UVR-exposed keratinocytes, particularly those 
with CPDs directly secrete immunoregulatory cytokines such as interleukin-10 (IL-
10), or mediators which stimulate its secretion from other cells (Beissert and Loser, 
2008). Once in the bloodstream, IL-10 acts as an immunoregulatory factor, which 
induces systemic immunosuppression via reducing antigen presentation in 
Langerhans cells (Aubin, 2003). Furthermore, the reduced immunosurveillance 
provided by Langerhans cells result in decreased effector T cell proliferation and 
differentiation and ultimately decreased antitumoural immune protection (Loser 
and Beissert, 2009). Recently it has been shown in murine epidermis that following 
UVR exposure, production of RANKL, a TNF family member is upregulated, and 
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binds to its RANK receptor of Langerhans cells (Beissert and Loser, 2008).  RANKL 
binding increases secretion of IL-10, amongst other immune related cytokines, 
which contribute to systemic immunosuppression, and formation of skin tumours. 
 
Another contributor to the inhibition of antigen presentation in Langerhans cells is 
the development of cis-urocanic acid. UCA, an isomer present in the stratum 
corneum, undergoes photoisomerisation following UVB exposure from stable trans-
UCA to cis-UCA, making it a powerful immunosuppressive agent (Hart et al., 2001). 
 Photocarcinogenesis 1.2.7
While acute UVR photoresponses appear to disappear within a few days, chronic 
and overexposure to UVR may result in genetic defects leading to the progression of 
premalignant actinic keratoses (AK) and ultimately squamous cell carcinomas (SCC), 
known as photocarcinogenesis (Melnikova and Ananthaswamy, 2005), as shown in 
figure 1.7 In acute UVR exposure, the p53 tumour suppressor gene is highly 
upregulated, however in UV-induced skin cancers it is commonly mutated and 
suppressed (Lee et al., 2003).  Cells containing p53 mutations do not undergo cell 
cycle arrest to facilitate DNA repair to remove “UV-signature mutations”, and avoid 
p53 induced apoptosis. Damaged cells are able to proliferate and graduate onto 
becoming premalignant AK lesions (Melnikova and Ananthaswamy, 2005). p53 
mutations occur early in the development of squamous cell carcinomas, often 
occurring in seemingly normal UV exposed murine skin months before the 
appearance of a tumour (Hussein, 2005). Similarly, chronically UVR exposed cells 
exhibit deregulated and inhibited Fas expression on the surface membrane, 
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allowing cells to resist extrinsic mechanisms of apoptosis and contribute to the 
malignant cell population of the skin (Melnikova and Ananthaswamy, 2005). In 
addition, persistent oxidative damage by chronic UVA radiation may result in the 
activation of protooncogenes commonly found in skin cancers such as c-fos and c-
jun (Nishigori, 2006). 
 
 
Figure ‎1.7 UV-induced initiation and progression of a human squamous cell 
carcinoma (modified from Melnikova and Ananthswamy, 2005). 
 
Skin cancers are generally divided into two groups; melanoma skin cancers (MSC) or 
non-melanoma skin cancers (NMSC), which include squamous cell carcinomas (SCC) 
and basal cell carcinomas (BCC). The current study will focus primarily on the events 
leading to the development of squamous cell carcinomas. 
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 Gender bias in photocarcinogenesis 1.2.8
In general, females with cancer are faced with a better prognosis than males with 
cancer (Molife et al., 2001). The prevalence of NMSCs, especially SCCs, are generally 
higher in the male population than in females (Foote et al., 2001, Preston and Stern, 
1992). This is particularly evident in the Australian population (Staples et al., 1998, 
Staples et al., 2006). It is evident that cutaneous melanoma also follows a similar 
trend, often occurring in the later decades of life, and in higher numbers in men 
than women (Leiter and Garbe, 2008). In humans, this has been attributed to male 
susceptibility to be exposed to more sun and not using sun protection, however 
recent studies have shown that there may be underlying biological characteristics 
that are involved in increasing proneness for SCCs.  
 
In study by Thomas Ahner and colleagues (2007), using a well established 
photocarcinogenesis mouse model, it was shown in a laboratory setting that male 
Skh:Hr1 mice exposed to UVR exhibit a greater number of SCC tumours compared 
to their female counterparts (Thomas-Ahner et al., 2007). Pro-carcinogenic DNA 
damage was seen as early as 48 hours following UVR exposure, with 8oxodG 
production greater in male mice than female mice. In a similar vein, the cutaneous 
inflammatory reaction to UVB was greater in females compared to males, 
suggesting that females are less immunosuppressed by UVB, which may be 
protective against malignant cell growth, progressing to cancer (Thomas-Ahner et 
al., 2007, Damian et al., 2008).   
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It has recently been discovered that the predominant steroid receptor in human 
skin is the oestrogen receptor- (ER-), in addition to ER-, which plays a role in the 
hair follicle growth cycle (Pelletier and Ren, 2004, Thornton et al., 2003b, Thornton 
et al., 2003a). Evidence suggests that activation of the ER- by agonist ligands has 
several anti-inflammatory and anti-carcinogenic properties (Catley et al., 2008, 
Cotrim et al., 2013). In addition, ER- signalling has proven to be effective at 
reducing immunosuppression in mice following exposure to UVR (Widyarini et al., 
2006) and the loss of ER- results in an increased expression of immunosuppressive 
cytokine IL-10 (Reeve et al., 2009).  Use of both oestrogen and phytoestrogen has 
proven to be anti-carcinogenic in mice exposed to UVR, whilst disruption of 
estrogen receptor signalling allowed the growth of transplanted tumours in murine 
skin (Cho et al., 2010, Widyarini et al., 2006). A very recent paper has suggested that 
a potential protective mechanism of ER- signalling is via downregulation of 
PI3K/Akt phosphorylation subsequently leading to inhibition of Wnt and -catenin 
activity which reduces SCC tumour cell survival (Chaudhary et al., 2013). 
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1.3 VITAMIN D – THE SUNSHINE VITAMIN 
 Background 1.3.1
Vitamin D exists in two forms, vitamin D2 (ergocalciferol) and vitamin D3 
(cholecalciferol). This fat soluble secosteroid may be obtained through dietary 
sources, plant or animal products respectively, or via biological production following 
skin exposure to UVR. Technically speaking, vitamin D is not a true vitamin, rather a 
hormone due to its ability to be synthesised in skin (Malloy et al., 1999). 
 Structure 1.3.2
The molecular structure of the vitamin D compound family, including the active 
metabolite, 1α,25-dihydroxyvitamin D3 (1,25(OH)2D), is chemically related to that of 
classical steroid hormones through its basis around a steroid hormone specific 
cyclopentanoperhydrophenanthrene 4 ring carbon skeleton (Norman et al., 1999). 
However, unlike its steroidal relatives, the 9-10 carbon-carbon bond of ring B is un-
joined, designating vitamin D into the secosteroid category. This is shown in figure 
1.8.  
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Figure ‎1.8 Chemical structure of the vitamin D metabolite 1,25(OH)2D3 (Okamura 
et al., 1995). 
In comparison to their classical steroid counterpart, molecules of the vitamin D 
superfamily are particularly conformationally flexible, due to three major structural 
regions of its carbon skeleton. Firstly, simple rotation of the 8-carbon side chain 
about the 5 carbon-carbon single bond allows for a plethora of differing molecular 
shapes. Additionally, as a result of the 9-10 carbon-carbon breakage, the 
cyclohexane-like A-ring is liberated from the B-ring and undergoes rapid 
interconversion between chair-chair conformers.  The mobility of the A-ring results 
in orientation of the 1-hydroxyl and 3-hydroxyl to move between axial and 
equatorial. Finally, the seco B-ring rotates freely around its 6-7 single carbon bond, 
producing 6-s-cis and 6-s-trans variates of conformation, which may be locked or 
flexible (Norman et al., 1999, Norman et al., 2001), shown in figure 1.9. It is the 
conformational flexibility of the vitamin D3 backbone, which allows for the 
generation of a vast number of ligand shapes, able to generate different biological 
responses through the vitamin D receptor (VDR).  
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Figure ‎1.9 Conformational flexibility of 1,25(OH)2D (Haussler et al., 2011) 
 
 Synthesis 1.3.3
As sunlight strikes skin cells, epidermal and dermal stores of 7-dehydrocholesterol 
(7-DHC) absorb UVB photons. Absorption of UV energy results in the cleavage of the 
9-10 carbon-carbon bond of the B-ring of 7-DHC to form the thermally unstable pre-
vitamin D3 (pre-D) molecule (Holick et al., 1980). In human skin the highest levels of 
pre-D  following UV irradiation are found in the stratum spinosum and basale cells 
of the epidermis (Holick, 1981). Pre-D is thermally isomerised over hours and days, 
at the optimal temperature of 37°C, to vitamin D3 which is released from the lipid 
bilayer into the extracellular space. Over exposure to UVR does not result in vitamin 
D toxicity, as pre- D and vitamin D absorb UVB photons and produce photoproducts 
such as lumisterol and tachysterol. Such products are thought to be biologically 
inert, with low calcemic capabilities (Holick, 2004). 
 
Vitamin D3 binds to the vitamin D-binding protein (DBP) in the dermal capillary bed, 
moving the biologically inactive vitamin D3 molecule into the bloodstream to target 
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organs of the vitamin D endocrine system for metabolism into a more active form 
(Holick, 2004). Similarly, dietary vitamin D (D2 or D3) absorbed through the small 
intestine and into the circulation is picked up by DBP (Lehmann and Meurer, 2010). 
In the liver, vitamin D is hydroxylated by the cytochrome P450 enzyme 25-
hydroxylase at the carbon-25 position to form 25-hydroxyvitamin D (25(OH)D). 
25(OH)D is transported to the kidney via DBP and undergoes further hydroxylation 
at the carbon-1 position by 25-hydroxyvitamin D-1-hydroxylase (1-hydroxylase) 
forming the biologically active 1-25-dihydroxyvitamin D3 metabolite (1,25(OH)2D; 
calcitriol) (Lehmann, 2003). In this active form, 1,25(OH)2D is able to induce 
biological responses throughout the body through organs expressing the vitamin D 
receptor (VDR). Renal formation of the active 1,25(OH)2D is tightly regulated by 
serum calcium levels via circulating parathyroid hormone (Lehmann and Meurer, 
2010). 
 
In addition to the hepatic/renal production of 1,25(OH)2D, several tissues have 
recently been discovered to contain either or both the aforementioned 
hydroxylation enzymes (Holick, 2004, Bikle et al., 1986). In particular it has been 
shown that epidermal cells contain the whole vitamin D production pathway, 
beginning with 7-DHC, including both 25-hydroxylase and 1-hydroxylase enzymes, 
ending in 1,25(OH)2D. There has also been evidence for fibroblasts containing 25-
hydroxylase, thus making more 25(OH)D available to neighbouring keratinocytes 
(Vantieghem et al., 2006). Such a symbiotic relationship between skin cells suggests 
that production of 1,25(OH)2D is important in the body’s autonomous protection 
from the sun. 
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To avoid hypercalcaemia, catabolism of 1,25(OH)2D and 25(OH)D occurs in most 
cells via negative feedback activation of the 24-hydroxylase enzyme to form inactive 
metabolites when there are high levels of 1,25(OH)2D. This system is inhibited when 
levels of calcium and PTH are low (St-Arnaud, 2008). 
 Transduction pathways 1.3.4
1,25(OH)2D is the predominant structural ligand of the vitamin D3 endocrine system. 
It exerts its biological effects via two pathways, shown in figure 1.10; a genomic 
pathway mediated by the well known nuclear VDR, and a non-genomic/rapid 
response pathway whose receptor is currently not established (Mizwicki and 
Norman, 2009, Nemere et al., 1984, Norman et al., 1999, Nemere et al., 1994, 
Zanello and Norman, 2004a).   
 
1.3.4.1 Vitamin D Receptor (VDR) 
As a nuclear receptor of the steroid family, the VDR is found in nucleated cells in 
most tissues of the human body including the intestine, kidney, bone, skin, 
parathyroid gland, pancreas, pituitary, cells of the immune and reproductive 
systems, amongst others (Wang et al., 2012c, Norman, 2008). The VDR is made up 
of six primary amino acid domains each designated a different functionality, 
specifically, a variable domain (A/B), a DNA binding domain (C), a hinge (D), a ligand 
binding domain (E) and a transcriptional activation domain (F) (Norman, 2008). 
 32 
 
1.3.4.2 Genomic pathway 
The biological responses of 1,25(OH)2D are mediated by the classic genomic 
pathway through stereospecific ligand binding to the nuclear vitamin D receptor 
(VDRnuc). The lipophilic 1,25(OH)2D molecule passes through the lipid bilayer of the 
plasma membrane and binds to the hydrophobic pocket in the ligand binding 
domain of the VDRnuc. Upon activation, the VDRnuc heterodimerises with a free 
retinoid X receptor (RXR) forming a VDR-RXR complex. Zinc fingers of the DNA 
binding domain recognise the VDR-RXR complex, allowing docking with vitamin D 
response elements (VDREs) in the DNA sequences of vitamin D target genes. 
Subsequent recruitment of protein comodulators assists interaction with the 
general transcription apparatus wherein gene transcription is promoted or 
repressed (Haussler et al., 2011). Resulting physiological effects are latent 
manifestations of genetic alterations.   
1.3.4.3 Non-genomic pathway 
The non genomic pathway activated by 1,25(OH)2D generates a biological response 
within seconds to minutes through a number of intracellular signalling pathways 
(Norman et al., 1999, Haussler et al., 2011, Norman, 2008). These include the 
opening of chloride and calcium channels, mitogen activated protein kinases 
(MAPKs), protein kinase C, phosphatidylinositol 3-kinase (PI3K), phospholipase C, 
and subsequent g-protein coupled second messenger systems such as cyclic 
monophosphate (cAMP). Activated messenger systems may cross talk with the 
nucleus to contribute to gene transcription (Norman, 2008). 
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The location of a binding protein/receptor via which 1,25(OH)2D  exerts its rapid 
response effects is still under examination. There is evidence for a rapid response 
binding protein for 1,25(OH)2D, first identified in the basolateral membrane of chick 
epithelium, involved in rapid calcium perfusion from the duodenum (Nemere et al., 
1994). Subsequent purification of the protein led to its definitive identification as 
the 66kD membrane-associated rapid response steroid binding (MARRS) protein, 
identical to ERp57/PDIA3 (Nemere et al., 2000). 
 
In the last decade, it has been proposed that the rapid actions of 1,25(OH)2D may 
occur via a putative alternative ligand binding pocket  within the ligand binding 
domain of the VDR (Mizwicki et al., 2004). Through molecular modelling, the natural 
6-s-cis locked analogue of 1,25(OH)2D, 1,25 dihydroxylumisterol3 (JN) which has 
weak genomic activity but equivalent 1,25(OH)2D rapid signalling, was shown to 
dock on the classic VDR through a pocket other than the genomic pocket to elicit its 
non-genomic cellular responses. The flexible 1,25(OH)2D  molecule was found to 
have a high affinity for both, with differing modes of binding. It is thought that 
vitamin D sterol binding at the VDR occurs kinetically through the AP, whilst in a 
thermodynamic manner at the GP, and thus subsequent responses are highly 
dependent on the conformation and orientation of the ligand present  (Mizwicki et 
al., 2004, Mizwicki and Norman, 2009). The AP prefers the planar 6-s-cis locked non-
genomic agonist vitamin D sterols, such as JN, whilst the bowl shaped GP binds 6-s-
trans conformed isomers of 1,25(OH)2D. The conformationally flexible 1,25(OH)2D  
molecule can take up both structures, thus making it the most potent agonist for 
both genomic and non-genomic biological responses. The AP forms complexes with 
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an array of 1,25(OH)2D  molecule conformations, whilst the GP is more restricted 
with its binding affinity (Mizwicki and Norman, 2009).   
 
Evidence for a bi-functional VDR comes from a study showing increased 1,25(OH)2D 
induced rapid chloride fluxes in wild type mouse osteoblasts, whilst mouse 
osteoblasts lacking a functional VDR showed no response (Zanello and Norman, 
2004a).  The VDR-KO mouse strain used in the aforementioned study were 
previously reported to exhibit genetic defects similar those seen in human vitamin 
D-resistant rickets type II, such as alopecia, growth retardation, impaired bone 
formation and rickets, amongst many others (Yoshizawa et al., 1997). 
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Figure ‎1.10 The genomic and non-genomic pathways of vitamin D actions (Mason, 
2010) 
 
 Actions 1.3.5
The classic role of 1,25(OH)2D is to work synergistically with parathyroid hormone 
(PTH) to maintain normal calcium homeostasis. When serum calcium levels fall 
below normal levels, PTH stimulates the formation of 1,25(OH)2D from the kidney 
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to act on the small intestine to increase intestinal absorption of calcium. In turn 
1,25(OH)2D encourages the maturation of osteoclasts resulting in bone resorption 
(St-Arnaud, 2008). 1,25(OH)2D also facilitates healthy skeletal growth and 
mineralisation by increasing absorption of phosphate, and promoting 
osteoblastogenesis (Marie and Kassem, 2011, Bikle, 2012).  Additionally, 1,25(OH)2D 
prevents apoptosis in osteoblasts (Vertino et al., 2005). In skin 1,25(OH)2D regulates 
keratinocyte proliferation, stimulates differentiation and maintains normal hair 
follicle cycling (Bikle, 2011a). Immunologically, the adaptive immune response is 
inhibited by 1,25(OH)2D, which in turn prevents autoimmunity and the diseases that 
follow. In a similar vein, 1,25(OH)2D stimulates innate immunity to aid in the 
prevention of infectious diseases (Bikle, 2011b). 1,25(OH)2D maintains an 
antiproliferative effect on most cells by slowing cell cycle progression at the G1 
phase, which make it a novel candidate for the treatment of diseases involving 
uncontrolled malignant cell growth such as cancer (Samuel and Sitrin, 2008). 
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1.4 PHOTOPROTECTION BY VITAMIN D 
The use of 1,25(OH)2D as a chemoprotective agent has been reported and accepted 
in several cancer types. In particular, over the last decade research into the use of 
vitamin D compounds to combat the formation of skin cancers has boomed, due to 
the depletion of the ozone layer and increasing number of worldwide skin cancer 
cases.  
 1,25(OH)2D  mediated protection against UVR-induced DNA damage, 1.4.1
apoptosis and immunosuppression   
Studies from the Mason group have shown that application of 1,25(OH)2D at 
physiological concentrations (10-9) to cultured keratinocytes either before, or 
immediately following UVR exposure (200 mj/cm2 UVB and 1170 mj/cm2 UVA) 
significantly reduces the formation of thymine dimer CPDs as early as 0.5-3 hours 
post-UVR, when compared to vehicle treated skin cells, detected using 
immunohistochemistry (Gupta et al., 2007, Wong et al., 2004, Sequeira et al., 
2012b). In addition to this, in vivo experiments in hairless mice from the group have 
supported these findings, and provided a novel photocarcinogenesis study showing 
evidence for 1,25(OH)2D prevention of SCCs in murine skin (Dixon et al., 2011). 
 
Using immuno dot-blot densitometric analysis, De Haes and colleagues were also 
able to show a significant reduction in CPD formation following UVR when cells 
were pre-incubated with 1,25(OH)2D for at least 18 hours prior to irradiation. In this 
study, maximal protection occurred at the pharmacological concentration of 10-6  
(De Haes et al., 2005). Whilst the data support the work of the Mason group, use of 
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pharmacological concentrations may not be viable in humans due to the hormone’s 
hypercalcaemic toxicity.  
 
In vivo and in vitro results from several groups have exposed a role for 1,25(OH)2D 
in the reduction of apoptotic sunburn cells and enhancement of keratinocyte 
survival following UVR (Manggau et al., 2001, Gupta et al., 2007, De Haes et al., 
2004a, Lee and Youn, 1998, De Haes et al., 2003, Dixon et al., 2011). On the other 
hand, one study by Benassi and colleagues using TUNEL assays, suggests that 
application of 1,25(OH)2D on keratinocytes increases apoptosis to a similar extent as 
UVB radiation (Benassi et al., 1997). This study however used high concentrations of 
1,25(OH)2D and did not test the extent of apoptosis of when the two variables were 
combined. 
 
UVR increases the formation of NO in skin, which interacts with ROS such as the 
superoxide anion generated by UVR to form peroxynitrite (Ravanat et al., 2001). 
Peroxynitrite belongs to the reactive nitrogen species (ROS) known to cause single 
strand DNA base mutations. In addition, presence of NO in skin cells prevents the 
repair of CPDs following UVR (Bau et al., 2001). The Mason group explored the 
effect of physiological doses of 1,25(OH)2D on combating the effects of indirect DNA 
damage by UVR-instigated ROS and RNS. In one study, using the Griess assay to 
detect nitrite levels it was found that application of 1,25(OH)2D following UVR 
exposure significantly increased the stable metabolite, in turn decreasing available 
NO products, as well as reducing CPD and sunburn cell formation (Gupta et al., 
2007). 
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More recently it was established using comet assays and immunohistochemical 
staining that 1,25(OH)2D reduces the appearance of 8oxodG mutations in 
keratinocytes as early as 0.5 hours following UVR (Gordon-Thomson et al., 2012).  
The same study showed that topical application of a physiological dose of 
1,25(OH)2D to hairless albino mouse skin significantly reduced appearance of 
8oxodG positive keratinocytes. Human skin explants exposed to UVR equivalent to 
Australian summer sun for 5-10 minutes showed significant decreases in the 
formation of CPDs, 8oxodG and 8-nitroguanosine mutations with the application of 
1,25(OH)2D at 1nM when compared to their vehicle counterparts at various time 
points following UVR (Song et al., 2012). 
 
Dixon and colleagues have shown that topical application of 1,25(OH)2D on hairless 
albino mice following UVR reversed systemic immunosuppression seen in untreated 
mice, 2 weeks after UVR (Dixon et al., 2007). 
 Mechanisms of 1,25(OH)2D 1.4.2
It is generally accepted that photoprotection by 1,25(OH)2D occurs substantially via 
the non-genomic pathway (Mason et al., 2010).  In the in vivo and in vitro studies by 
Dixon and colleagues, 1,25-dihydroxylumisterol (JN), a vitamin D analogue, with 
only the ability to induce the rapid response pathway decreases the formation of 
CPDs and apoptosis at the same physiological concentration of 1,25(OH)2D 
following UVR, with statistically equivalent potency (Dixon et al., 2007, Dixon et al., 
2005, Dixon et al., 2011). 
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Use of non-genomic antagonists completely reversed photoprotection by 
1,25(OH)2D whilst antagonists of the genomic pathway had no effect (Dixon et al., 
2007). 
 
Previous studies from this laboratory have shown that 1,25(OH)2D-mediated 
photoprotection against UV irradiation occurs via a non-genomic pathway (Dixon et 
al., 2007, Dixon et al., 2005, Wong et al., 2004, Sequeira et al., 2012a, Sequeira et 
al., 2012b). A number of reports on the actions of 1,25(OH)2D binding to a putative 
mVDR suggest that 1,25(OH)2D activates rapid ionic and molecular signalling 
pathways. These include the induction of protein kinase C, the mitogen activated 
protein kinase (MAPK) and phosphatidylinositol 3-kinase (PI3K) pathways and the 
opening of chloride and calcium channels (Norman et al., 2001). 
 
The role of the VDR in the non-genomic pathway is not completely understood, 
however recent evidence to suggest the location of the classic nuclear VDR present 
within plasma membrane caveolae which binds 1,25(OH)2D, and mediates its non-
genomic activity (Huhtakangas et al., 2004, Norman et al., 2002). Molecular 
modelling experiments identified alternative ligand-binding pockets within the VDR, 
distinct from the classic ligand binding domain, which have a high affinity for both 
trans- and cis-locked ligand shapes of 1,25(OH)2D and analogues (Mizwicki et al., 
2004). 
 
Additionally, it is well established that some non-genomic actions of specific 
1,25(OH)2D occur via specific 6-cis-locked molecular shapes binding to a membrane 
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associated rapid response steroid binding protein (MARRS), also known as ERp57. It 
has recently been shown through co-immunoprecipitation that the VDR and ERp57 
are physically linked. Sequeira and colleagues (2012b) found that in terms of 
photoprotection, blockade of ERp57 by Ab099, a neutralising antiserum, reduced 
the effectiveness of 1,25(OH)2D in reducing thymine dimer formation in UVR-
exposed fibroblasts (Sequeira et al., 2012b). This shows strong evidence for the role 
of the non-genomic pathway in photoprotection by 1,25(OH)2D and 1,25(OH)2D -
analogues.  
 
Previous reports have established that diisothiocyanatostilbene-2,2’-disulfonic acid 
(DIDS) inhibits 1,25(OH)2D non-genomic activation of chloride currents (Mizwicki et 
al., 2010, Zanello and Norman, 2004b, Zanello and Norman, 1997, Zanello and 
Norman, 1996, Zanello and Norman, 2006, Zanello and Norman, 2003).  One recent 
study from the Mason group showed that in keratinocytes, the presence of DIDS 
completely abolished 1,25(OH)2D -mediated reduction of thymine dimers following 
UVR, but had no effect on its own (Sequeira et al., 2012b). This suggests that the 
photoprotective effects of 1,25(OH)2D are mediated by the opening of these DIDS-
sensitive non-genomic chloride channels.  
 
Both UVR and 1,25(OH)2D enhance the expression of p53 in both melanocytes and 
keratinocytes as seen in studies by Gupta et al. (2007) and Sequeira et al. (2012a). 
This suggests that cells undergo longer cell cycle arrest, to allow for increased time 
to repair DNA damage, by XPC and DDB2 nucleotide excision repair enzymes, and 
reduce the need to form sunburn cells (Gupta et al., 2007). However, since the 
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study by Sequeira et al (2012b) demonstrated that p53 expression remained high in 
VDR null and ERp57 antiserum Ab099 treated fibroblasts, and displayed high 
numbers of thymine dimers following treatment with 1,25(OH)2D after UVR 
exposure, this hints at the presence of an alternate mechanism of thymine dimer 
reduction (Sequeira et al., 2012a). 
 
Studies by de Haes and colleagues used pathway inhibitors to show evidence for 
1,25(OH)2D induced inhibition of mitochondrial cytochrome c release, the JNK stress 
activated pathway and the production of IL-6, which led to a partial reduction in 
apoptotic cells post UVR (De Haes et al., 2003). In addition, 1,25(OH)2D activated 
anti-apoptotic PI3K/Akt and ERK signalling pathways and Bcl2 proteins from basal 
levels to enhance cell survival following UVR (De Haes et al., 2004a, De Haes et al., 
2003). The application of pharmacological inhibitors of ERK and PI3K somewhat 
reversed photoprotection against UVR-induced apoptosis, suggesting that 
1,25(OH)2D is photoprotective via the MEK/ERK and PI3K/Akt signalling pathways 
(De Haes et al., 2004a). Additionally, Western blotting showed that 1,25(OH)2D 
causes downregulation of JNK signalling following UVR, preventing JNK activated 
apoptosis (De Haes et al., 2003). While, on the other hand, UVR induced p38 
activation was not affected in the presence of 1,25(OH)2D (De Haes et al., 2003).   
 
Another proposed mechanism of photoprotection by 1,25(OH)2D is through the 
induction of metallothionein (MT) mRNA to reduce cell apoptosis (De Haes et al., 
2004b, Lee and Youn, 1998). One study noted that the reduction in apoptotic cells 
treated with 1,25(OH)2D following UVR resulted from the recruitment of 
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metallothionein, a free radical scavenger, to reduce ROS molecules contributing to 
apoptosis (Lee and Youn, 1998).  Mice lacking MT genes are generally more 
susceptible to UVR-induced immunosuppression, sunburn inflammation and 
apoptotic sunburn cells (Hanada et al., 1998, Reeve et al., 2000, Wang et al., 2004). 
Similarly, application of 1,25(OH)2D to skin cells induced sphingosine-1-phosphate 
(S1P), which is a regulator of cell survival by increasing Bcl-2 to reduce apoptosis 
(Manggau et al., 2001). 
 
In terms of 1,25(OH)2D and its immunomodulatory actions with UVR, there are 
mixed reports. Firstly, topical application of 1,25(OH)2D on Skh:Hr1 mice has been 
shown to prevent UVR-induced immunosuppression in mice, without having any 
basal immunosuppressive actions (Dixon et al., 2011, Dixon et al., 2005, Dixon et al., 
2007). On the other hand, there is evidence to suggest that 1,25(OH)2D at high 
doses is immunosuppressive in humans (Damian et al., 2010). Additionally, when 
used following UVR-exposure, it had no effect on immunosuppression whilst also 
providing protection from UVR-induced DNA damage and apoptosis (Damian et al., 
2010). In agreement with this, De Haes et al. (2003) and Mason et al. (2010) showed 
that 1,25(OH)2D suppressed levels of IL-6, a pro-inflammatory cytokine, in skin cells 
and mice respectively. IL-10 secretion, an immunosuppressive cytokine released 
from UVR-damaged cells is upregulated upon 1,25(OH)2D  application, as is the IL-10 
receptor on keratinocytes (Yu et al., 2011). Furthermore, 1,25(OH)2D suppresses the 
secretion of another pro-inflammatory cytokine, IL-12, from macrophages and 
dendritic cells, which then suppresses the activity of the T-helper cells involved in 
the acquired immune response (Bikle, 2009). An in vivo study has shown that 
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immunosuppressive T-regulatory cells are upregulated by 1,25(OH)2D (Gorman et 
al., 2007). 1,25(OH)2D also inhibits B cell proliferation and differentiation, and 
immunoglobulin production (Chen et al., 2007).  Thus the evidence leans towards 
1,25(OH)2D being immunosuppressive rather than protecting against 
immunosuppression in humans, which therefore shows the importance of finding a 
photoprotective analogue.  
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1.5 VITAMIN D-LIKE COMPOUNDS AND ANALOGUES 
Due to the fact that 1,25(OH)2D readily causes hypercalcaemia and because of its 
expensive price, the use of 1,25(OH)2D as a photoprotective agent in sunscreens is 
not viable. Thus it has become of increasing interest to discover alternative agents 
that are inexpensive and have low calcaemic activity. 
 20(OH)D3 1.5.1
Recent studies in vitamin D metabolism have exposed a novel role for a cytochrome 
P450 enzyme (CYP11A1) in the hydroxylation of vitamin D3 and its precursor 7-DHC. 
Known mostly for its role in oxidation and cleavage of the side chain on cholesterol 
to form pregnenolone, CYP11A1 also cleaves the side chain of 7-DHC and 
hydroxylates the side chain of vitamin D3 to produce over ten novel products, as 
shown in figure 1.11 (Slominski et al, 2012; Slominski et al, 2005; Guryev et al, 
2003). 20-hydroxyvitamin D3 (20(OH)D) has been identified as the main reaction 
product (Slominski et al., 2005). 
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Figure ‎1.11 CYP11A1 metabolism of vitamin D3 to 20(OH)D3 (Janjetovic et al., 
2009) 
 
Slominski et al (2012) provided in vivo evidence this novel pathway, using HPLC 
techniques, further identifying 20-hydroxyvitamin D3 (20(OH)D) as the major 
product of vitamin D3 metabolism by CYP11A1 in areas of the body expressing high 
levels of P450cc, such as the steroidogenic adrenal glands, placenta and germ cells 
which suggests it may produce systemic effects (Slominski et al, 2012). 
Furthermore, the CYP11A1 system has been shown to exist in the epidermal layer of 
the skin (Slominski et al., 1996, Slominski et al., 2004) and is upregulated upon 
UVB/UVC radiation (Skobowiat et al., 2011). 
 
20(OH)D is biologically active through binding to the VDR (Zbytek et al., 2008b, 
Tuckey et al., 2008b) however, knowledge of its biological significance is limited.  
Upon binding to the VDR, 20(OH)D can initiate heterodimerisation with the RXR to 
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increase inhibitor proteins for proliferation (Janjetovic et al., 2011b). It has been 
shown that 20(OH)D stimulates keratinocyte differentiation (Zbytek et al., 2008b) 
and decreases nuclear factor-B (NK-B) a transcription factor involved in the 
inflammatory response and the progression of cancer in cells (Janjetovic et al., 
2009).  
 
The anti-cancer effects of 20(OH)D have been shown in hepatocellular carcinoma 
and breast cancer cell lines, with the same effectiveness of 1,25(OH)2D at reducing 
colony numbers. Additionally, melanoma cell proliferation was inhibited with 
application of 20(OH)D due to targeting and blockade of NK-B activity (Wang et al., 
2012a). It has therefore been acknowledged that 20(OH)D has anti-proliferative 
activity (Janjetovic et al., 2011b). The advantage of 20(OH)D over 1,25(OH)2D use as 
an anti-cancer agent is that whilst both have antiproliferative effects, 20(OH)D 
produces none of the hypercalcemic effects of 1,25(OH)2D, as seen in mice and rats 
(Janjetovic et al., 2011b, Slominski et al., 2010). However, it should be noted that 
whilst 20(OH)D is a poor substrate for CYP27B1 hydroxylation in vivo, the enzyme 
which activates 25(OH)2D to 1,25(OH)2D, the product 1,20-dihydroxyvitamin D3 has 
some mild calcemic effects (Slominski et al., 2010). 
 1,25(OH)2D independent actions of the VDR, potential for 20(OH)D in 1.5.2
photoprotection 
Mice containing an ablated CYP27B1 gene that encodes for the 1-hydroxylase 
enzyme are unable to form active 1,25(OH)2D. In a study by Ellison and colleagues 
CYP27B1 -/- mice showed no increase in susceptibility to DMBA chemically induced 
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tumours compared to wildtype control mice whilst mice lacking full VDR 
functionality showed increased DMBA-induced carcinogenesis (Ellison et al., 2008).  
In the same study, VDR-KO mice exposed to UVR were shown to have decreased 
thymine dimer repair and enhanced photocarcinogenesis, whilst the effects of UVR 
on CYP27B1 -/- mice were not investigated. The authors suggested that it is the 
1,25(OH)2D-independent action of the VDR rather than 1,25(OH)2D ligands that 
mediate protection from skin carcinogenesis (Ellison et al., 2008). In a recent study 
by the Bikle group, CYP27B1 -/- mice did not develop tumours with chronic 
exposure to UVR (Bikle et al., 2013, Teichert et al., 2011). Such findings suggest that 
there may be other ligands which activate the VDR, produced by a different 
pathway from the classic CYP27B1 hydroxylation of 25(OH)2D.  
 
In regards to skin manifestations, 1-hydroxylase knockout mice exhibit a 
phenotype almost identical to their wildtype counterparts, with the exception of 
small disruptions in epidermal keratinocyte differentiation, and delays in recovery 
of normal barrier function (Bikle et al., 2004). In contrast VDR-KO mice develop 
thickened skin with an abnormal morphology, long curved nails, and alopecia 
(Zinser et al., 2002). 
 
Furthermore, the recent discovery of 20(OH)D which does not require 1-
hydroxylase to become biologically active provides evidence of alternate 
endogenous products which may mediate the non-genomic effects of the VDR, 
where 1,25(OH)2D is not available (Slominski et al., 2005, Slominski et al., 2012, 
Tuckey et al., 2008a, Guryev et al., 2003). Such an endogenously produced 
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compound may provide a bridge between the findings of Ellison and Tiechert, and 
Dixon, Wood and Kensler (Dixon et al., 2011, Ellison et al., 2008, Kensler et al., 2000, 
Wood et al., 1983).  
 Tetrahydrocurcumin 1.5.3
Several bodies of evidence suggest that curcuminoids may be great anti-cancer 
agents due to their antioxidant properties (Naito et al., 2002, Osawa et al., 1995). In 
particular, curcumin is already well established as an anti-cancer, anti-
neurodegenerative and anti-inflammatory agent, however is rapidly metabolised 
following digestion, limiting its effectiveness (Wu et al., 2013). 
THC is an inexpensive, colourless in vivo metabolite of the turmeric spice-derived 
yellow curcumin (diferuloylmethane) (Sugiyama et al., 1996). As seen in figure 1.12 
THC is formed by the hydrogenation of curcumin at the conjugated double bonds of 
the carbon skeleton which increases its antioxidant effectiveness (Somparn et al., 
2007). 
 
 
Figure ‎1.12 Hydrogenation of curcumin produces tetrahydrocurcumin (Sugiyama 
et al., 1996). 
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It has been suggested that the anti-cancer properties of THC may be due to the 
presence of the β-diketone moiety (Sugiyama et al., 1996). A recent study has 
shown that THC inhibits the PI3K/Akt pathway in a leukaemia cell line, and increases 
activity of the apoptotic ERK and JNK pathways, leading to cell death (Wu et al., 
2011). 
 
Conformational binding studies show that THC’s precursor curcumin can bind to 
both genomic and alternate pockets of the VDR, however it preferentially activates 
the latter (Mizwicki et al., 2010). In addition, at pharmacological concentrations, 
curcumin not only has an affinity for binding at the VDR, but also for activating 
genomic transcription (Jurutka et al., 2007, Bartik et al., 2010). The binding of THC 
to the VDR has not been studied as extensively as curcumin, and since 
hydrogenation of double bonds on the carbon chain does not change the planar 
shape, it might be assumed that THC acts in a similar way at the VDR. Despite the 
probability of curcuminoid transcriptional capabilities via the VDR, use of THC in 
mice has been shown to have no effect on weight, and is not cytotoxic at 
pharmacological doses (Naito et al., 2002). 
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1.6 AIMS AND HYPOTHESES 
 Aims 1.6.1
The aims of this project are: 
 To test whether THC, a component of the spice turmeric, known to have 
antioxidant effects at micromolar concentrations, is photoprotective at 
nanomolar concentrations against UVR-induced DNA damage in 
keratinocytes 
 To test whether 20(OH)D, a novel 1,25(OH)2D analogue reduces DNA 
damage in UVR-exposed fibroblasts and keratinocytes to a similar extent as 
1,25(OH)2D, and whether this photoprotection may be mediated by chloride 
channel opening. 
 To investigate possible molecular mechanisms involved in 1,25(OH)2D 
mediated photoprotection from UVR, in particular to determine the effects 
of inhibiting the Wnt signalling pathway on DNA damage in UVR-exposed 
keratinocytes.  
 To test whether 20(OH)D is photoprotective against UVR-induced DNA 
damage and immunosuppression to an immune response-eliciting antigen in 
Skh:Hr1 hairless mice and whether this is sex-specific.  
 To determine whether the estrogen receptor β (ERβ) is involved in 
photoprotection from UVR, using ERβ-knockout mice, and whether this 
effects the function of 20(OH)D.  
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 Hypotheses 1.6.2
The hypotheses to be tested are: 
 That 20(OH)D and THC in nanomolar concentrations are photoprotective to 
a similar extent as 1,25(OH)2D  
 That if 20(OH)D is photoprotective it exerts its effects via induction of 
chloride channel opening, as seen in 1,25(OH)2D -mediated photoprotection. 
 That inhibition of UVR-induced Wnt signalling pathways modifies UVR-
induced DNA damage, alone and in the presence of 1,25(OH)2D. 
 That 20(OH)D is photoprotective in vivo, in particular that it reduces UVR-
induced DNA damage following UV exposure. Additionally, that 20(OH)D has 
no effect on the basal immune response to a novel antigen but reduces UVR-
induced immune suppression against a novel antigen.  
 That photoprotection by 20(OH)D from UVR-induced DNA damage and 
immunosuppression is greater in females than males, and that this may be a 
result of presence of the ERβ gene. 
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2 METHODOLOGY 
2.1 MATERIALS 
 General reagents and materials 2.1.1
Unless otherwise stated, all reagents, chemicals and salts were purchased from 
Sigma Aldrich (St Louis, MO, USA). Seventy-five cm2 Falcon™ culture flasks and 
welled culture plates were purchased from Becton Dickinson Labware (Franklin 
Lakes, NJ, USA). Dulbecco’s Phosphate buffered saline (D-PBS) was purchased from 
Sigma-Aldrich (St Louis, MO, USA), whilst high glucose containing Dulbecco’s 
Modified Eagle Medium (DMEM) with and without calcium were from Invitrogen 
Life Technologies (NY, USA). Heat-inactivated foetal bovine serum was from SAFC 
Bioscience. MilliQ H2O was purified and supplied by the system supplied by the 
Molecular Biology Facility within the University of Sydney (Sydney, Australia).  
Antimycotic and antibiotic solutions were purchased from Invitrogen Life 
Technologies (NY, USA). Poly-L-lysine hydrobromide used in coating coverslips was 
obtained from Sigma-Aldrich (St Louis, MO, USA). Betadine antiseptic, 20 ml sterile 
centrifuge tubes and 50 ml sterile sample jars were bought from Livingstone 
International (Sydney, Australia). Cell-scrapers and cell culture and bacteriological 
grade Petri dishes were from Sarstedt Ag & Co. (Numbrecht, Germany). 
 General equipment 2.1.2
General cell culture and experimentation was undertaken using sterile techniques 
within a biohazard laminar flow hood purchased from Gelman Sciences Pty (Sydney, 
Australia). A water-jacketed incubator acquired from Forma Scientific (Sydney, 
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Australia) was used to maintain live cells at 37C and 5% CO2. Cells were 
cryopreserved under liquid nitrogen in a Dewar purchased from Taylor-Wharton 
(Albury, Australia). The centrifuge was purchased from Hettich Zentrifugen 
(Tuttlingen, Germany). Cells were viewed using a phase-contrast microscope from 
Olympus Optical Co Ltd (Tokyo, Japan) and counted manually with a Neubauer 
bright-line haemocytometer purchased from Weber Scientific International Ltd 
(Sussex, England). The MSE Micro-Centaur centrifuge was obtained from Lab Supply 
(Perth, Australia). The plate shaker was purchased from Flow Laboratories (Sydney, 
Australia) and the vortex mixer was from Thermolyne Corporation (Dubuque, IA, 
USA). The electronic balance was obtained from A&D Co. Ltd. (Tokyo, Japan), and 
the PHM80 portable pH meter was purchased from Radiometer Cophenhagen 
(Paris, France).  
 Equipment used in UV irradiation 2.1.3
The solar simulator used in the in vitro studies contained a FS20T12 UVB lamp and a 
FL20SBL UVA lamp from Phillips (Amsterdam, Holland). To ensure these lamps were 
emitting the desired spectral irradiance for experimentation, a calibrated OL754 
spectroradiometer from Optronics Laboratories Inc (Orlando, FL, USA) was utilised 
to measure the light. In vivo studies employed the use of six 40W F40T 10/BL UVA 
tubes from Hitachi (Tokyo, Japan) and a TL 100W/12 UVB tube from Phillips 
(Eindhoven, Holland). To filter out irradiation below 290 nm a cellulose tri-acetate 
sheet (thickness = 0.125 mm), purchased from Eastman Chemical Products 
(Kingsport, TN, USA) was used for both in vivo and in vitro experiments and used for 
no more than 4 hours total.  
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 Vitamin D compounds 2.1.4
1,25 dihydroxyvitamin D3 (1,25(OH)2D) was purchased from Cayman Chemical Co. 
(Ann Arbour, MI, USA).  Dr Robert Tuckey School of Biomedical, Biomolecular and 
Chemical Sciences, University of Western Australia, Crawley, Australia generously 
supplied the 20-hydroxyvitamin D3 (20(OH)D). Tetrahydrocurcumin (THC) was 
purchased from SAMI labs Ltd. (India). 1,25(OH)2D, 20(OH)D and THC were 
dissolved in spectroscopic grade 100% ethanol and stored under argon at -80C. The 
integrity of these compounds was tested prior to each experiment using a 
Nanodrop ND-1000 spectrophotometer purchased from Thermo Fisher Scientific 
(Australia) supplied by the Bosch Molecular Facility within the University of Sydney, 
Spectral scans of the compounds are shown in Figure 2.1. The concentration was 
calculated from their peak absorbance values divided by the molar extinction 
coefficient of each test compound (see Table 2.1).  
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Table ‎2-1 Spectrum peak at which the absorbance was recorded and extinction 
coefficient for each compound used to calculated their concentration, a measure 
of their integrity whilst in storage. 
Compound Spectrum peak at which 
absorbance was read 
Extinction coefficient () 
at spectrum peak  
1,25(OH)2D 265  18200 
20(OH)D 263 (Janjetovic et al., 
2009, Zbytek et al., 
2008b) 
18000  
THC 281 (Khopde et al., 2000) 15460  
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Figure ‎2.1 Spectral scans of (a) 0.1 mM 1,25(OH)2D3, (b) 0.1 mM 
20(OH)D and (c) 0.1 mM THC 
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  Inhibitors of Wnt signalling pathway and chloride channels 2.1.5
4,4’-Diisothiocyanatostilbene-2,2’-disulfonic acid disodium salt, DIDS, a chloride 
channel antagonist was purchased from Sigma-Aldrich (St Louis, MO, USA) and 
stored in spectroscopic grade DMSO under argon at room temperature. The Wnt 
inhibitor IWR-1-endo was purchased from Cayman Chemical Co. (Ann Arbour, MI, 
USA). 
 Materials used in immunohistochemistry 2.1.6
The mouse monoclonal IgG1 anti-thymine dimer antibody H3 (Roza et al., 1988) was 
obtained from Sigma-Aldrich, whilst the mouse monoclonal anti-8-oxodG clone 2E2 
(Soultanakis et al., 2000)  was purchased from Trevigen Inc. (Gathersburg, MD, 
USA). The DAKO LSAB kit and diaminobenzidine (DAB) were purchased from DAKO 
(Glostrup, Denmark). Images of the stained cells were acquired using the Nikon 
Eclipse E800 Macro-Imaging Microscope from Nikon Instruments Inc. (Melville, NY, 
USA) in conjunction with Leica DFC500 colour camera and LAS imaging software 
purchased from Leica Microsystems Ltd (Switzerland). Image analysis was 
undertaken using MetaMorph Imaging System, supplied by the Advanced 
Microscopy Facility of the Bosch Institute. 
 Materials used in genotyping 2.1.7
The REDExtract-N-Amp Tissue PCR kit and primers were purchased from Sigma-
Aldrich (St Louis, MO, USA). Use of the Hybaid PCR thermal cycler and UVP agarose 
gel digital imaging system were kindly provided by the Bosch Molecular Biology 
Facility (Sydney, Australia).  
 59 
 
 Materials used in animal studies 2.1.8
All animal studies were approved by The University of Sydney Animal Ethics 
Committee. Female and male Skh:hr1, albino, inbred mice were obtained from the 
University of Sydney Veterinary Pathology colony. The ethics approval number used 
for these experiments was K22/1-2011/3/5457. Oestrogen receptor  knockout 
(ERKO) mice originally designed by Krege and colleagues (Krege et al., 1998) and 
C57B1/6 mice used for wildtype comparison were manufactured by A/Prof Vivienne 
Reeve.  Mice were housed in wire topped plastic boxes at temperatures between 
23-25C, maintained by yellow lighting, with a continual supply of fresh H2O from a 
sipper. All conditions were facilitated and provided by A/Prof Vivienne Reeve, 
Photobiology Laboratory, Faculty of Veterinary Science within The University of 
Sydney. Mice were kept on Shepherds Premium Corn Cob bedding, (Techniplast), 
and fed with Gordon rat and mouse pellets (Yandeera, Australia). Polyethylene 
glycol and 4-ethoxymethylene-2-phenyl-2-oxazolin-5-one (oxazolone) (w/v) were 
purchased from Sigma-Aldrich (St Louis, MO, USA). The spring micrometer was 
sourced from Interapid (Zurich, Switzerland).  
 Compositions of media, buffers and solutions 2.1.9
Keratinocyte Growth Medium (KGM) 
To promote cell growth, without differentiation, keratinocytes in culture are grown 
in a low calcium medium. Human keratinocytes were grown in KGM containing 
DMEM without calcium, 2.2 g/L NaHCO3, 0.293 g/L glutamine, 2.385 g/L HEPES and 
500 g/L hydrocortisone. For isolation of cells from primary tissue, 0.03 g/L 
penicillin and 0.05 g/L streptomycin was added to the KGM. In culture of 
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keratinocytes 5000 ng/L epidermal growth factor (EGF), 10 nM cholera toxin with 
5% v/v sterilised fetal bovine serum (FBS) was included in the KGM. Henceforth 
these are referred to as supplements.  
0.25% Trypsin 
0.3525 g/L, NaHCO3, 2.5 g/L trypsin in MilliQ H20. 
0.1% Trypsin/0.02% EDTA 
0.2 g/L EDTA, 1 g/L D-glucose, 0.4 g/L KCl, 8 g/L NaCl, 0.580 g/L NaHCO3 and 1 g/L 
trypsin in MilliQ H20. 
Martinez buffer solution 
Proteins contained in cell medium may absorb some UV radiation during 
experimentation thus cells may not receive equal amounts of treatment. Thus clear 
Martinez solution is applied to cells for irradiation as it contains enough glucose for 
cellular metabolism, without absorbing UV radiation. Martinez solution was made 
up in MilliQ H2O and contained 0.4738 g/L NaCl, 0.41 g/L KCl, 0.244 g/L MgCl2.6H2O, 
0.1872 g/L NaH2PO4.2H2O, 1.9523 g/L NaHEPES, 1.7873 g/L HEPES, CaCl2.2H2O, 
1.8016 g/L D-glucose. 
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2.2 IN VITRO METHODS 
 Primary cell culture 2.2.1
The current project had approval from The University of Sydney Human Ethics 
Committee, using the ethics approval number as in 2.1.8. Primary human 
keratinocytes and fibroblasts were isolated from neonatal foreskins donated to the 
laboratory by a paediatric surgeon. Samples were provided only after informed 
consent from a parent or guardian was obtained. Each sample was processed 
separately and aseptically within a laminar flow biohazard hood. Upon arrival into 
the laboratory, the foreskin was maintained in medium containing the antibiotics 
penicillin and streptomycin, but no foetal calf serum at 4C for 48 hours post-
surgery until cell culture processing was performed. The antibiotics were essential 
for the prevention of any bacterial contamination. The foreskin was then washed 
with 70% ethanol twice and submerged in Dulbecco’s phosphate buffered saline 
(DPBS) containing the aforementioned antibiotics for 3 minutes. The foreskin was 
then washed and submerged in PBS for a further 3 minutes. The fatty hypodermis 
and blood vessels were removed and discarded. 
 Isolation of keratinocytes 2.2.2
The remaining skin containing the dermis and epidermis was dissected into 3 mm by 
3 mm pieces and rinsed in antiseptic Betadine. PBS was then used to wash the 
samples. The skin pieces were then transferred to a centrifuge tube containing 0.1% 
(w/v) sterilised dispase in DPBS with antibiotics and kept at 4C for 24 hours. 
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Dispase is a protease which cleaves fibronectin to dissociate the dermis from the 
epidermis.  
The following day, the epidermis was isolated from the dermis and submerged in 
0.1% trypsin/0.2% EDTA solution at 37C for 16-20 minutes with intermittent 
agitation to stimulate the reaction. The trypsin reaction was stopped by the 
addition of an equal volume of KGM with 5% (v/v) FBS. After cells were 
mechanically separated by agitation with a sterile transfer pipette, cells were 
centrifuged at room temperature for 5 minutes at 2000 rpm. The supernatant 
media was discarded and the cell pellet was resuspended in KGM growth medium. 
Cells were plated in 75 cm2 culture flasks and incubated at 37°C with 5% CO2 and 
media was replaced with fresh KGM growth medium after 24 or 48 hours to remove 
unattached cells and promote growth and proliferation. KGM growth media was 
changed and refreshed every 2 to 3 days until 70% confluency was achieved.  
 Passaging cell cultures 2.2.3
Cells were passaged upon reaching 70-90% confluence in the culture flask. Medium 
was decanted from the culture flask and the flask was rinsed once with DPBS. 0.1% 
trypsin/0.02% EDTA in DPBS was added to the flask and decanted after 10 seconds. 
“Dry” trypsinisation ensures that cells are allowed to round, and detach individually 
from the flask without forming a “sheet” which will not re-attach in a new flask or 
plate (Dr Mark Rybchyn, personal communication). Following trypsin exposure, the 
flask was left to incubate for 8 minutes for keratinocytes and 4 minutes for 
fibroblasts at 37C. At 5 minutes, the flask was agitated to ensure cells were 
successfully detaching from the bottom of the flask. After cells had lifted, KGM with 
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supplements for keratinocytes was added to neutralise the reaction. The resulting 
cell suspension was evenly reflasked into two or more culture flasks or plated for an 
experiment.  
 Cryopreservation 2.2.4
Upon reaching 70-90% confluence, cells that were not required for experimentation 
were frozen down and preserved. Cells were detached from the bottom of the 
culture flask as in 2.2.1.2, however the reaction was neutralised by the addition of 
the ice-cold 5% (v/v) DMSO in FBS freezing medium. The remaining cell suspension 
was transferred to cryovials and stored at -80C for approximately 24 hours. After 
this time, cryovials were stored in liquid nitrogen for long term preservation. 
 Retrieval of cells from cryopreservation 2.2.5
Cryovials were removed from the liquid nitrogen when required for 
experimentation and thawed briefly in a 37C waterbath. The cells were then 
transferred to a centrifuge tube containing KGM with 5% FBS and centrifuged for 5 
minutes at 1500 rpm at room temperature. The remaining supernatant was 
decanted and the cell pellet was gently resuspended in KGM with supplements and 
transferred to a 75 cm2 flask.  
 Poly-l-lysine coating coverslips 2.2.6
Cells will not adhere to glass, thus poly-L-lysine is used to coat the coverslips so that 
cells may be stained during immunohistochemistry. Glass coverslips (5mm 
diameter) were autoclaved and dried in a scintillation vial to ensure sterility. Under 
sterile conditions, 0.01% poly-L-lysine was added to the vials. The vial was 
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continuously agitated for 5 mins so that all coverslips were exposed to the polymer. 
The poly-L-lysine was removed and coverslips were rinsed with sterilised MilliQ H2O 
three times and then dried in sterile glass Petri dishes for at least 6 hours. The 
coated coverslips were stored in sterile sample jars at room temperature. 
 Plating for experimentation 2.2.7
Passage 2-5 cells were used for experimentation. As in 2.2.1.2 cells were passaged 
and resuspended in cell specific media. Ten l of the cell suspension was obtained 
and cell density was calculated using the haemocytometer. For use in whole cell 
immunohistochemistry in 96 well plates, keratinocytes were seeded onto poly-L-
lysine coated coverslips placed in each well, in quadruplicate for each treatment. 
For experiments using keratinocytes, 24 hours after plating, and at least 24 hours 
prior to experimentation, media was changed to supplement-free KGM with 5% 
FBS. This is to ensure that normal quiescent cell signalling pathways were restored 
before experimentation, as the supplements stimulate proliferation. 
 Ultraviolet irradiation 2.2.8
Cells were irradiated under aseptic conditions within a laminar flow hood, using the 
solar simulator described in 2.1.3. All cells received the same treatment with the 
exception of sham cells which were covered in aluminium foil so they did not 
absorb any UVR. Before irradiation media in both sham and UVR treatment groups 
was aspirated and replaced with Martinez buffer solution containing glucose to 
support cellular metabolism without absorbing UVR. The UVR setup inside the 
laminar flow hood is depicted in Figure 2.2. 
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UV irradiation below 290 nm was removed through a cellulose tri-acetate sheet 
used no more than 4 hours of irradiation in total. Plates were placed on a turn table 
and at exactly halfway through irradiation were turned 180 so that cells received 
even exposure of UVR. Post UVR, Martinez buffer solution was aspirated and media 
containing treatments was added to the wells. 
   
 
 
Figure ‎2.2 In vitro irradiation set up  
 
 
 
 
 
 
Aluminium 
foil covering 
sham-
irradiated 
cells 
Turntable 
UVB and UVB 
lamps 
Cellulose 
triacetate 
sheet 
over 
UVR-
exposed 
cells in 
96-well 
plate 
 66 
 
 UV lamps 2.2.9
Output of the UVA and UVB lamps was checked to ensure cells were receiving 
identical UVR doses throughout experimentation. A calibrated OL754 
spectroradiometer was used to measure spectral irradiance. Duration of irradiation 
(70 minutes) was calculated using the measured values so that cells received a UVR 
dose of 2138 mJ/cm2 of UVA and 610 mJ/cm2 of UVB. This is equivalent to 
approximately three times the minimal erythemal dose (MED) from sunlight. One 
MED produces mild redness of the skin.  For the duration of experimentation, 
irradiance in the UVC range below (290nm) were filtered out using cellulose 
triacetate sheets, to reflect the natural filtering effect of the ozone layer. Figure 2.3 
represents the irradiances taken from UV lamps with and without the cellulose 
triacetate filter and from sunlight at midday in March in Sydney, Australia.  
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Figure ‎2.3 Output of the UV lamps. UV irradiances as measure by a calibrated 
OL754 spectroradiometer. The black line demonstrates output without a triacetate 
filter. The red line represents experimental radiation with a cellulose triacetate 
filter, to mimic the filtering effect of the ozone, which is seen on the blue line taken 
at midday in March in Sydney, Australia 
 Application of treatments and inhibitors 2.2.10
For all experiments, cells were treated post-UVR with vehicle, 1,25(OH)2D, 20(OH)D, 
THC, inhibitors or a combination of the vitamin D compounds and an inhibitor. As 
stated in 2.1.5, inhibitors used were DIDS and IWR-1-endo. Inhibitors need a longer 
time to exert their inhibitory effects on cells, thus they were applied with Martinez 
buffer solution immediately before UVR and were present throughout the 
procedure. For keratinocytes, treatment media was KGM with 5% FBS. 
 Immunocytochemistry for the detection of thymine dimers and 8oxodG 2.2.11
Cells were incubated at 37C for 1 or 3 hours post-UVR and with treatment before 
fixation. Cells were rinsed with 100l DPBS/well  and then fixed with ice-cold 100% 
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methanol at -20C for 7-10 minutes. Subsequently cells were washed 3 times with 
MilliQ H2O and dried overnight. Endogenous peroxidases were blocked with the 
addition of 1% hydrogen peroxide (H2O2) (v/v) in MilliQ H2O for 5 minutes. Antigen 
retrieval was achieved by application of 70 mM NaOH in 100% ethanol to cells for 2 
minutes to denature DNA before proteolytic digestion using 1g/ml proteinase K 
for 5 minutes at room temperature for thymine dimer detection and 10 minutes at 
37C for 8-oxoguanine detection. The cells were then submerged in 50% horse 
serum (w/v) in PBS for 1 hour at room temperature on the plate shaker to block 
non-specific antibody binding. After application of H2O2, proteinase K and horse 
serum the cells were washed twice for 2 minutes with MilliQ H2O.  
 
The primary antibody for thymine dimer detection was mouse monoclonal IgG1 
anti-thymine dimer antibody H3 and for 8-oxoguanine detection was mouse 
monoclonal IgG1 anti-8-oxoguanine antibody 2E2. Anti-thymine dimer (5 g/ml) 
antibody or 8-oxoguanine (0.5 mg/ml) were diluted in 0.1% Tween-20 (v/v) in Tris-
buffered saline (TBST) and added to cells for 1 hour with continuous agitation on 
the plate shaker. The high sensitivity LSAB kit was utilised to visualise primary 
antibody binding. The LSAB yellow biotinylated secondary antibody was applied to 
the cells for 15 minutes (1 drop/well). Subsequently, streptavidin-linked HRP was 
added to the cells for 15 minutes at 1 drop per well. After exposure to the primary 
antibody and each reagent following, cells were washed twice for 2 minutes each 
with TBST. 3’3’-diaminobenzidine (DAB) chromagen solution (DAKO) was applied 5 
minutes to visualise and localise thymine dimer or 8-oxodG nuclear staining in the 
cells. Cells were then washed in MilliQ H2O and coverslips were mounted on 
 69 
 
Ultracruz, Santa Cruz Biotechnology (CA, USA) aqueous mountant that contains 4’,6-
diamidino-2-phenylindole (DAPI) counterstain. DAPI stained all nuclei blue 
specifically, with very little cytoplasmic labelling when observed with the UV filter in 
the Nikon epifluourescence microscopy, whilst DAB staining was visualised by bright 
field microscopy. 
 Image analysis 2.2.12
Coverslips were examined with 20x objective using the Nikon Eclipse E800 Macro-
Imaging Microscope. For bright field images, the light intensity remained constant 
throughout analysis of each experiment. A Leica DFC500 colour camera was used to 
capture brightfield image for the DAB stained DNA lesions DAPI fluorescence image 
of the same area was taken for counting the total nuclei in the same field. Three 
brightfield images and their corresponding DAPI images were taken of each sham 
coverslip, and four brightfield images and their corresponding DAPI images were 
taken of each UV coverslip for analysis.  
 
Using the MetaMorph Imaging System, images were analysed for the occurrence of 
thymine dimer or 8-oxodG staining.  Using greyscale and intensity transformation, 
saturation threshold values for positive staining were obtained from sham images 
and applied to the UV images for analysis. When DNA damaged nuclei take up the 
DAB stain, the DAPI staining becomes masked by the chromagen precipitate in the 
nuclei, the total number of nuclei in the image was calculated by combining the 
area of DAB staining with the total area of DAPI staining. Positively stained nuclei 
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with DNA damage were expressed as a percentage of the total nuclei in each region 
of interest (ROI). 
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2.3 IN VIVO METHODS 
 Maintenance and treatment of animals  2.3.1
Female and male Skh:hr1, albino, hairless mice and female C57 estrogen receptor  
knockout (ERKO) and wildtype C57/B16 mice were used for in vivo 
experimentation. Hairless mice were age matched and randomly separated into 14 
groups of 3 mice per group for immunohistochemistry studies and 8 groups of 5 
mice per group for immunosuppression studies. Sexes were kept separate. Mice 
were housed in wire topped plastic boxes lined with compressed corn cob bedding, 
with a constant supply of rodent pellets and fresh H2O. Since male mice are typically 
more aggressive than females, males remained in the same smaller boxes from 
birth with no more than 4 littermates in one box. Temperature was maintained at 
23-25C throughout experimentation. 
 Genotyping 2.3.2
Mice with a completely disrupted estrogen receptor  (ER) gene in both sexes 
appear to develop normally to adulthood and are phenotypically identical to their 
wild-type counterparts. However, female mice have reduced fertility, resulting in 
breeding difficulties. Thus breeding pairs must be heterozygous.  
 
DNA extraction solution was prepared on ice by mixing 50 l extraction and 12.5 l 
tissue preparation solutions from the REDExtract-N-Amp tissue polymerase chain 
reaction (PCR) kit in a 600 l microcentrifuge tube. After combining the two 
solutions, the mixture is viable for a maximum of two hours. A 1-1.5 cm tail sample 
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was cut from each mouse. In a Petri dish, the bony core was mechanically separated 
from the tail skin and both were surgically cut into smaller pieces. The pieces were 
placed into the tube containing DNA extraction solution and shaken to ensure all 
pieces were thoroughly exposed. The samples were vortexed and incubated at 
room temperature for 10 minutes, then heat shocked at 95˚C for 3 minutes. One 
hundred l of neutralisation solution was added to the tube, which was vortexed 
and spun down at room temperature. In two 200 l microcentrifuge tubes 2 l of 
DNA extraction solution supernatant, 7 l of distilled MilliQ H2O, 10 l of REDExtract 
-N-Amp PCR ReadyMIX, 2 l of each of the forward and reverse primers (Table 2.2) 
were mixed.  
Table ‎2-2 The forward and reverse primers used in PCR analysis of knockout mice 
Area of DNA Primer 
Forward 5′-GTGATGAGCTGAGGTGGTGCTT-3′ 
Reverse (normal ER gene)  5′-CATCCTTCACAGGACCAGACAC-3′ 
Reverse (mutant ER gene) 5′-GCAGCCTCTGTTCCACATACAC-3′ 
 
One tube contained wildtype primers and the other contained primers for the 
knockout genes. The tubes were vortexed and centrifuged briefly before DNA 
amplification in the PCR thermal cycler. Thermal cycling included initial 
denaturation for 3 mins at 94˚C, denaturation for 1 minute at 94˚C, annealing at 45-
68˚C for 1 minute, extension at 72˚C for 1-2 minutes and final extension for 10 
minutes at 72˚C before reducing the temperature to 4˚C.  
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Amplified DNA was identified using agarose gel electrophoresis. Twenty l of the 
PCR solution from the both the wildtype and knockout gene samples were added to 
the agarose gel, in corresponding wells. The gel was run at a constant voltage of 100 
V for 60 mins. Bands were visualised using the UVP agarose gel digital imaging 
system (fig. 2.3). Samples from homozygous knockout mice show a 1479-base pair 
(bp) band, whilst homozygous wild-type mice show a 1435-bp band. Samples from 
heterozygous mice show both bands. 
 
 
Figure ‎2.4 Confirmation of ERβ knockout mice, born from heterozygous parents. 
Samples 1 and 4 are heterozygous since the blot shows the presence of two bands. 
Samples 2 and 3 are homozygous for the knockout gene since they have no bands in 
the first lane of their pair. 
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 Topical treatments 2.3.3
Stock solutions of 1,25(OH)2D, 20(OH)D and THC were diluted in spectroscopic 
grade ethanol and then into polypropylene glycol and MilliQ H2O so that the ratio of 
treatment in ethanol:polypropylene glycol:MilliQ H2O was 2:1:1. Concentrations of 
the active agent were expressed as mol/cm2 where 100l of solution covered 
7cm2 of back skin.  
 UV irradiation 2.3.4
The solar simulator was switched on at least 30 minutes prior to irradiation of the 
mice so as to ensure the bulbs had warmed up and emitting the correct 
wavelengths. Wavelength activity was checked by radiometer and the time 
calculated for a 2.5 MED dose of UV radiation for each experiment. Mice receiving 
UVR were irradiated in open topped boxes covered with cellulose tri-acetate (0.125 
mm) to eliminate wavelengths below 290nm. As UV fluence is affected by 
temperature, a steady temperature was maintained via a direct fan. Since ER-KO 
mice and ER-WT mice are hairy, it was necessary to shave the dorsum of their 
backs to ensure their skin received the UVR.  For immunosuppression studies, skin 
fold thickness in all groups was measured and recorded immediately before UV 
irradiation, described in more detail in section 2.3.5. 
 
Immediately following UV irradiation, mice were treated with either vehicle, 1,25 
(OH)2D or 20(OH)D for immunosuppression studies, and either vehicle, 1,25(OH)2D, 
20(OH)D or THC for immunohistochemistry studies. One hundred l of the 
treatment was painted dorsally on the mouse using a pipette.  
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 Measurement of erythema and skin oedema 2.3.5
The inflammatory response to UV irradiation was observed by measurement of 
dorsal skinfold thickness using a spring micrometer (Fig. 2.4). Measurements were 
taken immediately prior to UV irradiation and at 24, 48 and 72 hours post UVR. 
Change in skinfold thickness was expressed as the difference between 
measurements taken at specified time points post UV irradiation and the pre 
measurements.  
 
Figure ‎2.5 Measurement of dorsal skinfold thickness on a hairless Skh:Hr1 mouse 
using a spring  micrometer 
 Contact hypersensitivity reaction 2.3.6
This laboratory has previously reported a protective effect of 1,25(OH)2D and 
vitamin D-like compounds against UVR-induced systemic immunosuppression. This 
is measured using the contact hypersensitivity (CHS) reaction, as described in Reeve 
(2002). One week after UV irradiation all mice were sensitised with 100 l of 2% 
 76 
 
oxazolone (w/v) in 100% ethanol applied to abdominal skin (Fig. 2.5). Sensitisation 
was repeated the following day to ensure there was sufficient exposure to the skin 
irritant to induce an immune response.  
 
 
Figure ‎2.6 Abdominal application of 2% oxazolone using a pipette to sensitise the 
mice 
Two weeks following UV irradiation, 5 l of 2% oxazolone was applied to each side 
of the pinnae of each ear of all mice. The degree to which the ears of the mice 
swelled is an indication of the secondary immune response to the re-exposure of 
the contact antigen. A spring micrometer was utilised to objectively measure the 
ear thickness prior to, and 16 hours following antigen challenge.  Mice were subject 
to a gaseous anaesthetic for a short period of time so as to gain accurate 
measurements of ear thickness, shown in figure 2.6.  
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Figure ‎2.7 Measurement of ear swelling on a hairless Skh:Hr1 mouse using a 
spring micrometer 
 
The degree of immunosuppression for UVR exposed mice was calculated as the 
difference between pre- and post-challenge ear thickness measurements of non-
irradiated mice as a proportion of the difference between pre- and post-challenge 
ear thickness measurements of irradiated mice for each treatment. Percentage of 
immunosuppression was calculated by subtracting the previous value from 100% 
(Dixon et al., 2007).   
 Harvesting of skin biopsies for immunohistochemical staining 2.3.7
Three hours post UV irradiation and treatment, mice were sacrificed by inhalation 
of CO2 within an enclosed chamber. Dorsal skin biopsies were dissected from the 
area between the shoulders known as the “hotspot” using surgical scissors, shown 
in figure 2.7. Skins were immediately preserved in HistoChoice (Amresco) for 6 
hours at 4C, before being washed with ethanol. Skins were taken to Blackburn 
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Pathology Facility where they were embedded on paraffin blocks, cut into 5 m 
sections and mounted onto glass slides for immunohistochemical staining.  
 
Figure ‎2.8 Example of a dorsal “hotspot” after exposure to UVR from which 
biopsies were taken for immunohistochemical staining  
 Immunohistochemistry for detection of thymine dimers in fixed mouse 2.3.8
skin 
Slides were prewarmed at 37C for 10 minutes before de-paraffinisation through 2 
washes of xylol for 10 minutes each. Sections were then rehydrated through graded 
alcohol solutions. This was achieved by exposure to two washes of absolute 
ethanol, two of 95%, one in 70% and then H2O for 2 minutes in each. Antigen 
retrieval was achieved by submerging slides in heated 0.01 M citrate buffer for 10 
Dorsal 
“hotspot
” 
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minutes at 95C, before two consecutive washes in TBS for 3 minutes each. Sections 
were then subject to 1% H2O2 for 5 minutes to block endogenous peroxidases with 
three subsequent washes in TBST for 2 minutes each. To block non-specific antibody 
binding, sections were allowed to sit in 10% horse serum in TBST for 30 minutes at 
room temperature with constant agitation. 
  
The DAKO Animal Research Kit was used for immunohistochemistry. The primary 
antibody (2 g/ml), mouse monoclonal antibody IgG1 to the thymine dimer clone H3 
was diluted in antibody diluent (DAKO) together with the biotinylation reagent 
containing biotinylated anti-mouse immunoglobulin in Tris-HCl with stabilising 
protein and 0.015 M sodium azide from the ARK kit for 15 minutes followed by the 
kit blocking reagent containing normal mouse serum and incubated for 5 minutes. 
The sections were then incubated in the solution for a further hour at room 
temperature. Streptavidin conjugated to the reporter molecule HRP was added to 
the sections for 15 minutes following which diaminobenzidene (DAB) chromagen 
was applied to the sections for 5 minutes to visualise direct localisation of thymine 
dimers in the skins. After exposure to the primary antibody and streptavidin-HRP, 
sections were rinsed in three two minute washes of TBST, whilst after DAB 
application, sections were washed in MilliQ H2O for 2 minutes.  
 
For the dehydration process, sections were exposed to one wash of MilliQ H2O, one 
wash in 70% ethanol, two washes in 95% ethanol, and two washes in absolute 
ethanol for 2 minutes each. Subsequently, slides were subjected to two washes of 
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xylol for 10 minutes each before coverslips were mounted with Entellin mounting 
medium for visualisation under the microscope.  
 Image analysis 2.3.9
Image analysis for the sections of mouse skin were carried out as detailed in 2.2.12, 
except that images were captured at 200x the original magnification and positive 
staining was expressed as percentage of total area of the epidermis. The amount of 
DNA damage was calculated as the proportion of DAB positive-stained nuclei in the 
epidermis 
2.4 Statistical analysis 
For in vitro studies of CPDs and oxidative stress in 96 well plates, results were from 
quadruplicates of each treatment. For ELISAs, results were derived from triplicates 
of each treatment. Except where indicated, each experiment was performed a 
minimum of two times. For in vivo studies of CPD formation, results are based on 3 
mice per treatment group and expressed as mean +/- 1 standard deviation. For 
immunosuppression, results are from a single experiment of 5 mice per treatment 
group and expressed as mean +/- 1 standard error of the mean (SEM). For all 
studies, treatment groups were compared by one way analysis of variance (ANOVA) 
followed by Tukey-Kramer post-test using the GraphPad Instat statistical program. A 
P value of less than 0.05 was considered significant.  
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3 PHOTOPROTECTION AGAINST UVR INDUCED DNA DAMAGE BY NOVEL VITAMIN 
D COMPOUNDS 
3.1 RESULTS 
 Effect of 1,25(OH)2D, 20(OH)D and THC on the presence of thymine dimers 3.1.1
in cultured keratinocytes following UVR 
Previous work in this laboratory has established that the application of 1nM 
1,25(OH)2D exerts a  photoprotective effect against DNA damage, in particular 
thymine dimers, a subset of cyclobutane pyrimidine dimer (CPD) in keratinocytes 
and fibroblasts following UVR (Dixon et al., 2005, Dixon et al., 2011, Sequeira et al., 
2012b, Song et al., 2012, Wong et al., 2004).  Additionally, several studies have 
demonstrated that the non-genomic 1,25(OH)2D analogues (JN, QW) and vitamin D-
like compounds such as curcumin at this concentration reduce the presence of UVR-
induced thymine dimers, to the same extent as 1,25(OH)2D itself (Poliakov, 2009; 
(Gordon-Thomson et al., 2012, Sequeira, 2011). Protective effects of 1,25(OH)2D 
were confirmed in the study, and protection was also shown for the first time by 
20(OH)D (1nM and 10nM) and THC (1nM). Figure 3.1 is a representation of images 
used for the analysis off thymine dimer positive staining in sham and UVR exposed 
cells. The image of vehicle-treated unirradiated cells (sham) (Fig. 3.1a) represents all 
the sham treated groups, as unirradiated skin treated with 1,25(OH)2D, 20(OH)D or 
THC, also showed no positive staining (not shown). There is increased staining in 
nuclei in vehicle treated cells (Fig. 3.1 b) following UVR compared to its sham 
counterpart (Fig.3.1a). As expected the number of positively stained nuclei in 
1,25(OH)2D-treated cells (Fig.3.1c) was markedly reduced in comparison to vehicle-
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treated cells, following UVR. Similarly, addition of 1nM 20(OH)D following UVR 
reduced positive staining compared to vehicle-treated UVR-exposed cells (Fig. 3.1d), 
indicating that 20(OH)D is photoprotective. This was also seen with treatment of 10 
nM 20(OH)D and 1nM THC with UVR (Fig.3.1e,f, respectively). Figure 3.2 
quantitatively shows a significant reduction in thymine dimers following UVR by 
1,25(OH)2D and various doses of 20(OH)D when compared to vehicle-treated cells. 
One nM THC was also effective in reducing thymine dimers following UVR.  
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Figure ‎3-1 Photomicrographs showing a reduction in UV-induced thymine dimers 
in keratinocytes after treatment with 1,25(OH)2D, 20(OH)D and THC 
a. b. 
c. d. 
e. f. 
g. 
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Keratinocytes were treated with vehicle (0.1% EtOH) in (a) unirradiated (sham) and 
after UV irradiation (b), and irradiated cells were treated with (c) 1nM 1,25(OH)2D , 
(d, e) 1nM or  10 nM 20(OH)D, or (f) 1nM THC immediately following UVR. Cells 
were fixed at 3 hours post-UVR, and subjected to immunohistochemical staining 
using an antibody directed against thymine dimers. Dark brown staining in nuclei 
indicate the presence of thymine dimers (dark arrow). Positive staining was absent 
in sham-irradiated cells, with all sham groups represented by the single micrograph. 
(g) shows an example of DAPI stained nuclei, used to calculate total nuclei. Scale bar 
represents 50m for all images. 
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Figure ‎3.2 1,25(OH)2D, 20(OH)D and THC reduce the number of thymine dimers in 
human keratinocytes following UVR. Keratinocytes were treated with vehicle (0.1% 
EtOH), 1nM 1,25(OH)2D, 1nM 20(OH)D, 10nM 20(OH)D, or 1nM THC immediately 
following UVR. Cells were fixed 3 hours post-UVR, and subjected to 
immunohistochemical staining using an antibody directed against thymine dimers. 
Image analysis was used to quantify stained nuclei as a proportion of total nuclei. 
Results are from a single experiment performed in quadruplicate, mean ± SD. 
Similar results were observed in a two further independent experiments. ***, ** 
represents significantly different to UV vehicle p<0.001, p<0.01 respectively; ### 
represents significantly different to sham groups, p<0.001.  
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 Effect of 1,25(OH)2D, 20(OH)D and THC on 8oxodG formation in cultured 3.1.2
keratinocytes following UVR 
It has previously been shown in our lab that 1,25(OH)2D and THC reduce the 
formation of oxidative DNA damage after UVR, indicated by a reduction in nuclear 
presence of 8oxoguanine (Dixon et al., 2011).  This finding, along with the 
antioxidant capacity of 20(OH)D was confirmed in the current study. Like thymine 
dimers, 8oxodG positive cells were indicated by a dark stain in the nuclei. Since 
oxidative damage occurs naturally in all cells in culture, heavy background staining 
was commonly observed in sham treated cells. Figure 3.3 shows representative 
micrographs of sham and UVR exposed keratinocytes, used to analyse 8oxodG 
staining. The image of sham irradiated cells treated with vehicle is representative of 
1,25(OH)2D, 20(OH)D and THC treated cells, as staining was similar between groups 
(Fig3.3a). Cells irradiated with UV and treated with vehicle show a marked increase 
of 8-oxoguanine positive staining (Fig.3.3b) in comparison to sham cells (Fig.3.3a). 
The number of positively stained cells in both 1,25(OH)2D-, 20(OH)D- and THC-
treated cells following UVR was decreased (Figs 3.3 c,d,e respectively) compared to 
their UVR vehicle treated counterparts. A quantitative representation of 8-
oxoguanine staining is shown in Figure 3.4.  
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a. b. 
c. d. 
e. f. 
g. 
Figure  3-3 Photomicrographs showing a reduction in UV-induced 8-
oxoguanine in human keratinocytes after treatment with 1,25(OH)2D, 
20(OH)D and THC 
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Keratinocytes were treated with vehicle (0.1% EtOH) in (a) unirradiated (sham) and 
after UV irradiation (b), and irradiated cells were treated with (c) 1nM1,25(OH)2D, 
(d, e) 1nM or  10 nM 20(OH)D, or (f) 1nM THC immediately following UVR. Cells 
were fixed at 3 hours post-UVR, and subjected to immunohistochemical staining 
using an antibody directed against 8-oxoguanine. Dark brown staining in nuclei 
indicate the presence of 8-oxoguanine (dark arrow). Positive staining was low in 
sham-irradiated cells, with all sham groups represented by the single micrograph. 
(g) shows an example of DAPI stained nuclei, used to calculate total nuclei. Scale bar 
represents 50m for all images. 
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Figure  3.4 1,25(OH)2D, 20(OH)D and THC reduce 8-oxoguanine formation present 
in keratinocytes following UVR. Keratinocytes were treated with vehicle (0.1% 
EtOH), 1nM 1,25(OH)2D, 1nM 20(OH)D, 10nM 20(OH)D, or 1nM THC immediately 
following UVR. Cells were fixed 3 hours post-UVR, and subjected to 
immunohistochemical staining using an antibody directed against 8 oxoguanine. 
Image analysis was used to quantify stained nuclei as a proportion of total nuclei. 
Results are from a single experiment performed in quadruplicate, mean ± SD. 
Similar results were observed in a 1 further experiment. *** represents significantly 
different to UV vehicle p<0.001; ### represents significantly different to sham 
groups, p<0.001. 
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 Effect of 1,25(OH)2D, 20(OH)D and THC on the presence of thymine dimers 3.1.3
in male and female hairless Skh:Hr1 mice following UVR 
Previous reports from this laboratory have also shown that 1,25(OH)2D and vitamin 
D-like compounds and analogues reduce the presence of UVR-induced thymine 
dimers in hairless Skh:Hr1 mice (Gordon-Thomson et al., 2012, Ryan, 2010, Song et 
al., 2012). Additionally, recent research has exposed a significant gender bias in 
both mice and humans, with males generally more susceptible to UVR-induced DNA 
damage and subsequent photocarcinogenesis than females. Therefore the 
protective effect of 1,25(OH)2D, 20(OH)D and THC against the formation of thymine 
dimers following exposure to UVR was tested in vivo in the present study in both 
sexes using the hairless Skh:Hr1 mouse model. The current study confirmed the 
protective effects of 1,25(OH)2D, and demonstrated for the first time those of 
20(OH)D and THC against UVR-induced thymine dimers, and also confirmed that 
males are more susceptible to DNA damage following UVR. Additionally, preliminary 
results of the current study suggest that lower concentrations of 1,25(OH)2D are not 
as effective in reducing UVR-induced thymine dimers in male mice, compared to 
their female counterparts. 
 
Figure 3.5 is a representation of images used for the analysis of thymine dimer 
positive staining in sham and UVR exposed murine skin. The image of vehicle-
treated unirradiated skin (Fig. 3.5a) represents all sham treated groups, as 
unirradiated skin treated with 1,25(OH)2D, 20(OH)D or THC, also showed no positive 
staining (not shown).The presence of thymine dimers was highest in UVR-exposed 
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epidermis of  mice in the vehicle group (Fig. 3.5b), reflected in the darkly stained 
nuclei. The number of positively stained cells in male skins treated with 
4.6pmol/cm2 1,25(OH)2D was reduced (Fig. 3.5c) in comparison to vehicle-treated 
cells following UVR (Fig. 3.5b, however this reduction was more striking in female 
skins (Fig. 3.5d). Similarly, groups of both sexes who received treatment with 23 and 
46pmol/cm2 1,25(OH)2D following UVR had little to no thymine dimer positive 
staining, equivalent to sham groups. A similar reduction in positive staining 
following UVR seen with 23 and 46pmol/cm2 20(OH)D and 115pmol/cm2 THC 
treatments in both sexes. Figure 3.6(a,b) is the quantitative representation of 
positively stained cells as a percentage of total epidermal area in sham and UVR-
exposed female and male mice. It can be seen that sham-irradiated mice in all 
treatment groups, regardless of sex, showed insignificant presence of thymine 
dimers. On the other hand, in mice of both sexes exposed to UVR, thymine dimer 
formation was highest in vehicle treatment, with males evidently expressing more 
compared to females. Additionally, UVR-exposed mice showed a significant 
reduction in thymine dimers following treatment with all doses of 1,25(OH)2D, 
20(OH)D and THC, compared to their vehicle treatment.  
 
Figure 3.7 (a and b) is a quantitative depiction of photoprotection by the different 
compounds, expressed as a percentage of vehicle. In both sexes 1,25(OH)2D 
appears to be concentration dependent, however, it can be seen that in males, 
topical application of 4.6pmol/cm2 1,25(OH)2D was not as effective in reducing 
thymine dimers as it was in female mice. Effectiveness of 20(OH)D was comparable 
to 46pmol/cm2 1,25(OH)2D in both sexes. As seen in UVR exposed keratinocytes, 
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treatment with THC was highly effective in reducing thymine dimers in murine 
epidermis. 
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Figure  3-5 Photomicrographs showing 1,25(OH)2D, 20(OH)D and THC reduce the 
presence of thymine dimers in female and male murine epidermis following UVR 
 
f. 
a. b. 
c. 
d. 
e. 
g. h. 
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Groups of 3 mice were treated immediately after 2.5MED UVR with vehicle 
(0.1%(v/v) EtOH) (b), 4.6pmol/cm2 1,25(OH)2D (c), 23pmol/cm
2 1,25(OH)2D (d), 
46pmol/cm2 1,25(OH)2D (e), 23pmol/cm
2 20D (f), 46pmol/cm2 20D (g) or 
115pmol/cm2 THC (h). Mice in sham groups were treated with the same solutions as 
their UV-irradiated counterparts, (a) is a representation of the staining seen in the 
sham groups. Dorsal skin biopsies were dissected from the “hotspot” 3 hours post-
UVR, fixed in HistoChoice, and subjected to immunohistochemical staining using an 
antibody directed against thymine dimers. Shown are representative images of 
staining in each treatment group in female mice, which also qualitatively reflect 
those of the male mice treatment groups. Darkly stained nuclei indicate the 
presence of thymine dimers, highlighted by the dark arrow. CPD staining was absent 
in sham-irradiated mice, with all sham groups represented by the single 
micrograph, whilst there is a clear increase in positively stained nuclei in vehicle-
treated cells following UVR. Scale bar represents 10m for all images.  
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Figure ‎3.6 1,25(OH)2D, 20(OH)D and THC reduced the presence of thymine dimers 
3 hours following UVR in male and female Skh:Hr1 hairless, albino mice. a. 
Thymine dimers in female mice; b. Thymine dimers in male mice. Groups of 3 mice 
were treated immediately after 2.5MED UVR with vehicle (0.1%(v/v) EtOH), 
4.6pmol/cm2 1,25(OH)2D, 23pmol/cm
2 1,25(OH)2D, 46pmol/cm
2 1,25(OH)2D, 
23pmol/cm2 20D, 46pmol/cm2 20D or 115pmol/cm2 THC. Dorsal skin biopsies were 
dissected from the “hotspot” 3 hours post-UVR, fixed in Histochoice, and subjected 
to immunohistochemical staining using an antibody directed against thymine 
dimers. Image analysis was used to quantify stained cells as a proportion of total 
epidermal area. Results are from a single experiment, mean ± SD. ***, ** 
represents significantly different to UV vehicle p<0.001, p<0.01 respectively; @@@ 
a. 
b. 
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represents significantly different to UV 4.6pmol/cm2 1,25(OH)2D p<0.001. Sham 
groups were not significantly different to each other (p>0.05, not shown). 
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Figure ‎3.7 Effect of 1,25(OH)2D, 20(OH)D and THC on protection against DNA 
damage expressed as a percentage of vehicle in a) female and b) male Skh:Hr1 
hairless albino mice. *, *** represents significantly different to 4.6pmol/cm2 
1,25(OH)2D, at 3 hours post UVR, p<0.05, 0.001, respectively. Results are from a 
single experiment, with 3 mice per group. 
 
 
 
 
a. 
b. 
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 Effect of DIDS on 1,25(OH)2D and 20(OH)D reduction of thymine dimers 3.1.4
following UVR 
It has been established in this lab that DIDS, a chloride channel antagonist, 
completely reverses the protective effect of 1,25(OH)2D and in thymine dimer 
formation (Dixon et al., 2007, Dixon et al., 2011). The current study not only 
confirmed this finding but also suggests that the protective effect of 20(OH)D is also 
inhibited by DIDS. According to previous work in this lab, DIDS was used at 50μM to 
block outwardly rectifying chloride channels (Sequeira et al., 2012a). Figure 3.8 
shows a significant reduction in thymine dimers when keratinocytes were treated 
with 1nM1,25(OH)2D or 20(OH)D compared to vehicle-treated cells. As expected 
DIDS on its own at 50μM had no protective effect. The combination of 50μM DIDS 
and 1nM 125D was not significantly different to vehicle or 50μM DIDS treated cells, 
which shows that DIDS completely reverses the protective effect of 125D. The same 
phenomena was seen in the combination of 50μM DIDS and 1nM 20(OH)D.  
 99 
 
 
Figure ‎3.8 DIDS completely reverses 1,25(OH)2D- and 20(OH)D-induced reduction 
of thymine dimers in human keratinocytes following UVR.  
Keratinocytes were treated immediately before UVR with vehicle (0.1% DMSO) or 
50μM DIDS. Immediately following UVR, cells were incubated with vehicle (1% EtOH 
and 1% DMSO), 1nM 1,25(OH)2D, 50μM DIDS, the combination of 1,25(OH)2D and 
50μM DIDS, 1nM 20(OH)D, and the combination of 1nM 20(OH)D and 50μM DIDS. 
Cells were fixed 3 hours post-UVR, and subjected to immunohistochemical staining 
using an antibody directed against thymine dimers. Image analysis was used to 
quantify stained nuclei as a proportion of total nuclei. Results express the mean of 
quadruplicate wells ± SEM pooled from a total of two independently tested 
experiments. *** represents significantly different from vehicle, p<0.001; ###, # 
represent significantly different from the corresponding sham group, p<0.001, 
p<0.05 respectively; @@@ represents significantly different to 1nM 1,25(OH)2D, 
p<0.001; %%% represent significantly different to 1nM 20(OH)D, p<0.001. 
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 Effect of the Wnt pathway inhibitor IWR-1 on the photoprotective effects 3.1.5
of 1,25(OH)2D- and 20(OH)D-induced reduction of thymine dimers 
following UVR. 
In the current study, IWR-1, a Wnt inhibitor was used to determine whether Wnt 
signalling is involved in vitamin D compound-mediated protection against DNA 
damage, namely thymine dimers. As expected, at 3 hours post-UVR exposure, 
1,25(OH)2D and 20(OH)D were significantly photoprotective at 1nM, compared to 
vehicle treatment (fig 3.9). IWR-1 at 12 μM was also photoprotective, although not 
to the same extent as 1,25(OH)2D and 20(OH)D. Additionally, protection against 
thymine dimers remained when 1nM 1,25(OH)2D and 12 mM IWR-1 were combined 
or 1nM 20(OH)D and 12 mM IWR-1 were combined. 
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Figure ‎3.9 The Wnt pathway inhibitor IWR-1 reduced thymine dimers and had no 
effect on 1,25(OH)2D- and 20(OH)D-induced reduction of thymine dimers 
following UVR.  Keratinocytes were treated immediately before UVR with vehicle 
(0.1% DMSO) or 12μM IWR-1. Immediately following UVR, cells were incubated 
with vehicle (1% EtOH and 1% DMSO), 1nM 1,25(OH)2D, 12μM IWR-1, the 
combination of 1,25(OH)2D and 12μM IWR-1, 1nM 20(OH)D, or the combination of 
1nM 20(OH)D and 12μM IWR-1 immediately following UVR. Cells were fixed 3 hours 
post-UVR, and subjected to immunohistochemical staining using an antibody 
directed against thymine dimers. Image analysis was used to quantify stained nuclei 
as a proportion of total nuclei. Results express the mean of quadruplicate wells ± 
SD. Similar results were seen in one further experiment. *** represents significantly 
different from vehicle, p<0.001; ###, # represent significantly different from the 
corresponding sham group, p<0.001, p<0.05 respectively; @@@ represents 
significantly different to 1nM 1,25(OH)2D, p<0.001; %%% represent significantly 
different to 1nM 20(OH)D, p<0.001. 
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3.2 DISCUSSION 
 Photoprotection by 1,25(OH)2D,  20(OH)D and THC 3.2.1
Reports from this laboratory have shown the photoprotective abilities of 
1,25(OH)2D and 1,25(OH)2D analogues against the formation of UVR-induced 
thymine dimers. The current study confirmed this finding in both in vitro and in vivo 
experiments. While thymine dimers are not mutagenic, they accurately represent 
the proportion of mutagenic pyrimidine dimers such as cytosine-thymine dimers 
that form following UVR exposure (Mouret et al., 2006, Matsumura and 
Ananthaswamy, 2004). In this study thymine dimer formation was detected via 
immunohistochemistry with a monoclonal antibody and image analysis. Various 
reports have previously shown that 1,25(OH)2D is photoprotective against the 
formation of DNA damage thus this was used as the positive control for the 
experiments (Bikle et al., 2013, Dixon et al., 2007, Dixon et al., 2005, Dixon et al., 
2011, Gordon-Thomson et al., 2012, Sequeira et al., 2012a, Sequeira et al., 2012b). 
The current study confirmed this finding. Application of 20(OH)D or THC following 
exposure to UVR caused a reduction in thymine dimers in both cultured 
keratinocytes and Skh:Hr1 mouse epithelium, indicating protection against UVR-
induced DNA damage. 
 
20(OH)D, along with other metabolites, is formed via the hydroxylation of the side 
chain of vitamin D3 by the CYP11A1 enzyme present in the skin (Slominski et al., 
2012b, Tuckey et al., 2011, Slominski et al., 2005b, Guryev et al., 2003a, Tuckey et 
al., 2008b). 20(OH)D has already been shown to have 1,25(OH)2D-like activity by 
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inducing the differentiation of keratinocytes and monocytes, as well as anti-
proliferative and anti-inflammatory effects in human keratinocytes and melanoma 
cells (Zbytek et al., 2008a, Janjetovic et al., 2011a, Slominski et al., 2013), making it 
an excellent anticancer candidate.   
 
As a newly discovered molecule, there is no data on the photoprotective 
capabilities of 20(OH)D. Despite the evidence for photoprotection by 1,25(OH)2D, its 
use as a topical photoprotective agent is not viable since it causes toxic 
hypercalcaemia. 20(OH)D is far more chemically stable than 1,25(OH)2D and does 
not cause hypercalcaemia, even at high doses (Wang et al., 2012a) and thus shows 
promise as a novel pharmacological agent to enhance photoprotection. VDR 
knockout (VDRKO) mice, which do not express the genes for encoding the VDR, are 
more prone to the development of photocarcinogenesis. It has been reported that 
1α-hydroxylase knockout mice, which cannot 1α-hydroxylate vitamin D compounds 
to produce 1,25(OH)2D or presumably 1,25-dihydroxylumisterol (JN), are not more 
susceptible to photocarcinogenesis (Bikle et al., 2012).. This strongly suggests that 
other vitamin D derivatives, such as 20(OH)D, could potentially contribute to 
protection from UV damage, by binding to the VDR.  
 
Prior studies on the effects of 20(OH)D have shown that it binds to the VDR, though 
at a lower affinity than 1,25(OH)2D to exert its effects (Zbytek et al., 2008b, 
Janjetovic et al., 2011b). However, results from the Mason group have also shown 
that whilst photoprotection by 1,25(OH)2D requires the VDR, the VDR does not 
necessarily need to be intact. Fibroblasts from donors with hereditary vitamin D-
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resistant rickets (HDVRR) with a defective DNA binding domain, or a mutation in 
helix H1 of the ligand binding domain, were still protected from UVR-induced DNA 
damage with 1,25(OH)2D application compared to non-treated fibroblasts. 
Mutations in these areas of the receptor mean that genomic effects of ligand 
binding are abolished. Fibroblasts which did not express the VDR at all were not 
protected from UV induced DNA damage by 1,25(OH)2D (Sequeira et al., 2012b). \ 
Treatment of normal fibroblasts with an antiserum to the membrane bound 
putative vitamin D receptor (siRNA to ERp57) reversed 1,25(OH)2D-mediated 
protection (Zbytek et al., 2008b, Janjetovic et al., 2011b). This suggests ligand 
binding to both the VDR and ERp57 to initiate non-genomic effects as one of the 
essential steps photoprotection. The membrane bound receptor ERp57, 
preferentially binds the planar 6-s-cis locked non-genomic agonists of vitamin D 
sterols, such as JN (Mizwicki et al., 2004, Mizwicki et al., 2010, Mizwicki and 
Norman, 2009). The biologically active form of 20(OH)D, is in the s-enantiomer form 
(Zbytek et al., 2008b) also mediates non-genomic effects following binding to the 
VDR, without generating genomic effects (Slominski et al., 2010). This makes 
20(OH)D a viable option as an ERp57 or alternate VDR pocket agonist, through 
which could mediate photoprotection against UVR. However, further molecular 
modelling studies on its confirmation and VDR-binding would be required to fully 
determine this theory. 
 
It has recently been observed in this laboratory that 1,25(OH)2D reduces DNA 
damage resulting from the potent oxidative stress caused by UVR (Gordon-
Thomson et al., 2012, Gupta et al., 2007, Sequeira et al., 2012b). Previous results 
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from this group have shown by immunohistochemical staining of mouse skin that 
1,25(OH)2D at a concentration of 23mol/cm
2 reduced formation of 8-oxo-7,8-
dihydro-2'-deoxyguanosine (8oxodG), the predominant UVR-induced oxidative 
lesion, following UVR when compared to untreated mice at 3 hours post treatment. 
Furthermore, using a newly developed comet assay, human 8-oxoguanine 
glycosylase (hOGG) repair enzyme sites were shown to be reduced as early as 30 
minutes following UVR with 1,25(OH)2D compared to vehicle (Gordon-Thomson et 
al., 2012). Thus, use of 1,25(OH)2D was used as a positive control and results 
presented in this chapter indicate that in cultured keratinocytes, 1,25(OH)2D 
reduced 8oxodG lesions compared to vehicle treated cells.  8oxodG is formed by 
oxidative radical-mediated oxidation of guanine on DNA strands, by UVR induced 
ROS, such as super oxide and hydroxyl radicals (Cadet et al., 2003, Cadet et al., 
2005). Reduction in 8oxodG when tissue is treated with 1,25(OH)2D  suggests that 
1,25(OH)2D  has antioxidant capacity or enhances repair of these lesions.  
 
THC as an antioxidant has mixed reviews. THC has been shown to have stronger 
antioxidant activity than its parent molecule curcumin (Okada et al., 2001, Osawa et 
al., 1995, Sugiyama et al., 1996), in several types of cells whilst in others it is not as 
effective (Murakami et al., 2008, Hong et al., 2004). Curcumin is a known 
suppressor of the expression of iNOS, JNK, nuclear factor kappa B (NF-b) and COX-
2, all mediators of cellular inflammation and oxidation (Hong et al., 2004, Menon 
and Sudheer, 2007). THC reduced the oxidation of low density lipoproteins (LDLs) 
both in in vivo and in vitro models, suggesting that it might be a good candidate for 
the prevention of atherosclerosis (Naito et al., 2002). The oxidative mechanism of 
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THC is thought to be attributed to scavenging of oxidative free radicals such as 
tertbutoxyls and peroxyls (Sugiyama et al., 1996). Similarly, hydrogenation of the 
central carbon bonds of curcumin to get THC make it a better scavenger of radicals 
in red blood cell haemolysis models, even in comparison to a known anti-oxidant, 
trolox (Somparn et al., 2007). It should be noted however that in the previously 
mentioned studies on the antioxidant abilities of THC, the THC was used was at 
micromolar concentrations, whereas the current study saw functional antioxidant 
effects at nanomolar concentrations. 
 
Considering the current results showing that THC reduced UVR-induced oxidative 
damage, and that oxidative damage may also contribute to CPD formation (Gordon-
Thomson et al., 2012), it is possible to propose that THC prevents both CPD 
formation and oxidative mutations in DNA via scavenging free radicals caused by 
UVR. Additionally it is known that curcumin is an analogue of 1,25(OH)2D and can 
bind to the alternative pocket of the VDR, to induce non-genomic effects, as seen 
with 1,25(OH)2D (Jurutka et al., 2007). Given that THC and curcumin have similar 
chemical structure and THC displays almost identical effects to curcumin (Pari and 
Amali, 2005), it is therefore possible that THC at nanomolar concentrations may be 
exerting photoprotection from UVR via binding to the alternate pocket of the VDR. 
The data in this chapter however are preliminary results so further inquiries into 
anti-oxidant capabilities of the two compounds must be sought.  
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 Mechanisms of photoprotection by 1,25(OH)2D and 20(OH)D 3.2.2
The mechanism of photoprotection from DNA damage through the non-genomic 
actions of 1,25(OH)2D is not yet well understood. It has previously been 
demonstrated via whole-cell patch clamping that 1,25(OH)2D and related 
compounds cause upregulation of chloride channels in osteoblastic ROS cell lines 
resulting rapid non-genomic changes within the cell (Zanello and Norman, 2006, 
Zanello and Norman, 1996, Zanello and Norman, 1997, Zanello and Norman, 2003). 
Using DIDS, a specific chloride channel inhibitor, the non-genomic effects of the 
1,25(OH)2D were abolished in this cell line. Recent findings from this laboratory 
have shown the involvement of these outwardly rectifying chloride channels in 
photoprotection against formation of UVR-induced thymine dimer-type CPDs by 
1,25(OH)2D (Sequeira et al., 2012a).   
 
Since 20(OH)D binds to the VDR (Zbytek et al., 2008b)  and has been shown to 
produce the non-genomic effects of 1,25(OH)2D almost exclusively (Slominski et al., 
2010), it was of interest to investigate whether chloride channel blockade by DIDS 
reversed its effect on DNA damage following UVR. UVR- induced thymine dimer 
formation was reduced in the current study following treatment with 1,25(OH)2D 
and 20(OH)D at a low dosage titration compared to controls. As a positive control, I 
showed that photoprotection by 1,25(OH)2D following UVR was reversed with the 
addition of DIDS, as was discovered in the study by Sequiera et al (2012). The 
photoprotective effect of 20(OH)D was completely reversed in the presence of 
DIDS. It is evident that 20(OH)D-mediated protection against UVR-induced CPD 
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formation occurs via induction and upregulation of chloride channels following 
binding to the VDR. This supports the hypothesis that the photoprotective abilities 
of 20(OH)D occur in a similar manner to the non-genomic effects of 1,25(OH)2D 
binding to the VDR.  
 
An additional mechanism of photoprotection by 1,25(OH)2D is thought to be via the 
induction or inhibition of several molecular and intracellular signalling pathways 
pertaining to altered apoptosis activation (De Haes et al., 2003). 1,25(OH)2D caused 
an increase in phosphorylation of ERK and Akt compared to untreated cells (De 
Haes et al., 2004a). Treatment of keratinocytes with MEK/ERK or PI3K/Akt 
inhibitors, PD98059 or LY294002 following UVR, reversed the anti-apoptotic effect 
of 1,25(OH)2D, suggesting that 1,25(OH)2D promotes cellular survival after UV 
exposure via these pathways. However, it is difficult to know whether this effect is 
due to 1,25(OH)2D alone, since UVR itself promotes activation of ERK and Akt also 
(Peus et al., 1999, Wang et al., 2004). 
 
As for DNA damage, previous studies from this group have shown that inhibition of 
the PI3K/Akt or ERK pathway by wortmannin or ERK peptide inhibitor significantly 
reduce the formation of CPDs 3 hours following exposure to UVR, in comparison to 
untreated cells (Sequeira, 2011).. This is similar to the previous reports which show 
that use of ERK and PI3K/Akt inhibitors reduce apoptosis following UVR (Peus et al., 
1999, Wang et al., 2003). On a methodological note, results from De Haes et al 
(2004a) required pharmacological concentrations (10-6M) of 1,25(OH)2D to achieve 
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an anti-apoptotic effect, whilst our group, have shown that 1,25(OH)2D is effective 
at physiological concentrations (10-9M). 
 
It has been shown in osteoblasts that phosphorylation of Akt in turn phosphorylates 
-catenin, allowing it to move to the nucleus to begin gene transcription for cell 
survival (Rybchyn et al., 2011). Phosphatidylinositol 3’-OH kinase (PI3K) is known to 
be activated in keratinocytes exposed to UVR (Wang et al., 2003)  and its activation 
is known to cause recruitment of Akt to the plasma membrane (Stein and 
Waterfield, 2000). Induction of the PI3K/Akt pathway in skin cells exposed to low 
dose UVR is associated with a decrease in the presence of apoptotic proteins such 
as cytochrome c and caspases 3, 8 and 9 (Peus et al., 1999, Wang et al., 2003). 
 
At present the link between the ability of 1,25(OH)2D to reduce both apoptosis and 
DNA damage is not totally understood. The current study showed that inhibition of 
Wnt caused a slight but significant reduction in thymine dimers following UVR 
compared to vehicle treated keratinocytes, but not to the same significance as 
1,25(OH)2D or 20(OH)D. This is perhaps indicative that downstream targets of Wnt 
may have been activated via other pathways such as PI3K/Akt, that were affected 
by 1,25(OH)2D and 20(OH)D in order  to reduce the presence of UVR-induced 
thymine dimers.   
 
The difficulty of interpreting the present results lies in the fact that the Wnt 
inhibitor IWR-1-endo alone caused a moderate reduction in the number of thymine 
dimers present following UVR-exposure in keratinocytes. Additionally, 
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photoprotection against UVR-induced DNA damage by 1,25(OH)2D or 20(OH)D 
remained in the presence of the IWR-1-endo. Interestingly although the Wnt-
inhibitor was effective at UVR photoprotection on its own, the combination of 
1,25(OH)2D or 20(OH)D plus IWR-1 did not produce compounded effectiveness of 
photoprotection, when compared to 1,25(OH)2D or 20(OH)D alone. The 
maintenance of photoprotection with 1,25(OH)2D and 20(OH)D in the presence of 
the Wnt inhibitor suggests that there are other intracellular mechanisms occurring 
which are facilitating their photoprotective abilities.   
 
A study by Haussler et al (2010) found that in keratinocytes the VDR upregulates the 
transcriptional activity of -catenin, independently of a bound ligand. Thus the 
photoprotective abilities of the VDR ligands, such as 1,25(OH)2D or 20(OH)D which 
are both produced endogenously, may occur via the ligand binding to the VDR 
which make it unavailable for -catenin interaction, decreasing proto-oncogenic 
gene transcription. Since unregulated growth activity is one of the six hallmarks of 
cancer (Hanahan and Weinberg, 2011, Hanahan and Weinberg, 2000) ligand binding 
to the VDR by naturally occurring hormones such as 1,25(OH)2D or 20(OH)D, causing 
inhibition of -catenin signalling may play a role in the multifaceted mechanism of 
1,25(OH)2D and 1,25(OH)2D -like compound prevention of photocarcinogenesis. In 
addition, basal cell carcinomas (BCCs) of keratinocytes were demonstrated to have 
abnormally high nuclear -catenin levels with low VDR expression (Aszterbaum et 
al., 1999), which suggests that the protective effects of ligand binding to the VDR 
are lost with a complete gain of function in the -catenin pathway, allowing 
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unregulated growth (Chen et al., 2009, Ordonez-Moran et al., 2008, Palmer et al., 
2008, Pendas-Franco et al., 2008). Moreover, that the protective abilities of 
1,25(OH)2D and other VDR ligands, may be most protective at the early stages of 
photocarcinogenesis. 
 
Upregulation of Wnt activity is a common occurrence in several types of cancers 
(Polakis, 2000, Segditsas and Tomlinson, 2006). Blockade of Wnt activity by IWR-1-
endo increases intracellular proteosomal degradation of -catenin, ultimately 
downregulating the transcription of proto-oncogenes (Chen et al., 2009). 
Downregulation of the Wnt signalling pathway has also been reported to reduce 
UV-induced skin carcinogenesis (Chaudhary et al., 2013). 
 
The protective abilities of 1,25(OH)2D and its analogues may not be limited to 
prevention of the formation of DNA damage, but also in the repair of UV-induced 
DNA damage. Studies from the Mason lab have shown that 1,25(OH)2D and 1α-25-
dihydroxylumisterol (JN), a vitamin D-like compound, reduce the formation of 
nitrotyrosine and nitrates in human keratinocytes  (Dixon et al., 2011, Gupta et al., 
2007, Sequeira et al., 2012a). Presence of nitric oxide products inhibits the efficacy 
of DNA repair (Bau et al., 2001) and induces DNA damage (Gordon-Thomson et al., 
2012), thus their reduction may allow for enhanced DNA repair and diminish the 
formation of thymine dimers and nitrosative DNA lesions. Furthermore, the Mason 
lab has shown that p53 is upregulated in primary human keratinocytes following  
treatment with UVR, and this was further heightened in cells treated with both UVR 
and 1,25(OH)2D (Sequeira et al., 2012b). p53 is the major cell cycle checkpoint 
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regulator, increasing time for DNA damage repair or apoptosis if the damage is 
unrepairable (Matsumura and Ananthaswamy, 2002).  Since 20(OH)D and THC are 
equally as photoprotective as 1,25(OH)2D  against the formation of UV-induced DNA 
damage, further studies into their effects on nitric oxide products and p53, and 
would be advantageous.  
 Gender bias in photoprotection 3.2.3
It is currently well established that prevalence of skin cancer is higher in males than 
females, and that prognosis for most cancers is generally better for females than for 
males (Molife et al., 2001, Thomas-Ahner et al., 2007, Leiter and Garbe, 2008, 
Staples et al., 1998, Staples et al., 2006).  In the present studies, development of 
thymine dimers was greater in male mice in comparison to female mice following 
the same time of exposure to the same dose of UVR, which suggests that the 
disparity in photocarcinogenesis between the sexes may occur even as early as the 
first DNA damage.  
 
Moreover, in agreement with previous findings, 1,25(OH)2D decreased the 
formation of CPDs in mice skin 3 hours following UVR exposure. However, whilst 
treatment with 1,25(OH)2D following UVR was effective at reducing thymine dimer 
formation in both sexes, the reduction was more pronounced in females than males 
at the lowest dosage (4.6mol/cm2).  
 
Application of 20(OH)D also significantly reduced the appearance of thymine dimers 
following UVR, to an equal extent as 1,25(OH)2D at the same concentration. 
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However, 20(OH)D was not applied at 4.6mol/cm2, thus it cannot be concluded 
that 20(OH)D would be more effective in males than females at this concentration. 
Similarly, THC was used only at 115mol/cm2, a concentration known to effectively 
reduce DNA damage (Ryan, 2010). 
 
At present there is limited data on the difference in effectiveness of 
photoprotection by 1,25(OH)2D between male and female mice. However, results 
from this study suggest that female skin requires a smaller concentration of 
1,25(OH)2D than does male skin to achieve protection from UVR-induced DNA 
damage, indicating the existence of another factor mediating protection in females. 
 
In general, males are more susceptible to UVR-induced immunosuppression, 
sunburn, and photocarcinogenesis than females (Broekmans et al., 2003, Damian et 
al., 2008, Foote et al., 2001, Preston and Stern, 1992). Furthermore, following 
menopause, women with drastically reduced oestrogen production, have decreased 
skin elasticity, increased dryness and dermal thickness, all of which are improved 
with oestrogen therapy (Bottai et al., 2013). Taken together, this suggests that 
oestrogen or a female sex hormone receptor is vital in the maintenance of skin 
health and protection from UVR. 
 
Skin cells, both keratinocytes and fibroblasts, treated with exogenous 17-estradiol 
show a reduction in peroxide-induced oxidative damage in comparison to their 
vehicle treated counterparts (Bottai et al., 2013). Since UVR causes oxidative 
damage (Matsumura and Ananthaswamy, 2004) and oxidative damage may lead to 
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the formation of CPDs (Gordon-Thomson et al., 2012, Gupta et al., 2007), this 
indicates that in females, endogenous 17-estradiol may attenuate both direct and 
indirect forms of UVR-induced damage. In contrast, pre-treatment of HaCaT cells 
with 17-estradiol slowed removal of UVB-induced thymine dimers 4 hours 
following UV irradiation (Evans et al., 2003). As a result, it was concluded that since 
nucleotide excision repair (NER) is responsible for the elimination of CPDs, 
treatment with exogenous oestrogen inhibited NER, and thus oestrogens may also 
play a role in the progression of DNA damage to pathologic mutations in 
photocarcinogenesis (Evans et al., 2003).  
  
Recently, it has been proposed that the gender bias seen in carcinogenesis may be 
mediated by oestrogen receptor (ER)- signalling (Catley et al., 2008, Chaudhary et 
al., 2013, Cho et al., 2010, Reeve et al., 2009, Thornton et al., 2003b). Male and 
female human skin contains mostly ER- with no significant difference in 
distribution between the sexes (Thornton et al., 2003b). ER- has been shown to 
mediate tumour suppression in colon, kidney and hepatic tumours, and had been 
shown to reduce immunosuppression induced by UVR (Cho et al., 2010).  
 
Furthermore, a recent study by Chaudhary et al. (2013) showed that topical 
treatment with an ER- agonist, Erb-041, on UVB-exposed Skh:Hr1 hairless mice 
caused a reduction in UVB-induced tumour growth compared to vehicle treated 
cells. Furthermore, the study showed that Erb-041 attenuated growth and 
proliferation of a squamous cell carcinoma cell line, and also prevented invasiveness 
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and migration of tumours via downregulation of Wnt signalling, which hindered -
catenin mediated cell growth and angiogenesis (Chaudhary et al., 2013). These 
findings, in conjunction with the results from the current study provide evidence for 
a role in inhibition of Wnt and ER- agonists in the prevention of 
photocarcinogenesis, from its beginnings with DNA damage to tumour metastasis. 
In other studies from the Mason group, use of an ER- inhibitor in female Skh:Hr1 
mice reduced the ability of 1,25(OH)2D to decrease DNA damage induced by UVR 
(Tongkao-on, 2014).  
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4 PHOTOPROTECTION AGAINST UVR-INDUCED INFLAMMATION AND 
IMMUNOSUPPRESSION USING NOVEL VITAMIN D COMPOUNDS IN MICE 
4.1 RESULTS 
 Effect of 1,25(OH)2D and 20(OH)D on the acute inflammatory effects of 4.1.1
UVR in hairless Skh:Hr1 mice 
Several preliminary reports from this laboratory have shown that 1,25(OH)2D and 
various compounds reduce inflammation and oedema produced in mouse skin 
following UVR (Dixon et al., 2011, Poliakov, 2009, Ryan, 2010). This finding was 
confirmed in the current study. Hairless Skh:Hr1 female mice were exposed to 
2.5MED UVR or sham-UVR and immediately treated with vehicle, 23 ρmol/cm2 
1,25(OH)2D, 23 ρmol/cm
2 20(OH)D, or 46 ρmol/cm2 20(OH)D. The inflammatory 
erythema reaction to UVR exposure was quantified by measuring the increase in 
dorsal skinfold thickness (Fig 4.1). UVR-exposed mice in all groups displayed 
inflamed and oedematous dorsal skin for approximately 3 days following UVR, 
whilst their sham-irradiated counterparts showed no signs of skin changes between 
pre- and post-treatment. Groups of mice exposed to UVR and treated with vehicle 
were more susceptible to the acute inflammatory effects of UVR, generally 
displaying the greatest increase in skinfold thickness, when compared to other 
treatment groups. On the other hand, 20(OH)D at both concentrations significantly 
reduced inflammation, whilst 1,25(OH)2D had no significant effect. Erythema and 
oedema became less prevalent at approximately 72 hours and treatment and UVR-
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exposed mice showed signs of desquamation, or “peeling” with tough, thickened 
skin.  
 
 
Figure ‎4.1 Two concentrations of 20(OH)D reduce the acute inflammatory effects 
of UVR in female Skh:Hr1 hairless mice. Groups of 5 mice were exposed to 2.5MED 
UVR or sham-UVR and immediately treated with vehicle, 23 ρmol/cm2 1,25(OH)2D, 
23 ρmol/cm2 20(OH)D, or 46 ρmol/cm2 20(OH)D. Mid dorsal skin-fold thickness was 
measured at 24 hours post UVR to give a quantification of inflammation and 
oedema. *, ** represents significantly different to UV vehicle p<0.05, p<0.01 
respectively; ### represents significantly different to sham groups, p<0.001. Sham 
groups were not significantly different from each other, p>0.05. 
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In addition to the initial experiment, the effect of treatment with 1,25(OH)2D and 
20(OH)D on UVR-induced skin inflammation was studied in male and female 
Skh:Hr1 mice to determine any variation between sexes. A higher dose of 
1,25(OH)2D (46 ρmol/cm
2) was used in the successive experiment as the lower dose 
(23 ρmol/cm2) had previously shown no protection against UVR-induced 
inflammation in females.  
 
In this experiment, mice in all treatment groups exposed to 2.5MED UVR showed a 
significant increase in skin inflammation, compared to their sham-UVR 
counterparts, as seen in Figure 4.2 (a and b). In general, the extent of UVR-induced 
inflammation was greater in female groups (fig 4.2a), compared to males (fig 4.2b), 
however treatment with 1,25(OH)2D and both concentrations of 20(OH)D was more 
effective in reducing inflammation in females than males.  
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Figure ‎4.2 Effect of 1,25(OH)2D and 20(OH)D on UVR-induced skin inflammation in 
a. male and b. female Skh:Hr1 hairless mice.  
a. 
b. 
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Groups of 5 mice were exposed to 2.5MED UVR or sham-UVR and immediately 
treated with vehicle, 46 ρmol/cm2 1,25(OH)2D, 23 ρmol/cm
2 20(OH)D, or 46 
ρmol/cm2 20(OH)D. Mid dorsal skin-fold thickness was measured at 48 hours post 
UVR to give a quantification of inflammation and oedema. *, *** represents 
significantly different to UV vehicle p<0.05, p<0.001 respectively; ### represents 
significantly different to sham groups, p<0.001. Sham groups were not significantly 
different from each other, p>0.05. 
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 Effect of 1,25(OH)2D and 20(OH)D on UVR-induced immunosuppression in 4.1.2
female Skh:Hr1 mice 
Previous data from this lab has shown evidence for defence from UVR-induced 
immunosuppression by 1,25(OH)2D and its analogues in Skh:Hr1 mice (Dixon et al, 
2005, Dixon et al 2011). In order to determine whether 20(OH)D may be protective 
against UVR-induced immunosuppression, using the contact hypersensitivity (CHS) 
test, mice from 4 out of the 8 groups were irradiated with 2.5MED of UVR and 
immediately following UVR all mice were treated with vehicle,  23 pmol/cm2 
1,25(OH)2D, 23 pmol/cm
2 20(OH)D, or 46 pmol/cm2 20(OH)D. One week following 
UVR all mice were sensitised with 2% oxazolone ventrally, and a further 7 days later, 
mice were challenged with the same antigen, away from the initial site of 
sensitisation on the each side of the pinnae of the ears.  
 
The effect of 1,25(OH)2D and 20(OH)D on UVR-induced systemic 
immunosuppression was assessed by using difference in ear thickness 
measurements taken from both UV-irradiated and sham mice pre- and post-
challenge. Generally, elicitation of the local reaction is seen most notably 16 to 20 
hours post-challenge. Immunosuppression is manifest in a lack of, or sub-normal 
ear swelling following challenge, compared to sham-UVR vehicle treated mice. 
 
Figure 4.3a shows the CHS response at 16 hours following challenge was seen most 
notably in sham-UVR groups. Application of 1,25D(OH)2D or 20(OH)D at both doses 
had no effect on ear swelling following challenge in mice exposed to sham-UVR, 
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compared to the sham-UVR vehicle-treated control group. UVR caused suppression 
of the systemic CHS response to oxazolone and as expected, mice treated with 
vehicle following irradiation exhibited significantly less ear swelling compared to 
mice in the vehicle treated sham-UVR group. Suppression was reversed in mice 
treated with 1,25(OH)2D or 20(OH)D at both doses. 
 
Figure 4.3b is a quantitative representation of immunosuppression in UVR-exposed 
mice expressed as a percentage of their sham counterparts in each treatment 
group. Immunosuppression in mice treated with vehicle was 37.5±5.7%, which was 
reduced to 7.8±4.4% with 23 pmol/cm2 1,25(OH)2D. Treatment with 23 pmol/cm
2 or 
46 pmol/cm2 20(OH)D significantly reversed immunosuppression to 3.6±0.5% and 
4.8±0.6%, respectively. There was no significant difference in protection from UVR-
induced immunosuppression between 1,25(OH)2D and 20(OH)D at both doses.  
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Figure ‎4.3 1,25(OH)2D and 20D reduce UVR-induced immunosuppression in female 
Skh:Hr1 hairless albino mice. Groups of 5 mice were irradiated with 2.5MED UVR 
and treated immediately with 23 pmol/cm2 1,25(OH)2D, 23 pmol/cm
2 20D or 46 
pmol/cm2. Ear thickness measurements were recorded pre-oxazolone challenge and 
16 hours following challenge. a) Difference in change in ear thickness between pre- 
and 16 hours post-challenge b) Percent immunosuppression, calculated as 
described in 2.3.6. *** represents significantly different to vehicle at 16 hours post 
UVR (***p<0.001). Results are from a single experiment.  
a. 
b. 
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 Effect of a high dose of 1,25(OH)2D and 20(OH)D on UVR-induced 4.1.3
immunosuppression in both male and female Skh:Hr1 mice. 
In contrast to the findings of Dixon et al (2007) that vitamin D compounds protect 
against UVR-induced immunosuppression and have no basal immunosuppressive 
effects in mice, the Mason group and others previously reported in humans that at 
high physiological concentrations 1,25(OH)2D was immunosuppressive (Damien et 
al, 2010, Zuo et al, 1992). Additionally, Gorman et al (2009) found that in BALBc 
hairy mice topical application of 1,25(OH)2D alone was slightly immunosuppressive, 
and when used in combination with UVR-exposure had an additive effect on UVR-
induced immunosuppression. In addition, it has been shown that male mice with 
normal serum 25(OH)D levels have a reduced CHS response compared with females 
under the same conditions. Since the initial immunosuppression experiment 
showed that a low dose of 1,25(OH)2D (23 pmol/cm
2) did not cause basal 
immunosuppression, and a higher dose of 1,25(OH)2D (46 pmol/cm
2) was required 
to reduced oedema following UVR exposure,  it was of interest to test whether the 
higher dose caused basal immunosuppression and further, whether 20(OH)D at the 
same concentration was comparable. In the current study male and female Skh:Hr1 
mice were exposed to either 2.5 MED UVR or sham-UVR, and were treated 
immediately treated with vehicle, 46 pmol/cm2 1,25(OH)2D, 23 pmol/cm
2 20(OH)D, 
or 46 pmol/cm2 20(OH)D. Sensitisation and challenge was undertaken as in section 
4.1.2. 
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In this experiment, peak ear swelling was seen within 16-18 hours post-oxazolone 
challenge, and for both males and females, the sham-UVR vehicle treated mice 
elicited the greatest swelling or the ears (fig 4.4). In males, application of 46 
pmol/cm2 1,25(OH)2D and 23 pmol/cm
2or 46 pmol/cm2 20(OH)D caused basal 
reduction in ear swelling compared to sham-UVR vehicle, with no additional 
exposure to UVR (fig 4.4a) for 20(OH)D. Treatment with 46pmol/cm2 1,25(OH)2D  
and UVR caused the greatest reduction in CHS response compared to both 
concentrations of 20(OH)D under sham and UVR conditions. In females, UVR caused 
significant suppression of the CHS response (fig 4.4b). Treatment with 23 pmol/cm2 
20(OH)D had no effect on the basal CHS response, and also protected against UVR-
induced CHS suppression.  Application of 46 pmol/cm2 1,25(OH)2D and 46 pmol/cm
2 
20(OH)D  caused reduction in ear swelling, however this was slightly reversed in the 
UVR-exposed 46 pmol/cm2 20(OH)D treated mice.  
 
Figure 4.5 shows percent immunosuppression in UVR-exposed mice expressed by 
comparison with their sham counterparts in each treatment group (see 2.3.6). In 
the male vehicle group, the percentage immunosuppression was 41.5±5.2% whilst 
in females it was 28.7±2.1%, showing that males were more susceptible to UVR-
induced immunosuppression. It could be argued that it is not possible to interpret 
results in the face of immune suppression by test agent alone. Nevertheless data 
analysis showed that there was slightly less reduction in ear swelling caused by UV 
in male mice treated with 46 pmol/cm2 1,25(OH)2D, while in female mice treatment 
with 46 pmol/cm2 1,25(OH)2D caused no further reduction in ear  swelling.  In both 
sexes, despite basal suppression of the CHS response, treatment with 46 pmol/cm2 
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1,25(OH)2D significantly reduced UVR-induced immunosuppression, 30.57±3.11% in 
males and 3.0±0.4% in females. Males treated with 20(OH)D at 23 pmol/cm2 
showed 4.6±0.6% , and 46pmol/cm2 were 0.9±0.1% immunosuppressed, which was 
more effective than 46 pmol/cm2 1,25(OH)2D (fig 4.5a). At 23 pmol/cm
2 20(OH)D 
female mice had significantly lower UVR-induced immunosuppression, 4.0±0.4%, 
and a greater change in ear swelling compared with no UV in mice treated with 46 
pmol/cm2 and UV (fig 4.5b).  
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Figure ‎4.4 Change in ear thickness between pre- and 16-18 hours post-challenge in 
a) male and b) female Skh:Hr1 mice. Groups of 5 mice were irradiated with 2.5MED 
UVR and treated immediately with 23 pmol/cm2 1,25(OH)2D, 23 pmol/cm
2 20(OH)D 
or 46 pmol/cm2 20(OH)D. Ear thickness measurements were recorded pre-
oxazolone challenge and 16 hours following challenge.*,*** represents significantly 
different to sham vehicle, p<0.05, 0.001 respectively. @, @@, @@@ represents 
significantly different to UV 1,25(OH)2D, p<0.05, 0.01, 0.001 respectively. 
a. 
b. 
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Figure ‎4.5 1,25(OH)2D and 20(OH)D reduce UVR-induced immunosuppression 
compared to 1,25(OH)2D and 20(OH)D sham treated mice in a) male and b) female 
Skh:Hr1 hairless albino mice. **, *** represents significantly different to vehicle at 
16 hours post UVR, p<0.01, 0.001 respectively. Results are from a single 
experiment, with 5 mice per group.  
 
 
 
 
 
a. 
b. 
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 Effect of 20(OH)D on UVR-induced immunosuppression in female estrogen 4.1.4
receptor β-knockout (ERβ-KO) and wildtype mice 
It has previously been reported that female mice with an ablated estrogen receptor-
β (ER-β) show a significant decreased protection against UVR-induced 
immunosuppression and enhanced tumour growth  (Cho et al, 2010). In addition to 
this preliminary reports from the Mason lab have shown that female ER-β knockout 
mice are more susceptible to CPD formation following UVR, and that 1,25(OH)2D-
mediated protection against UVR-induced immunosuppression is reversed with 
topical application of  ICI 182780, an  ER-β antagonist, in female Skh:Hr1 mice 
(Tongkao-on, 2014). Since, I also found that male Skh:Hr1 mice were more 
susceptible to immunosuppression and that 20(OH)D-mediated protection was 
better than 1,25(OH)2D-mediated protection, yet female Skh:Hr1 mice treated with 
1,25(OH)2D or 20(OH)D were equally protected (4.4), I tested the effect of 20(OH)D 
on UVR-induced immunosuppression on ER-β knockout mice in comparison to 
wildtype.  
 
Under the same conditions as 4.3 and 4.4, mice were either exposed or not exposed 
to 2.5 MED UVR and immediately treated with vehicle (0.1% v/v ethanol), 23 
pmol/cm2 20(OH)D or 46 pmol/cm2 20(OH)D.  Since these mice were hairy, they 
were shaved dorsally prior to irradiation to ensure skin exposure to UVR and 
treatment. Additionally, seven days following UVR, mice were shaved and painted 
with 2% oxazolone on their ventral side. In this experiment, ear thickness 
measurements were taken 16-18 hours post-oxazolone challenge, two weeks after 
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UVR, since this was when peak swelling occurred.  As expected, the thickest ear 
swelling in response to challenge were those of sham-UVR vehicle treated mice in 
both ER-β and wildtype groups (fig 4.6). UVR caused suppression of the CHS 
response in both groups. Application of 23 pmol/cm2 20(OH)D had no basal 
immunosuppressive effects in mice from either group, and in wildtype mice it 
reversed UVR-induced suppression of CHS but had no protective effect in ER-β 
knockout mice (fig 4.6b). In wildtype mice, 46 pmol/cm2 20(OH)D was suppressive 
on its own, but did inhibit UVR-induced suppression of CHS (fig 4.6a). In the ER-β 
knockout mice, 46 pmol/cm2 20(OH)D alone suppressed CHS though not 
significantly. Ear swelling was similar with or without UV in mice treated with 46 
pmol/cm2 20(OH)D (fig 4.6b). 
 
Calculated protection against UVR-induced immunosuppression for wildtype and 
ER-β knockout mice is depicted in Figure 4.7a and Figure 4.7b, respectively. ER- β 
knockouts were 17% more immunosuppressed than their wildtype equivalents with 
vehicle treatment. Wildtype mice were completely protected at both 
concentrations of 20(OH)D. On the other hand, at 23pmol/cm2 20(OH)D had no 
protective effects in ER-β knockout mice, whilst 46 pmol/cm2 was protective, at 
least compared with sham mice treated with the same concentration 20(OH)D. 
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Figure ‎4.6 Difference in change in ear thickness between pre- and 16-18 hours 
post-challenge in female a) wildtype and b) ERβ-KO mice. Groups of 5 mice were 
irradiated with 2.5MED UVR and treated immediately with vehicle, 23 pmol/cm2 
20(OH)D or 46 pmol/cm2 20(OH)D. Ear thickness measurements were recorded pre-
oxazolone challenge and 16-18 hours following challenge.*,** represents 
significantly different to vehicle, p<0.05 and p<0.01, respectively. 
 
 
a. 
b. 
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Figure ‎4.7 1,25(OH)2D and 20(OH)D reduce UVR-induced immunosuppression in 
female a) wildtype and b) ERβ-KO mice. *** represents significantly different to 
vehicle at 16-18 hours post UVR, p<0.001. ### represents significantly different 
from each other, p<0.001. Results are from a single experiment, with 5 mice per 
group.  
 
 
 
a. 
b. 
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4.2 Discussion 
 1,25(OH)2D and 20(OH)D and UVR-induced inflammation 4.2.1
Acute exposure to UV irradiation is characterised initially by erythema and oedema 
(Matsumura and Ananthaswamy, 2002) and then cornification of keratinocytes 
within several days of the exposure (Lippens et al., 2005). Currently there is limited 
data on the effect of 1,25(OH)2D on UVR-induced inflammation, however 
preliminary results from this group have shown that 1,25(OH)2D (Dixon et al., 2011), 
and analogues such as curcumin and THC, significantly reduce inflammation in mice 
exposed to UVR, in comparison to littermates treated with vehicle. The effect of 
1,25(OH)2D on UVR-induced inflammation was used as a positive control, to test 
whether 20(OH)D acts as an anti-inflammatory agent following UVR in female and 
male albino Skh:Hr1 mice. In vehicle treated mice exposed to 2.5MED UVR, 
inflammation in the form of erythema and oedema was seen within 24 hours, whilst 
unirradiated mice showed no manifestations. As expected, 1,25(OH)2D caused a 
reduction in inflammation, as measured by skin thickness, following UVR in all 
experiments, with the most pronounced effect seen in males at the higher dosage 
(46mol/cm2). The decrease in skinfold thickness following UVR radiation by 
application of 1,25(OH)2D to female mice in section 4.1.1 was not significant which 
is contradictory to previous findings from this laboratory. Since this finding arose 
from a single initial experiment, without further testing it is not explicitly clear 
whether this is a true inconsistency or due to experimentation bias, such as human 
error in skinfold measurements. Time constraints prevented repetition of this 
investigation. 
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Female mice tended to respond better to applications of 20(OH)D compared to 
males, with maximal protection at 23mol/cm2. However, 20(OH)D at both 
concentrations reduced UVR-induced inflammation in males also. Furthermore, 
topical application of 20(OH)D did not cause inflammation in unirraditated mice, 
which was expected since it has been shown that 1,25(OH)2D does not cause any 
basal inflammation.  
Cyclooxygenase-2 (COX-2) is an enzyme induced by proinflammatory reagents in 
most tissues of the body (Horton et al., 1999, Williams et al., 1999). Its induction 
breaks down arachidonic acid to the inflammatory prostaglandin PG-E2 from 
(Williams et al., 1999), which is known to be a mediator of the vascular permeability 
causing erythema and oedema associated with UVR exposure (Warin, 1978b, 
Clydesdale et al., 2001). COX-2 induction and chronic inflammation has been 
implicated in the development and formation of carcinogenesis in many systems 
and because of this has been the target of development of non-steroidal anti-
inflammatory drugs (NSAIDS) as chemopreventative agents (Williams et al., 1999, 
Speed and Blair, 2011). 
It has previously been described that use of topical application of anti-inflammatory 
agents reduces the formation of tumours in UVR-exposed skin (Burns et al., 2013, 
Wilgus et al., 2004). Furthermore, a retrospective study in Denmark identified that 
incidences of malignant melanoma and SCC were lower in a population of people 
who were taking the commonly prescribed COX-2 inhibitors diclofenac, etodolac, 
and meloxicam (Johannesdottir et al., 2012). Similarly, topical application of the 
specific COX-2 inhibitor celecoxib in combination with ibuprofen, a non-specific 
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COX-2 inhibitor, to UVB irradiated mice decreased oedema and PG-E2 levels 
associated with UVR-induced inflammation (Johannesdottir et al., 2012). 
Furthermore, diclofenac, a topical COX-2 inhibitor reduced formation of tumour 
burden in mice exposed to 10 days of 1MED UVB, compared to untreated mice 
(Wilgus et al., 2000). These findings highlight the role of COX-2 in inflammation and 
photocarcinogenesis.  
Both 1,25(OH)2D and a low-calcaemic analogue, 1α,25(OH)2-16-ene-23-yne-D3 
caused inhibition of COX-2 in the RAW 264.7 lipopolysaccharide (LPS) stimulated 
mouse macrophage cells (Aparna et al., 2008). Furthermore the analogue inhibited 
proliferation of LPS activated mouse macrophages through reduction in iNOS and 
interleukin (IL)-2, both mediators of the inflammatory response (Aparna et al., 
2008).  This suggests that 1,25(OH)2D may be mediating its anti-inflammatory 
effects via COX-2 inhibition. Since an analogue with low genomic effects has proven 
to be as effective as 1,25(OH)2D at reducing inflammation via inhibition of COX-2, 
and 20(OH)D significantly reduced skinfold thickness following UVR, this shows 
promise that 20(OH)D may be an efficient anti-inflammatory agent working via a 
similar pathway.  
1,25(OH)2D is a known inhibitor of nuclear factor kappa-B (NF-B) by upregulating 
the NF-B-inhibitor IB- (Cohen-Lahav et al., 2007, Cohen-Lahav et al., 2006, Riis 
et al., 2004). NF-B is an intracellular a transcription factor involved in activating 
inflammatory mediators, such as increasing expression of COX-2 (Du et al., 2007). As 
a newly discovered molecule, there is limited evidence for the role of 20(OH)D as an 
anti-inflammatory agent. However, one paper has provided strong evidence that 
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20(OH)D inhibited NF-B by simultaneously upregulated IB- in human 
transformed and normal keratinocytes to the same extent as active 1,25(OH)2D, and 
that this effect was mediated via binding to the VDR (Janjetovic et al., 2009). Such 
evidence suggests that the decrease in skinfold thickness with topical application of 
1,25(OH)2D and 20(OH)D seen in the current experiment may be due their direct 
modulation of inflammatory mediators such as COX-2, or indirectly via pro-
inflammatory transcription factors such as NF-B.  
Another mechanism for the reduction in inflammation by 1,25(OH)2D is through 
suppression of pro-inflammatory IL-6, previously shown to be decreased in UV 
irradiated keratinocytes by concentration dependent application of 1,25(OH)2D (De 
Haes et al., 2003). Preliminary in vivo studies in this laboratory have also shown 
reduced IL-6 expression following UVR in mice treated with 1,25(OH)2D (Mason et 
al., 2010). 
In agreement with previous research (Thomas-Ahner et al., 2007, Reeve et al., 
2012), the present study found that female mice exhibited a greater increase in skin 
fold thickness compared to males following UVR, suggestive that their inflammatory 
response to UVR was greater. Moreover, mice skin displayed different responses to 
1,25(OH)2D and 20(OH)D depending on their gender, and the concentration of the 
utilised. It is well established that there are several differences between male and 
female skin, which has been attributed to factors such as hormones, protein 
expression and biochemical properties (Tur, 1997). Men generally have thicker 
epidermal layers than women (Seidenari et al., 1994), however women display 
greater amounts subcutaneous adipose tissue (Sjostrom et al., 1972). It was noted 
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in the current study that male mice had rough, thicker skin compared with female 
mice who had softer, pink skin.  
In terms of hormones, oestrogen is said to be a major determining factor in the 
difference between male and female skin. Female skin contains the enzyme 
aromatase, which converts excess testosterone to estradiol, the active form of 
oestrogen. As discussed in section 3.2.3, application of 17-estradiol to peroxide 
treated keratinocytes reduced oxidative damage (Widyarini et al., 2006), which 
shows a protective role for estradiol in pro-oxidative insults to the skin, such as UV. 
Further evidence for the protective role of oestrogen in skin lies in the fact that 
during the time following menopause, women’s skin thins substantially with a loss 
of barrier function, hypothesised to be due to the loss of circulating oestrogen 
(Shuster et al., 1975). Transepidermal water loss is greatest at the time during the 
menstrual cycle, when serum levels of oestrogen are at their lowest, just prior to 
menses, suggestive that oestrogen also helps maintain the barrier function of the 
skin. Validation of this comes from hormone replacement therapy studies that show 
skin thickness in post-menopausal women was increased by topical application of 
an oestrogen (Maheux et al., 1994). 
A recent study by collaborators of this group, observed via immunohistochemical 
staining, a smaller increase in the pro-inflammatory cytokine IL-6 in male mice 
following UVR, compared with the large increase seen in UVR-irradiated female 
mice (Reeve et al., 2012). Oestrogen generally stimulates the immune system, and it 
has been observed that women of reproductive age express higher amounts of pro-
inflammatory cytokines mediated through a heightened T1-helper cell response to 
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an antigen (Whitacre et al., 1999). Furthermore, results from a study in the female 
immune reaction showed that post-menopausal females spontaneously produce 
cytokines IL-4, IL-6, IL-10, IFN-γ and TNF-α. Presence of high amounts of these 
cytokines caused antagonism of each other making there net effect 
immunosuppressive (Dao and Kazin, 2007). It is likely that the loss of oestrogen 
reduces stimulation of the pro-inflammatory response. It should also be noted that 
the greater proportion of autoimmune diseases occur in women compared to men 
(Dao and Kazin, 2007). Influences of oestrogen may explain the greater skinfold 
thickness measured in females compared to males following UVR in this study and 
the results from Reeve et al., (2012).  
A recent paper by Chaudhary et al., (2013) found that use of Erb-041, an ER-1 
agonist in a Skh:Hr1 photocarcinogenesis model, reduced UVB-induced 
inflammation via reduction in IL-6, IL-10, iNOS, COX-2 and NF-B, amongst several 
others. The reduction in these cytokines was mediated via reduced phosphorylation 
of the MAPK/ERK signalling pathway, associated with cell inflammation and stress 
signalling. Furthermore, myeloperoxidase activity an indicator of neutrophil 
infiltration was reduced in Erb-041 treated mice (Chaudhary et al., 2013).   
The role of naturally occurring hormones 1,25(OH)2D and 20(OH)D in the skin in 
terms of anti-inflammation in humans is still not certain, and whether their effect is 
mediated by other naturally occurring hormones or gender-specific factors is 
certainly an area that needs further validation through experimentation. 
 139 
 
 1,25(OH)2D and 20(OH)D and immunosuppression 4.2.2
The current study confirmed previous findings that mice treated with vehicle alone 
after UVR showed an impaired response to the second application of the antigen, 
indicating immunosuppression. As expected (Dixon et al., 2007, Dixon et al., 2005), 
1,25(OH)2D at 23mol/cm
2  reversed UVR-induced immunosuppression in female 
Skh:Hr1 mice, measured by the contact hypersensitivity reaction. Additionally, at 
this concentration (23mol/cm2), 1,25(OH)2D did not cause any basal 
immunosuppression in unirradiated mice. Treatment with 1,25(OH)2D, at the higher 
concentration of 46mol/cm2 was basally immunosuppressive in both females and 
males, an outcome of topical 1,25(OH)2D treatment also seen in humans (Damian et 
al., 2008). This dose of 1,25(OH)2D prevented further UVR-induced 
immunosuppression in females and reduced further UV-immunosuppression in 
males compared to vehicle.   
 
It was also shown, for the first time, that at a concentration of 23mol/cm2 20(OH)D 
caused no basal immunosuppression and was as effective as 1,25(OH)2D at reducing 
immunosuppression following UVR in female mice. Like 1,25(OH)2D, 20(OH)D at 
46mol/cm2 did cause some basal immunosuppression in both sexes, and at 
23mol/cm2, despite the basal reduction in the immune response, further immune 
suppression by UVR was not observed in either male and female mice. The difficulty 
in interpreting the current results is that the vitamin D compounds were 
immunosuppressive on their own, which makes statements like “they reversed 
immunosuppression caused by UVR” somewhat problematic. Interestingly, the 
preliminary investigation (section 4.1.2, figure 4.3b) showed that 20(OH)D at 
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46mol/cm2 caused no basal immunosuppression in female mice, whilst further 
experimentation (section 4.1.3, figure 4.4b) demonstrated that there was basal 
immunosuppression. Determining the source of this inconsistency is challenging 
and since this is the first time 20(OH)D has been tested in UVR-immunosuppressive 
mice studies, further experimentation and repetition that was not possible due to 
time constraints,  is necessary to clarify these findings.  
 
As described in section 4.2.1, studies on the action of 20(OH)D on keratinocytes 
showed that it blocks activation of NF-B, via inhibition of IL-1 and 
lipopolysaccharide, known stimulators of the inflammatory response (Janjetovic et 
al., 2009). Whilst this is advantageous following acute inflammation, inhibition of 
NF-B transcription is immunosuppressive, which suggests that 20(OH)D is likely to 
be immunosuppressive. Given that NF-B has been implicated in the skin 
photoresponse to UVR, and 20(OH)D is produced by CYP11A1 action on vitamin D, 
this may be one endogenous pathway through which UVR-induced 
immunosuppression is mediated. On the other hand, studies by Gorman and 
colleagues have shown that UVR-induced immunosuppression still occurs both 
locally and globally in animal models of vitamin-D deficiency and repletion (Gorman 
et al., 2007). 
 
In contrast to being basally immunosuppressive, the current study also shows that 
both 1,25(OH)2D and 20(OH)D prevented additional  immune suppression following 
UVR, with the caveat expressed above, which suggests that there are other 
mechanisms of action through which these agents confer partial protection. It has 
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been observed that removal of UVR-induced DNA damage results in a reduced 
immunosuppression in mice (Applegate et al., 1989). Since 20(OH)D and 1,25(OH)2D 
at the same concentrations used in the CHS experiments reduced formation of both 
thymine dimers and 8oxodG, this is likely to be a mechanism through which they 
are protective against UVR-induced immunosuppression also.  
 
The presence of Metallothionein I and II isoforms have been implicated in the 
prevention of tissue damage in the epidermis, via their ROS scavenging abilities as 
potent antioxidants. Cells with high expression of metallothionein appear to be 
resistant to sunburn cells, apoptotic keratinocytes, caused by UVR (Hanada et al., 
1998, Reeve et al., 2000, Wang et al., 2004). The relevance of this to the current 
results comes from Reeve and colleagues (2012) that metallothionein KO mice, 
unable to express metallothionein, are more prone to immunosuppression 
following UVR exposure.  Additionally, since 1,25(OH)2D upregulates mRNA 
expression of metallothionein mRNA (De Haes et al., 2004b), this may be a 
mechanism through which it prevents UVR-induced immunosuppression. While the 
upregulation of MT by 1,25(OH)2D us likely, further studies to test whether 20(OH)D 
affects metallothionein expression would be helpful.  
 
As seen in both inflammation and DNA damage, there also appeared to be a gender 
bias present in the immunosuppression results. In agreement with previous reports 
(Reeve et al., 2012, Thomas-Ahner et al., 2007), male Skh:Hr1 mice were more 
immunosuppressed than females following UVR. This has also been noted in 
experiments with humans by our collaborators (Damian et al., 2008).  
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IL-10 is an immunosuppressive cytokine known to be released in keratinocytes 
following UVR exposure. IL-10 induction causes a reduction in the CHS response in 
mice, and this was shown to be greater in males following UVR compared to their 
female counterparts (Reeve et al., 2012).   In addition, topical oestrogens inhibited 
UVR-induced immunosuppression during a CHS test in mice. In male mice injected 
with 17β-estradiol following UVR, photo-immunosuppression was reversed, along 
with a reduction in serum IL-10, a major anti-inflammatory, immunosuppressive 
cytokine (Cho et al., 2010). Moreover, when females were exposed to UVR and 
treated with anti-estradiol agents or tamoxifen, IL-10 serum levels increased 
significantly, which ultimately reduced the CHS response (Hiramoto et al., 2004).   
Use of ICI 182,780 an estrogen receptor antagonist, caused exacerbation of UVR-
induced immunological suppression (Widyarini et al., 2006). The expression of the 
ER-1 receptor female skin is not significantly different to that of male skin 
(Thornton et al., 2003b). However, since females produce the natural oestrogen 
ligand for the receptor at greater concentrations than males, the presence of the 
natural ligand may explain the difference in photoprotection between the sexes.  
In relation to gender bias and immunosuppression with 1,25(OH)2D, preliminary 
experimentation from our group has shown that found that 1,25(OH)2D reduction 
of UVR-induced CHS suppression in female Skh:Hr1 mice was reversed following 
treatment with ICI 182780 (Tongkao-on et al., 2012). Since there is evidence for the 
1,25(OH)2D reducing pro-inflammatory cytokines IL-6 (De Haes et al., 2003, Mason 
et al., 2010) and IL-12 (Bikle, 2009), and increasing IL-10 receptor gene expression 
(Michel et al., 1997) in keratinocytes, an immunosuppressive cytokine, and these 
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cytokines have been shown to be decreased by an ER- agonist (Chaudhary et al., 
2013) it is possible that 1,25(OH)2D and other photoprotective analogues may 
interact with oestrogen signalling to produce greater protection against UVR-
induced immune response suppression in female mice.  
Given that the current studies showed that there was higher UVR-induced 
immunosuppression in males compared to females, and there is evidence for the 
role of ER- in mediation of photoprotection (Cho et al., 2010, Reeve et al., 2009, 
Widyarini et al., 2006), it seemed valid to use ER- KO mouse model for further 
immunosuppression studies. The results showed that application of 20(OH)D at 
23mol/cm2 did not produce any basal immunosuppressive results, in either WT 
and ER- null mice, however KO mice were not protected from UVR-induced 
immunosuppression at this concentration of 20(OH)D, where their WT counterparts 
were. Such findings suggest that the mechanisms through which the lowest dose of 
20(OH)D that reduces immunosuppression following UVR, requires ER- signalling. 
Inhibition of further UVR-induced immunosuppression in ER- KO mice, was seen at 
the higher concentration of 46mol/cm2 20(OH)D. At this dose of 20(OH)D WT mice 
showed significantly reduced ear swelling, indicating immunosuppression. These 
results are consistent with the proposal that the presence of ER- in skin 
potentiates the actions of 20(OH)D. Further studies might benefit from the use of 
ICI 182780 the ER-1 antagonist in conjunction with 20(OH)D in WT mice, to 
complement  the current findings.  
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5 CONCLUSIONS AND FUTURE DIRECTIONS  
This study has shown for the first time that use of 20(OH)D in both in vitro and in 
vitro models following UVR exposure is photoprotective to a similar  extent as  
1,25(OH)2D. 20(OH)D reduced direct UV-induced DNA damage, thymine dimers, 3 
hours after UVR in both cultured human keratinocytes and Skh:Hr1 hairless mouse 
skin. Furthermore, 20(OH)D reduced formation of indirect UV-induced DNA 
damage, 8oxodG, in cultured human keratinocytes, within the same timeframe. Use 
of the curcuminoid THC produced analogous results under the same settings, which 
is in line with previous data. Photoprotection by 20(OH)D was greater in females 
than males.  
 
Previous studies from the Mason group showed evidence for chloride currents an 
essential mechanism for 1,25(OH)2D protection against UVR-induced DNA damage 
(Sequeira et al., 2012a). Results from this study showed that chloride channel 
permeability is also vital for 20(OH)D mediated reduction in thymine dimer 
formation in cultured human keratinocytes. Since 20(OH)D and THC do not cause 
some of the genomic effects of 1,25(OH)2D such as hypercalcaemia, but have been 
shown to bind to the VDR, there is reason to consider that 20(OH)D exerts its 
photoprotective effects via the non-genomic ERp57/MARRS binding protein like 
1,25(OH)2D (Sequeira et al., 2012b).  But this remains to be directly tested. 
 
Downregulation of Wnt has been shown to reduce UVR-induced skin carcinogenesis 
in mice (Chaudhary et al., 2013), and the present study showed that inhibition of 
 146 
 
Wnt was photoprotective on its own and had no effect on photoprotection by 
1,25(OH)2D and 20(OH)D on the formation of thymine dimers in cultured human 
keratinocytes as early as 3 hours following UVR. Experimentation into the 
downstream targets of Wnt, such as -catenin, and whether 1,25(OH)2D and 
20(OH)D or other ligand binding to the VDR interacts with them to mediate their 
photoprotective effects against UVR-induced DNA damage would be a reasonable 
proposal. Furthermore, since 1,25(OH)2D has been shown to reduce UVR-induced 
skin carcinogenesis, and preliminary studies from the Mason group show that 
1,25(OH)2D increases nucleotide excision repair proteins (Song, 2014), further study 
with 20(OH)D on this is necessary. Similarly, recent results from Halliday and 
colleagues on HaCaT cells and melanocytes showed that use of nicotinamide, a 
precursor in the formation of ATP, reduces 8oxodG and thymine dimers following 
exposure to UVR (Surjana et al., 2013, Thompson et al., 2014). Since both 
1,25(OH)2D and 20(OH)D reduce these forms of DNA damage additional 
experimentation is necessary to determine whether they have an effect on energy 
production and DNA repair.  
 
The results also indicate that 20(OH)D was as efficacious as 1,25(OH)2D at 
preventing UVR-induced inflammation and inhibits further immunosuppression 
caused by UVR, however at high doses caused some basal immunosuppression as is 
seen with 1,25(OH)2D, and immunosuppression was in general greater in male mice. 
In experiments with ER- KO mice reversal of the UVR-induced immunosuppression 
required high doses of 20(OH)D which also caused basal immunosuppression, 
suggesting photoprotection at the lower dose may be  mediated by an interaction 
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between 20(OH)D and ER- signalling. More study into the interactions between 
inflammatory cytokines influenced by 1,25(OH)2D and 20(OH)D and ER- are 
necessary for elucidation of their immunosuppressive and anti-inflammatory effects 
following UVR exposure, and may explain some of the gender bias in the results of 
this study.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 148 
 
REFERENCES 
APARNA, R., SUBHASHINI, J., ROY, K. R., REDDY, G. S., ROBINSON, M., USKOKOVIC, 
M. R., VENKATESWARA REDDY, G. & REDDANNA, P. 2008. Selective 
inhibition of cyclooxygenase-2 (COX-2) by 1alpha,25-dihydroxy-16-ene-23-
yne-vitamin D3, a less calcemic vitamin D analog. J Cell Biochem, 104, 1832-
42. 
APPLEGATE, L. A., LEY, R. D., ALCALAY, J. & KRIPKE, M. L. 1989. Identification of the 
molecular target for the suppression of contact hypersensitivity by 
ultraviolet radiation. J Exp Med, 170, 1117-31. 
ASSEFA, Z., VAN LAETHEM, A., GARMYN, M. & AGOSTINIS, P. 2005. Ultraviolet 
radiation-induced apoptosis in keratinocytes: on the role of cytosolic factors. 
Biochim Biophys Acta, 1755, 90-106. 
ASZTERBAUM, M., EPSTEIN, J., ORO, A., DOUGLAS, V., LEBOIT, P. E., SCOTT, M. P. & 
EPSTEIN, E. H., JR. 1999. Ultraviolet and ionizing radiation enhance the 
growth of BCCs and trichoblastomas in patched heterozygous knockout 
mice. Nat Med, 5, 1285-91. 
AUBIN, F. 2003. Mechanisms involved in ultraviolet light-induced 
immunosuppression. Eur J Dermatol, 13, 515-23. 
BARONI, A., BUOMMINO, E., DE GREGORIO, V., RUOCCO, E., RUOCCO, V. & WOLF, 
R. 2012. Structure and function of the epidermis related to barrier 
properties. Clin Dermatol, 30, 257-62. 
BARTIK, L., WHITFIELD, G. K., KACZMARSKA, M., LOWMILLER, C. L., MOFFET, E. W., 
FURMICK, J. K., HERNANDEZ, Z., HAUSSLER, C. A., HAUSSLER, M. R. & 
JURUTKA, P. W. 2010. Curcumin: a novel nutritionally derived ligand of the 
vitamin D receptor with implications for colon cancer chemoprevention. J 
Nutr Biochem, 21, 1153-61. 
BAU, D. T., GURR, J. R. & JAN, K. Y. 2001. Nitric oxide is involved in arsenite 
inhibition of pyrimidine dimer excision. Carcinogenesis, 22, 709-16. 
BEISSERT, S. & LOSER, K. 2008. Molecular and cellular mechanisms of 
photocarcinogenesis. Photochem Photobiol, 84, 29-34. 
BENASSI, L., OTTANI, D., FANTINI, F., MARCONI, A., CHIODINO, C., GIANNETTI, A. & 
PINCELLI, C. 1997. 1,25-dihydroxyvitamin D3, transforming growth factor 
beta1, calcium, and ultraviolet B radiation induce apoptosis in cultured 
human keratinocytes. J Invest Dermatol, 109, 276-82. 
BESARATINIA, A., YOON, J. I., SCHROEDER, C., BRADFORTH, S. E., COCKBURN, M. & 
PFEIFER, G. P. 2011. Wavelength dependence of ultraviolet radiation-
induced DNA damage as determined by laser irradiation suggests that 
cyclobutane pyrimidine dimers are the principal DNA lesions produced by 
terrestrial sunlight. FASEB J, 25, 3079-91. 
BIKLE, D. D. 2009. Vitamin D and immune function: understanding common 
pathways. Curr Osteoporos Rep, 7, 58-63. 
BIKLE, D. D. 2011a. Vitamin D metabolism and function in the skin. Mol Cell 
Endocrinol, 347, 80-9. 
BIKLE, D. D. 2011b. Vitamin D regulation of immune function. Vitamins and 
Hormones, 86, 1-21. 
BIKLE, D. D. 2012. Vitamin D and bone. Curr Osteoporos Rep, 10, 151-9. 
 149 
 
BIKLE, D. D., CHANG, S., CRUMRINE, D., ELALIEH, H., MAN, M. Q., CHOI, E. H., 
DARDENNE, O., XIE, Z., ARNAUD, R. S., FEINGOLD, K. & ELIAS, P. M. 2004. 25 
Hydroxyvitamin D 1 alpha-hydroxylase is required for optimal epidermal 
differentiation and permeability barrier homeostasis. J Invest Dermatol, 122, 
984-92. 
BIKLE, D. D., ELALIEH, H., WELSH, J., OH, D., CLEAVER, J. & TEICHERT, A. 2012. 
Protective role of vitamin D signaling in skin cancer formation. J Steroid 
Biochem Mol Biol. 
BIKLE, D. D., ELALIEH, H., WELSH, J., OH, D., CLEAVER, J. & TEICHERT, A. 2013. 
Protective role of vitamin D signaling in skin cancer formation. J Steroid 
Biochem Mol Biol, 136, 271-9. 
BIKLE, D. D., NEMANIC, M. K., GEE, E. & ELIAS, P. 1986. 1,25-Dihydroxyvitamin D3 
production by human keratinocytes. Kinetics and regulation. J Clin Invest, 78, 
557-66. 
BODE, A. M. & DONG, Z. 2003. Mitogen-activated protein kinase activation in UV-
induced signal transduction. Sci STKE, 2003, RE2. 
BOTTAI, G., MANCINA, R., MURATORI, M., DI GENNARO, P. & LOTTI, T. 2013. 
17beta-estradiol protects human skin fibroblasts and keratinocytes against 
oxidative damage. J Eur Acad Dermatol Venereol, 27, 1236-43. 
BRASH, D. E. 1997. Sunlight and the onset of skin cancer. Trends Genet, 13, 410-4. 
BROEKMANS, W. M., VINK, A. A., BOELSMA, E., KLOPPING-KETELAARS, W. A., 
TIJBURG, L. B., VAN'T VEER, P., VAN POPPEL, G. & KARDINAAL, A. F. 2003. 
Determinants of skin sensitivity to solar irradiation. Eur J Clin Nutr, 57, 1222-
9. 
BURNS, E. M., TOBER, K. L., RIGGENBACH, J. A., SCHICK, J. S., LAMPING, K. N., 
KUSEWITT, D. F., YOUNG, G. S. & OBERYSZYN, T. M. 2013. Preventative 
topical diclofenac treatment differentially decreases tumor burden in male 
and female Skh-1 mice in a model of UVB-induced cutaneous squamous cell 
carcinoma. Carcinogenesis, 34, 370-7. 
CADET, J., DOUKI, T., GASPARUTTO, D. & RAVANAT, J. L. 2003. Oxidative damage to 
DNA: formation, measurement and biochemical features. Mutat Res, 531, 5-
23. 
CADET, J., SAGE, E. & DOUKI, T. 2005. Ultraviolet radiation-mediated damage to 
cellular DNA. Mutat Res, 571, 3-17. 
CATLEY, M. C., BIRRELL, M. A., HARDAKER, E. L., DE ALBA, J., FARROW, S., HAJ-
YAHIA, S. & BELVISI, M. G. 2008. Estrogen receptor beta: expression profile 
and possible anti-inflammatory role in disease. J Pharmacol Exp Ther, 326, 
83-8. 
CHAUDHARY, S. C., SINGH, T., TALWELKAR, S. S., SRIVASTAVA, R. K., ARUMUGAM, 
A., WENG, Z., ELMETS, C. A., AFAQ, F., KOPELOVICH, L. & ATHAR, M. 2013. 
Erb-041, an estrogen receptor beta agonist inhibits skin photocarcinogenesis 
in SKH-1 hairless mice by down-regulating WNT signaling pathway. Cancer 
Prev Res (Phila). 
CHEN, B., DODGE, M. E., TANG, W., LU, J., MA, Z., FAN, C. W., WEI, S., HAO, W., 
KILGORE, J., WILLIAMS, N. S., ROTH, M. G., AMATRUDA, J. F., CHEN, C. & 
LUM, L. 2009. Small molecule-mediated disruption of Wnt-dependent 
signaling in tissue regeneration and cancer. Nat Chem Biol, 5, 100-7. 
 150 
 
CHEN, S., SIMS, G. P., CHEN, X. X., GU, Y. Y., CHEN, S. & LIPSKY, P. E. 2007. 
Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell 
differentiation. J Immunol, 179, 1634-47. 
CHO, J. L., ALLANSON, M. & REEVE, V. E. 2010. Oestrogen receptor-beta signalling 
protects against transplanted skin tumour growth in the mouse. Photochem 
Photobiol Sci, 9, 608-14. 
CHRISTENSEN, A. D. & HAASE, C. 2012. Immunological mechanisms of contact 
hypersensitivity in mice. APMIS, 120, 1-27. 
CLYDESDALE, G. J., DANDIE, G. W. & MULLER, H. K. 2001. Ultraviolet light induced 
injury: immunological and inflammatory effects. Immunol Cell Biol, 79, 547-
68. 
COHEN-LAHAV, M., DOUVDEVANI, A., CHAIMOVITZ, C. & SHANY, S. 2007. The anti-
inflammatory activity of 1,25-dihydroxyvitamin D3 in macrophages. J Steroid 
Biochem Mol Biol, 103, 558-62. 
COHEN-LAHAV, M., SHANY, S., TOBVIN, D., CHAIMOVITZ, C. & DOUVDEVANI, A. 
2006. Vitamin D decreases NFkappaB activity by increasing IkappaBalpha 
levels. Nephrol Dial Transplant, 21, 889-97. 
CORSINI, E. & GALLI, C. L. 2000. Epidermal cytokines in experimental contact 
dermatitis. Toxicology, 142, 203-11. 
COTRIM, C. Z., FABRIS, V., DORIA, M. L., LINDBERG, K., GUSTAFSSON, J. A., AMADO, 
F., LANARI, C. & HELGUERO, L. A. 2013. Estrogen receptor beta growth-
inhibitory effects are repressed through activation of MAPK and PI3K 
signalling in mammary epithelial and breast cancer cells. Oncogene, 32, 
2390-402. 
CROSS, D. A., ALESSI, D. R., COHEN, P., ANDJELKOVICH, M. & HEMMINGS, B. A. 
1995. Inhibition of glycogen synthase kinase-3 by insulin mediated by 
protein kinase B. Nature, 378, 785-9. 
D’ORAZIO, J. A., JARRETT, S., MARSCH, A., LAGREW, J. & CLEARY, L. 2013. Melanoma 
— Epidemiology, Genetics and Risk Factors, Recent Advances in the Biology, 
Therapy and Management of Melanoma, InTech. 
DAMIAN, D. L., KIM, Y. J., DIXON, K. M., HALLIDAY, G. M., JAVERI, A. & MASON, R. S. 
2010. Topical calcitriol protects from UV-induced genetic damage but 
suppresses cutaneous immunity in humans. Exp Dermatol, 19, e23-30. 
DAMIAN, D. L., PATTERSON, C. R., STAPELBERG, M., PARK, J., BARNETSON, R. S. & 
HALLIDAY, G. M. 2008. UV radiation-induced immunosuppression is greater 
in men and prevented by topical nicotinamide. J Invest Dermatol, 128, 447-
54. 
DAO, H., JR. & KAZIN, R. A. 2007. Gender differences in skin: a review of the 
literature. Gend Med, 4, 308-28. 
DE GRUIJL, F. R. 2008. UV-induced immunosuppression in the balance. Photochem 
Photobiol, 84, 2-9. 
DE HAES, P., GARMYN, M., CARMELIET, G., DEGREEF, H., VANTIEGHEM, K., 
BOUILLON, R. & SEGAERT, S. 2004a. Molecular pathways involved in the 
anti-apoptotic effect of 1,25-dihydroxyvitamin D3 in primary human 
keratinocytes. J Cell Biochem, 93, 951-67. 
DE HAES, P., GARMYN, M., DEGREEF, H., VANTIEGHEM, K., BOUILLON, R. & 
SEGAERT, S. 2003. 1,25-Dihydroxyvitamin D3 inhibits ultraviolet B-induced 
 151 
 
apoptosis, Jun kinase activation, and interleukin-6 production in primary 
human keratinocytes. J Cell Biochem, 89, 663-73. 
DE HAES, P., GARMYN, M., VERSTUYF, A., DE CLERCQ, P., VANDEWALLE, M., 
DEGREEF, H., VANTIEGHEM, K., BOUILLON, R. & SEGAERT, S. 2005. 1,25-
Dihydroxyvitamin D3 and analogues protect primary human keratinocytes 
against UVB-induced DNA damage. J Photochem Photobiol B, 78, 141-8. 
DE HAES, P., GARMYN, M., VERSTUYF, A., DE CLERCQ, P., VANDEWALLE, M., 
VANTIEGHEM, K., DEGREEF, H., BOUILLON, R. & SEGAERT, S. 2004b. Two 14-
epi analogues of 1,25-dihydroxyvitamin D3 protect human keratinocytes 
against the effects of UVB. Arch Dermatol Res, 295, 527-34. 
DE LAAT, W. L., JASPERS, N. G. & HOEIJMAKERS, J. H. 1999. Molecular mechanism of 
nucleotide excision repair. Genes Dev, 13, 768-85. 
DE WINTER, S., VINK, A. A., ROZA, L. & PAVEL, S. 2001. Solar-simulated skin 
adaptation and its effect on subsequent UV-induced epidermal DNA 
damage. J Invest Dermatol, 117, 678-82. 
DIFFEY, B. L. 2002. Sources and measurement of ultraviolet radiation. Methods, 28, 
4-13. 
DIKER-COHEN, T., KOREN, R. & RAVID, A. 2006. Programmed cell death of stressed 
keratinocytes and its inhibition by vitamin D: the role of death and survival 
signaling pathways. Apoptosis, 11, 519-34. 
DIXON, K. M., DEO, S. S., NORMAN, A. W., BISHOP, J. E., HALLIDAY, G. M., REEVE, V. 
E. & MASON, R. S. 2007. In vivo relevance for photoprotection by the 
vitamin D rapid response pathway. J Steroid Biochem Mol Biol, 103, 451-6. 
DIXON, K. M., DEO, S. S., WONG, G., SLATER, M., NORMAN, A. W., BISHOP, J. E., 
POSNER, G. H., ISHIZUKA, S., HALLIDAY, G. M., REEVE, V. E. & MASON, R. S. 
2005. Skin cancer prevention: a possible role of 1,25dihydroxyvitamin D3 
and its analogs. J Steroid Biochem Mol Biol, 97, 137-43. 
DIXON, K. M., NORMAN, A. W., SEQUEIRA, V. B., MOHAN, R., RYBCHYN, M. S., 
REEVE, V. E., HALLIDAY, G. M. & MASON, R. S. 2011. 1alpha,25(OH)(2)-
vitamin D and a nongenomic vitamin D analogue inhibit ultraviolet radiation-
induced skin carcinogenesis. Cancer Prev Res (Phila), 4, 1485-94. 
DU, Z., WEI, L., MURTI, A., PFEFFER, S. R., FAN, M., YANG, C. H. & PFEFFER, L. M. 
2007. Non-conventional signal transduction by type 1 interferons: the NF-
kappaB pathway. J Cell Biochem, 102, 1087-94. 
ELLISON, T. I., SMITH, M. K., GILLIAM, A. C. & MACDONALD, P. N. 2008. Inactivation 
of the vitamin D receptor enhances susceptibility of murine skin to UV-
induced tumorigenesis. J Invest Dermatol, 128, 2508-17. 
EVANS, M. D., BUTLER, J. M., NICOLL, K., COOKE, M. S. & LUNEC, J. 2003. 17 beta-
Oestradiol attenuates nucleotide excision repair. FEBS Lett, 535, 153-8. 
FOOTE, J. A., HARRIS, R. B., GIULIANO, A. R., ROE, D. J., MOON, T. E., CARTMEL, B. & 
ALBERTS, D. S. 2001. Predictors for cutaneous basal- and squamous-cell 
carcinoma among actinically damaged adults. Int J Cancer, 95, 7-11. 
FRIEDBERG, E. C. 2001. How nucleotide excision repair protects against cancer. Nat 
Rev Cancer, 1, 22-33. 
GORDON-THOMSON, C., GUPTA, R., TONGKAO-ON, W., RYAN, A., HALLIDAY, G. M. 
& MASON, R. S. 2012. 1alpha,25 dihydroxyvitamin D3 enhances cellular 
 152 
 
defences against UV-induced oxidative and other forms of DNA damage in 
skin. Photochem Photobiol Sci, 11, 1837-47. 
GORMAN, S., KURITZKY, L. A., JUDGE, M. A., DIXON, K. M., MCGLADE, J. P., MASON, 
R. S., FINLAY-JONES, J. J. & HART, P. H. 2007. Topically applied 1,25-
dihydroxyvitamin D3 enhances the suppressive activity of CD4+CD25+ cells 
in the draining lymph nodes. J Immunol, 179, 6273-83. 
GUPTA, R., DIXON, K. M., DEO, S. S., HOLLIDAY, C. J., SLATER, M., HALLIDAY, G. M., 
REEVE, V. E. & MASON, R. S. 2007. Photoprotection by 1,25 
dihydroxyvitamin D3 is associated with an increase in p53 and a decrease in 
nitric oxide products. J Invest Dermatol, 127, 707-15. 
GURYEV, O., CARVALHO, R. A., USANOV, S., GILEP, A. & ESTABROOK, R. W. 2003. A 
pathway for the metabolism of vitamin D3: unique hydroxylated metabolites 
formed during catalysis with cytochrome P450scc (CYP11A1). Proc Natl Acad 
Sci U S A, 100, 14754-9. 
HALLIDAY, G. M. & CADET, J. 2012. It's all about position: the basal layer of human 
epidermis is particularly susceptible to different types of sunlight-induced 
DNA damage. J Invest Dermatol, 132, 265-7. 
HANADA, K., SAWAMURA, D., HASHIMOTO, I., KIDA, K. & NAGANUMA, A. 1998. 
Epidermal proliferation of the skin in metallothionein-null mice. J Invest 
Dermatol, 110, 259-62. 
HANAHAN, D. & WEINBERG, R. A. 2000. The hallmarks of cancer. Cell, 100, 57-70. 
HANAHAN, D. & WEINBERG, R. A. 2011. Hallmarks of cancer: the next generation. 
Cell, 144, 646-74. 
HANAWALT, P. C. 2002. Subpathways of nucleotide excision repair and their 
regulation. Oncogene, 21, 8949-56. 
HART, P. H., GRIMBALDESTON, M. A. & FINLAY-JONES, J. J. 2001. Sunlight, 
immunosuppression and skin cancer: role of histamine and mast cells. Clin 
Exp Pharmacol Physiol, 28, 1-8. 
HAUSSLER, M. R., JURUTKA, P. W., MIZWICKI, M. & NORMAN, A. W. 2011. Vitamin D 
receptor (VDR)-mediated actions of 1alpha,25(OH)(2)vitamin D(3): genomic 
and non-genomic mechanisms. Best Pract Res Clin Endocrinol Metab, 25, 
543-59. 
HIRAMOTO, K., TANAKA, H., YANAGIHARA, N., SATO, E. F. & INOUE, M. 2004. Effect 
of 17beta-estradiol on immunosuppression induced by ultraviolet B 
irradiation. Arch Dermatol Res, 295, 307-11. 
HOLICK, M. F. 1981. The Cutaneous Photosynthesis of Previtamin D3: A Unique 
Photoendocrine System. J Investig Dermatol, 77, 8. 
HOLICK, M. F. 2004. Vitamin D: importance in the prevention of cancers, type 1 
diabetes, heart disease, and osteoporosis. Am J Clin Nutr, 79, 362-71. 
HOLICK, M. F., USKOKOVIC, M., HENLEY, J. W., MACLAUGHLIN, J., HOLICK, S. A. & 
POTTS, J. T., JR. 1980. The photoproduction of 1 alpha,25-dihydroxyvitamin 
D3 in skin: an approach to the therapy of vitamin-D-resistant syndromes. N 
Engl J Med, 303, 349-54. 
HONG, J., BOSE, M., JU, J., RYU, J. H., CHEN, X., SANG, S., LEE, M. J. & YANG, C. S. 
2004. Modulation of arachidonic acid metabolism by curcumin and related 
beta-diketone derivatives: effects on cytosolic phospholipase A(2), 
cyclooxygenases and 5-lipoxygenase. Carcinogenesis, 25, 1671-9. 
 153 
 
HORTON, J. K., WILLIAMS, A. S., SMITH-PHILLIPS, Z., MARTIN, R. C. & O'BEIRNE, G. 
1999. Intracellular measurement of prostaglandin E2: effect of anti-
inflammatory drugs on cyclooxygenase activity and prostanoid expression. 
Anal Biochem, 271, 18-28. 
HUHTAKANGAS, J. A., OLIVERA, C. J., BISHOP, J. E., ZANELLO, L. P. & NORMAN, A. W. 
2004. The vitamin D receptor is present in caveolae-enriched plasma 
membranes and binds 1 alpha,25(OH)2-vitamin D3 in vivo and in vitro. Mol 
Endocrinol, 18, 2660-71. 
HUSSEIN, M. R. 2005. Ultraviolet radiation and skin cancer: molecular mechanisms. 
J Cutan Pathol, 32, 191-205. 
JANE, S. M., TING, S. B. & CUNNINGHAM, J. M. 2005. Epidermal impermeable 
barriers in mouse and fly. Curr Opin Genet Dev, 15, 447-53. 
JANJETOVIC, Z., BROZYNA, A. A., TUCKEY, R. C., KIM, T. K., NGUYEN, M. N., 
JOZWICKI, W., PFEFFER, S. R., PFEFFER, L. M. & SLOMINSKI, A. T. 2011a. High 
basal NF-[kappa]B activity in nonpigmented melanoma cells is associated 
with an enhanced sensitivity to vitamin D3 derivatives. British Journal of 
Cancer, 105, 1874-1884. 
JANJETOVIC, Z., BROZYNA, A. A., TUCKEY, R. C., KIM, T. K., NGUYEN, M. N., 
JOZWICKI, W., PFEFFER, S. R., PFEFFER, L. M. & SLOMINSKI, A. T. 2011b. High 
basal NF-kappaB activity in nonpigmented melanoma cells is associated with 
an enhanced sensitivity to vitamin D3 derivatives. Br J Cancer, 105, 1874-84. 
JANJETOVIC, Z., ZMIJEWSKI, M. A., TUCKEY, R. C., DELEON, D. A., NGUYEN, M. N., 
PFEFFER, L. M. & SLOMINSKI, A. T. 2009. 20-Hydroxycholecalciferol, product 
of vitamin D3 hydroxylation by P450scc, decreases NF-kappaB activity by 
increasing IkappaB alpha levels in human keratinocytes. PLoS One, 4, e5988. 
JENA, N. R. 2012. DNA damage by reactive species: Mechanisms, mutation and 
repair. J Biosci, 37, 503-17. 
JENA, N. R. & MISHRA, P. C. 2012. Formation of ring-opened and rearranged 
products of guanine: mechanisms and biological significance. Free Radic Biol 
Med, 53, 81-94. 
JOHANNESDOTTIR, S. A., CHANG, E. T., MEHNERT, F., SCHMIDT, M., OLESEN, A. B. & 
SORENSEN, H. T. 2012. Nonsteroidal anti-inflammatory drugs and the risk of 
skin cancer: a population-based case-control study. Cancer, 118, 4768-76. 
JURUTKA, P. W., BARTIK, L., WHITFIELD, G. K., MATHERN, D. R., BARTHEL, T. K., 
GUREVICH, M., HSIEH, J. C., KACZMARSKA, M., HAUSSLER, C. A. & HAUSSLER, 
M. R. 2007. Vitamin D receptor: key roles in bone mineral pathophysiology, 
molecular mechanism of action, and novel nutritional ligands. J Bone Miner 
Res, 22 Suppl 2, V2-10. 
KADEKARO, A. L., KAVANAGH, R. J., WAKAMATSU, K., ITO, S., PIPITONE, M. A. & 
ABDEL-MALEK, Z. A. 2003. Cutaneous photobiology. The melanocyte vs. the 
sun: who will win the final round? Pigment Cell Res, 16, 434-47. 
KANITAKIS, J. 2002. Anatomy, histology and immunohistochemistry of normal 
human skin. Eur J Dermatol, 12, 390-9; quiz 400-1. 
KENSLER, T. W., DOLAN, P. M., GANGE, S. J., LEE, J. K., WANG, Q. & POSNER, G. H. 
2000. Conceptually new deltanoids (vitamin D analogs) inhibit multistage 
skin tumorigenesis. Carcinogenesis, 21, 1341-5. 
 154 
 
KHOPDE, S. M., PRIYADARSINI, K. I., GUHA, S. N., SATAV, J. G., VENKATESAN, P. & 
RAO, M. N. 2000. Inhibition of radiation-induced lipid peroxidation by 
tetrahydrocurcumin: possible mechanisms by pulse radiolysis. Biosci 
Biotechnol Biochem, 64, 503-9. 
KREGE, J. H., HODGIN, J. B., COUSE, J. F., ENMARK, E., WARNER, M., MAHLER, J. F., 
SAR, M., KORACH, K. S., GUSTAFSSON, J. A. & SMITHIES, O. 1998. Generation 
and reproductive phenotypes of mice lacking estrogen receptor beta. Proc 
Natl Acad Sci U S A, 95, 15677-82. 
KRIPKE, M. L., COX, P. A., ALAS, L. G. & YAROSH, D. B. 1992. Pyrimidine dimers in 
DNA initiate systemic immunosuppression in UV-irradiated mice. Proc Natl 
Acad Sci U S A, 89, 7516-20. 
KULMS, D. & SCHWARZ, T. 2000. Molecular mechanisms of UV-induced apoptosis. 
Photodermatol Photoimmunol Photomed, 16, 195-201. 
KULMS, D. & SCHWARZ, T. 2002. Independent contribution of three different 
pathways to ultraviolet-B-induced apoptosis. Biochem Pharmacol, 64, 837-
41. 
KUMAR, P. & CLARKE, M. (eds.) 2012. Clinical Medicine, Philedelphia, USA: Elsevier. 
LEE, J. & YOUN, J. I. 1998. The photoprotective effect of 1,25-dihydroxyvitamin D3 
on ultraviolet light B-induced damage in keratinocyte and its mechanism of 
action. J Dermatol Sci, 18, 11-8. 
LEE, J. K., KIM, J. H., NAM, K. T. & LEE, S. H. 2003. Molecular events associated with 
apoptosis and proliferation induced by ultraviolet-B radiation in the skin of 
hairless mice. J Dermatol Sci, 32, 171-9. 
LEHMANN, A. R. 2003. DNA repair-deficient diseases, xeroderma pigmentosum, 
Cockayne syndrome and trichothiodystrophy. Biochimie, 85, 1101-11. 
LEHMANN, B. & MEURER, M. 2010. Vitamin D metabolism. Dermatol Ther, 23, 2-12. 
LEITER, U. & GARBE, C. 2008. Epidemiology of melanoma and nonmelanoma skin 
cancer--the role of sunlight. Adv Exp Med Biol, 624, 89-103. 
LIPPENS, S., DENECKER, G., OVAERE, P., VANDENABEELE, P. & DECLERCQ, W. 2005. 
Death penalty for keratinocytes: apoptosis versus cornification. Cell Death 
Differ, 12 Suppl 2, 1497-508. 
LIPPENS, S., HOSTE, E., VANDENABEELE, P., AGOSTINIS, P. & DECLERCQ, W. 2009. 
Cell death in the skin. Apoptosis, 14, 549-69. 
LOSER, K. & BEISSERT, S. 2009. Regulation of cutaneous immunity by the 
environment: an important role for UV irradiation and vitamin D. Int 
Immunopharmacol, 9, 587-9. 
MAHEUX, R., NAUD, F., RIOUX, M., GRENIER, R., LEMAY, A., GUY, J. & LANGEVIN, M. 
1994. A randomized, double-blind, placebo-controlled study on the effect of 
conjugated estrogens on skin thickness. Am J Obstet Gynecol, 170, 642-9. 
MAKIN, J. 2011. Implications of climate change for skin cancer prevention in 
Australia. Health Promot J Austr, 22 Spec No, S39-41. 
MALLOY, P. J., PIKE, J. W. & FELDMAN, D. 1999. The vitamin D receptor and the 
syndrome of hereditary 1,25-dihydroxyvitamin D-resistant rickets. Endocr 
Rev, 20, 156-88. 
MANGGAU, M., KIM, D. S., RUWISCH, L., VOGLER, R., KORTING, H. C., SCHAFER-
KORTING, M. & KLEUSER, B. 2001. 1Alpha,25-dihydroxyvitamin D3 protects 
 155 
 
human keratinocytes from apoptosis by the formation of sphingosine-1-
phosphate. J Invest Dermatol, 117, 1241-9. 
MARIE, P. J. & KASSEM, M. 2011. Extrinsic mechanisms involved in age-related 
defective bone formation. J Clin Endocrinol Metab, 96, 600-9. 
MARIEB, E. N. & HOEHN, K. N. 2012. Human Anatomy and Physiology, New Jersey, 
USA, Pearson Benjamin Cummings. 
MASON, R. S., SEQUEIRA, V. B., DIXON, K. M., GORDON-THOMSON, C., POBRE, K., 
DILLEY, A., MIZWICKI, M. T., NORMAN, A. W., FELDMAN, D., HALLIDAY, G. M. 
& REEVE, V. E. 2010. Photoprotection by 1alpha,25-dihydroxyvitamin D and 
analogs: further studies on mechanisms and implications for UV-damage. J 
Steroid Biochem Mol Biol, 121, 164-8. 
MATSUMURA, Y. & ANANTHASWAMY, H. N. 2002. Short-term and long-term 
cellular and molecular events following UV irradiation of skin: implications 
for molecular medicine. Expert Rev Mol Med, 4, 1-22. 
MATSUMURA, Y. & ANANTHASWAMY, H. N. 2004. Toxic effects of ultraviolet 
radiation on the skin. Toxicol Appl Pharmacol, 195, 298-308. 
MELNIKOVA, V. O. & ANANTHASWAMY, H. N. 2005. Cellular and molecular events 
leading to the development of skin cancer. Mutat Res, 571, 91-106. 
MENON, V. P. & SUDHEER, A. R. 2007. Antioxidant and anti-inflammatory properties 
of curcumin. Adv Exp Med Biol, 595, 105-25. 
MICHEL, G., GAILIS, A., JARZEBSKA-DEUSSEN, B., MUSCHEN, A., 
MIRMOHAMMADSADEGH, A. & RUZICKA, T. 1997. 1,25-(OH)2-vitamin D3 
and calcipotriol induce IL-10 receptor gene expression in human epidermal 
cells. Inflamm Res, 46, 32-4. 
MIZWICKI, M. T., KEIDEL, D., BULA, C. M., BISHOP, J. E., ZANELLO, L. P., WURTZ, J. 
M., MORAS, D. & NORMAN, A. W. 2004. Identification of an alternative 
ligand-binding pocket in the nuclear vitamin D receptor and its functional 
importance in 1alpha,25(OH)2-vitamin D3 signaling. Proc Natl Acad Sci U S A, 
101, 12876-81. 
MIZWICKI, M. T., MENEGAZ, D., YAGHMAEI, S., HENRY, H. L. & NORMAN, A. W. 
2010. A molecular description of ligand binding to the two overlapping 
binding pockets of the nuclear vitamin D receptor (VDR): structure-function 
implications. J Steroid Biochem Mol Biol, 121, 98-105. 
MIZWICKI, M. T. & NORMAN, A. W. 2009. The vitamin D sterol-vitamin D receptor 
ensemble model offers unique insights into both genomic and rapid-
response signaling. Sci Signal, 2, re4. 
MOLIFE, R., LORIGAN, P. & MACNEIL, S. 2001. Gender and survival in malignant 
tumours. Cancer Treat Rev, 27, 201-9. 
MOURET, S., BAUDOUIN, C., CHARVERON, M., FAVIER, A., CADET, J. & DOUKI, T. 
2006. Cyclobutane pyrimidine dimers are predominant DNA lesions in whole 
human skin exposed to UVA radiation. Proc Natl Acad Sci U S A, 103, 13765-
70. 
MURAKAMI, Y., ISHII, H., TAKADA, N., TANAKA, S., MACHINO, M., ITO, S. & 
FUJISAWA, S. 2008. Comparative anti-inflammatory activities of curcumin 
and tetrahydrocurcumin based on the phenolic O-H bond dissociation 
enthalpy, ionization potential and quantum chemical descriptor. Anticancer 
Res, 28, 699-707. 
 156 
 
MURPHY, G. M. 2009. Ultraviolet radiation and immunosuppression. Br J Dermatol, 
161 Suppl 3, 90-5. 
MUTHUSAMY, V. & PIVA, T. J. 2010. The UV response of the skin: a review of the 
MAPK, NFkappaB and TNFalpha signal transduction pathways. Arch 
Dermatol Res, 302, 5-17. 
NAITO, M., WU, X., NOMURA, H., KODAMA, M., KATO, Y., KATO, Y. & OSAWA, T. 
2002. The protective effects of tetrahydrocurcumin on oxidative stress in 
cholesterol-fed rabbits. J Atheroscler Thromb, 9, 243-50. 
NEMERE, I., DORMANEN, M. C., HAMMOND, M. W., OKAMURA, W. H. & NORMAN, 
A. W. 1994. Identification of a specific binding protein for 1 alpha,25-
dihydroxyvitamin D3 in basal-lateral membranes of chick intestinal 
epithelium and relationship to transcaltachia. J Biol Chem, 269, 23750-6. 
NEMERE, I., RAY, R. & MCMANUS, W. 2000. Immunochemical studies on the 
putative plasmalemmal receptor for 1, 25(OH)(2)D(3). I. Chick intestine. Am J 
Physiol Endocrinol Metab, 278, E1104-14. 
NEMERE, I., YOSHIMOTO, Y. & NORMAN, A. W. 1984. Calcium transport in perfused 
duodena from normal chicks: enhancement within fourteen minutes of 
exposure to 1,25-dihydroxyvitamin D3. Endocrinology, 115, 1476-83. 
NISHIGORI, C. 2006. Cellular aspects of photocarcinogenesis. Photochem Photobiol 
Sci, 5, 208-14. 
NORMAN, A. W. 2008. From vitamin D to hormone D: fundamentals of the vitamin 
D endocrine system essential for good health. Am J Clin Nutr, 88, 491S-499S. 
NORMAN, A. W., HENRY, H. L., BISHOP, J. E., SONG, X. D., BULA, C. & OKAMURA, W. 
H. 2001. Different shapes of the steroid hormone 1alpha,25(OH)(2)-vitamin 
D(3) act as agonists for two different receptors in the vitamin D endocrine 
system to mediate genomic and rapid responses. Steroids, 66, 147-58. 
NORMAN, A. W., OLIVERA, C. J., BARRETO SILVA, F. R. & BISHOP, J. E. 2002. A 
specific binding protein/receptor for 1alpha,25-dihydroxyvitamin D(3) is 
present in an intestinal caveolae membrane fraction. Biochem Biophys Res 
Commun, 298, 414-9. 
NORMAN, A. W., SONG, X., ZANELLO, L., BULA, C. & OKAMURA, W. H. 1999. Rapid 
and genomic biological responses are mediated by different shapes of the 
agonist steroid hormone, 1alpha,25(OH)2vitamin D3. Steroids, 64, 120-8. 
OKADA, K., WANGPOENGTRAKUL, C., TANAKA, T., TOYOKUNI, S., UCHIDA, K. & 
OSAWA, T. 2001. Curcumin and especially tetrahydrocurcumin ameliorate 
oxidative stress-induced renal injury in mice. J Nutr, 131, 2090-5. 
OKAMURA, W. H., MIDLAND, M. M., HAMMOND, M. W., ABD RAHMAN, N., 
DORMANEN, M. C., NEMERE, I. & NORMAN, A. W. 1995. Chemistry and 
conformation of vitamin D molecules. J Steroid Biochem Mol Biol, 53, 603-
13. 
ORDONEZ-MORAN, P., LARRIBA, M. J., PALMER, H. G., VALERO, R. A., BARBACHANO, 
A., DUNACH, M., DE HERREROS, A. G., VILLALOBOS, C., BERCIANO, M. T., 
LAFARGA, M. & MUNOZ, A. 2008. RhoA-ROCK and p38MAPK-MSK1 mediate 
vitamin D effects on gene expression, phenotype, and Wnt pathway in colon 
cancer cells. J Cell Biol, 183, 697-710. 
OSAWA, T., SUGIYAMA, Y., INAYOSHI, M. & KAWAKISHI, S. 1995. Antioxidative 
activity of tetrahydrocurcuminoids. Biosci Biotechnol Biochem, 59, 1609-12. 
 157 
 
PALMER, H. G., ANJOS-AFONSO, F., CARMELIET, G., TAKEDA, H. & WATT, F. M. 2008. 
The vitamin D receptor is a Wnt effector that controls hair follicle 
differentiation and specifies tumor type in adult epidermis. PLoS One, 3, 
e1483. 
PARI, L. & AMALI, D. R. 2005. Protective role of tetrahydrocurcumin (THC) an active 
principle of turmeric on chloroquine induced hepatotoxicity in rats. J Pharm 
Pharm Sci, 8, 115-23. 
PARK, H. Y., KOSMADAKI, M., YAAR, M. & GILCHREST, B. A. 2009. Cellular 
mechanisms regulating human melanogenesis. Cell Mol Life Sci, 66, 1493-
506. 
PATTISON, D. I. & DAVIES, M. J. 2006. Actions of ultraviolet light on cellular 
structures. EXS, 131-57. 
PELLETIER, G. & REN, L. 2004. Localization of sex steroid receptors in human skin. 
Histol Histopathol, 19, 629-36. 
PENDAS-FRANCO, N., GARCIA, J. M., PENA, C., VALLE, N., PALMER, H. G., 
HEINANIEMI, M., CARLBERG, C., JIMENEZ, B., BONILLA, F., MUNOZ, A. & 
GONZALEZ-SANCHO, J. M. 2008. DICKKOPF-4 is induced by TCF/beta-catenin 
and upregulated in human colon cancer, promotes tumour cell invasion and 
angiogenesis and is repressed by 1alpha,25-dihydroxyvitamin D3. Oncogene, 
27, 4467-77. 
PEUS, D., VASA, R. A., BEYERLE, A., MEVES, A., KRAUTMACHER, C. & PITTELKOW, M. 
R. 1999. UVB activates ERK1/2 and p38 signaling pathways via reactive 
oxygen species in cultured keratinocytes. J Invest Dermatol, 112, 751-6. 
PFEIFER, G. P. & BESARATINIA, A. 2012. UV wavelength-dependent DNA damage 
and human non-melanoma and melanoma skin cancer. Photochem 
Photobiol Sci, 11, 90-7. 
POLAKIS, P. 2000. Wnt signaling and cancer. Genes Dev, 14, 1837-51. 
POLIAKOV, S. 2009. Photoprotection by a potential vitamin D analog. Bachelor of 
Medical Science (Hons), University of Sydney. 
PRESTON, D. S. & STERN, R. S. 1992. Nonmelanoma cancers of the skin. N Engl J 
Med, 327, 1649-62. 
RANGWALA, S. & TSAI, K. Y. 2011. Roles of the immune system in skin cancer. Br J 
Dermatol, 165, 953-65. 
RASTOGI, R. P., RICHA, KUMAR, A., TYAGI, M. B. & SINHA, R. P. 2010. Molecular 
mechanisms of ultraviolet radiation-induced DNA damage and repair. J 
Nucleic Acids, 2010, 592980. 
RAVANAT, J. L., DOUKI, T. & CADET, J. 2001. Direct and indirect effects of UV 
radiation on DNA and its components. J Photochem Photobiol B, 63, 88-102. 
REEVE, V. E. 2002. Ultraviolet radiation and the contact hypersensitivity reaction in 
mice. Methods, 28, 20-4. 
REEVE, V. E., ALLANSON, M., CHO, J. L., ARUN, S. J. & DOMANSKI, D. 2009. 
Interdependence between heme oxygenase-1 induction and estrogen-
receptor-beta signaling mediates photoimmune protection by UVA radiation 
in mice. J Invest Dermatol, 129, 2702-10. 
REEVE, V. E., ALLANSON, M., DOMANSKI, D. & PAINTER, N. 2012. Gender 
differences in UV-induced inflammation and immunosuppression in mice 
 158 
 
reveal male unresponsiveness to UVA radiation. Photochem Photobiol Sci, 
11, 173-9. 
REEVE, V. E., NISHIMURA, N., BOSNIC, M., MICHALSKA, A. E. & CHOO, K. H. 2000. 
Lack of metallothionein-I and -II exacerbates the immunosuppressive effect 
of ultraviolet B radiation and cis-urocanic acid in mice. Immunology, 100, 
399-404. 
RIIS, J. L., JOHANSEN, C., GESSER, B., MOLLER, K., LARSEN, C. G., KRAGBALLE, K. & 
IVERSEN, L. 2004. 1alpha,25(OH)(2)D(3) regulates NF-kappaB DNA binding 
activity in cultured normal human keratinocytes through an increase in 
IkappaBalpha expression. Arch Dermatol Res, 296, 195-202. 
ROBERTSON, A. B., KLUNGLAND, A., ROGNES, T. & LEIROS, I. 2009. DNA repair in 
mammalian cells: Base excision repair: the long and short of it. Cell Mol Life 
Sci, 66, 981-93. 
ROZA, L., VAN DER WULP, K. J., MACFARLANE, S. J., LOHMAN, P. H. & BAAN, R. A. 
1988. Detection of cyclobutane thymine dimers in DNA of human cells with 
monoclonal antibodies raised against a thymine dimer-containing 
tetranucleotide. Photochem Photobiol, 48, 627-33. 
RYAN, A. 2010. Photoprotection by vitamin D-like compounds. Bachelor of Medical 
Science (Honours), University of Sydney. 
RYBCHYN, M. S., SLATER, M., CONIGRAVE, A. D. & MASON, R. S. 2011. An Akt-
dependent increase in canonical Wnt signaling and a decrease in sclerostin 
protein levels are involved in strontium ranelate-induced osteogenic effects 
in human osteoblasts. J Biol Chem, 286, 23771-9. 
SAMUEL, S. & SITRIN, M. D. 2008. Vitamin D's role in cell proliferation and 
differentiation. Nutr Rev, 66, S116-24. 
SEGDITSAS, S. & TOMLINSON, I. 2006. Colorectal cancer and genetic alterations in 
the Wnt pathway. Oncogene, 25, 7531-7. 
SEIDENARI, S., PAGNONI, A., DI NARDO, A. & GIANNETTI, A. 1994. Echographic 
evaluation with image analysis of normal skin: variations according to age 
and sex. Skin Pharmacol, 7, 201-9. 
SEQUEIRA, V. B. 2011. Doctor of Philosophy, University of Sydney. 
SEQUEIRA, V. B., RYBCHYN, M. S., GORDON-THOMSON, C., TONGKAO-ON, W., 
MIZWICKI, M. T., NORMAN, A. W., REEVE, V. E., HALLIDAY, G. M. & MASON, 
R. S. 2012a. Opening of Chloride Channels by 1alpha,25-Dihydroxyvitamin 
D(3) Contributes to Photoprotection against UVR-Induced Thymine Dimers 
in Keratinocytes. J Invest Dermatol. 
SEQUEIRA, V. B., RYBCHYN, M. S., TONGKAO-ON, W., GORDON-THOMSON, C., 
MALLOY, P. J., NEMERE, I., NORMAN, A. W., REEVE, V. E., HALLIDAY, G. M., 
FELDMAN, D. & MASON, R. S. 2012b. The role of the vitamin D receptor and 
ERp57 in photoprotection by 1alpha,25-dihydroxyvitamin D3. Mol 
Endocrinol, 26, 574-82. 
SHIVJI, M. K., PODUST, V. N., HUBSCHER, U. & WOOD, R. D. 1995. Nucleotide 
excision repair DNA synthesis by DNA polymerase epsilon in the presence of 
PCNA, RFC, and RPA. Biochemistry, 34, 5011-7. 
SHUSTER, S., BLACK, M. M. & MCVITIE, E. 1975. The influence of age and sex on skin 
thickness, skin collagen and density. Br J Dermatol, 93, 639-43. 
 159 
 
SJOSTROM, L., SMITH, U., KROTKIEWSKI, M. & BJORNTORP, P. 1972. Cellularity in 
different regions of adipose tissue in young men and women. Metabolism, 
21, 1143-53. 
SKOBOWIAT, C., DOWDY, J. C., SAYRE, R. M., TUCKEY, R. C. & SLOMINSKI, A. 2011. 
Cutaneous hypothalamic-pituitary-adrenal axis homolog: regulation by 
ultraviolet radiation. Am J Physiol Endocrinol Metab, 301, E484-93. 
SLOMINSKI, A., ERMAK, G. & MIHM, M. 1996. ACTH receptor, CYP11A1, CYP17 and 
CYP21A2 genes are expressed in skin. J Clin Endocrinol Metab, 81, 2746-9. 
SLOMINSKI, A., JANJETOVIC, Z., TUCKEY, R. C., NGUYEN, M. N., BHATTACHARYA, K. 
G., WANG, J., LI, W., JIAO, Y., GU, W., BROWN, M. & POSTLETHWAITE, A. E. 
2013. 20S-hydroxyvitamin D3, noncalcemic product of CYP11A1 action on 
vitamin D3, exhibits potent antifibrogenic activity in vivo. J Clin Endocrinol 
Metab, 98, E298-303. 
SLOMINSKI, A., SEMAK, I., ZJAWIONY, J., WORTSMAN, J., LI, W., SZCZESNIEWSKI, A. 
& TUCKEY, R. C. 2005. The cytochrome P450scc system opens an alternate 
pathway of vitamin D3 metabolism. FEBS J, 272, 4080-90. 
SLOMINSKI, A., ZJAWIONY, J., WORTSMAN, J., SEMAK, I., STEWART, J., PISARCHIK, 
A., SWEATMAN, T., MARCOS, J., DUNBAR, C. & R, C. T. 2004. A novel 
pathway for sequential transformation of 7-dehydrocholesterol and 
expression of the P450scc system in mammalian skin. Eur J Biochem, 271, 
4178-88. 
SLOMINSKI, A. T., JANJETOVIC, Z., FULLER, B. E., ZMIJEWSKI, M. A., TUCKEY, R. C., 
NGUYEN, M. N., SWEATMAN, T., LI, W., ZJAWIONY, J., MILLER, D., CHEN, T. 
C., LOZANSKI, G. & HOLICK, M. F. 2010. Products of vitamin D3 or 7-
dehydrocholesterol metabolism by cytochrome P450scc show anti-leukemia 
effects, having low or absent calcemic activity. PLoS One, 5, e9907. 
SLOMINSKI, A. T., KIM, T. K., CHEN, J., NGUYEN, M. N., LI, W., YATES, C. R., 
SWEATMAN, T., JANJETOVIC, Z. & TUCKEY, R. C. 2012. Cytochrome P450scc-
dependent metabolism of 7-dehydrocholesterol in placenta and epidermal 
keratinocytes. Int J Biochem Cell Biol, 44, 2003-18. 
SOMPARN, P., PHISALAPHONG, C., NAKORNCHAI, S., UNCHERN, S. & MORALES, N. 
P. 2007. Comparative antioxidant activities of curcumin and its demethoxy 
and hydrogenated derivatives. Biol Pharm Bull, 30, 74-8. 
SONG, E. J. 2014. 
SONG, E. J., GORDON-THOMSON, C., COLE, L., STERN, H., HALLIDAY, G. M., DAMIAN, 
D. L., REEVE, V. E. & MASON, R. S. 2012. 1alpha,25-Dihydroxyvitamin D(3) 
reduces several types of UV-induced DNA damage and contributes to 
photoprotection. J Steroid Biochem Mol Biol. 
SOULTANAKIS, R. P., MELAMEDE, R. J., BESPALOV, I. A., WALLACE, S. S., BECKMAN, 
K. B., AMES, B. N., TAATJES, D. J. & JANSSEN-HEININGER, Y. M. 2000. 
Fluorescence detection of 8-oxoguanine in nuclear and mitochondrial DNA 
of cultured cells using a recombinant Fab and confocal scanning laser 
microscopy. Free Radic Biol Med, 28, 987-98. 
SPEED, N. & BLAIR, I. A. 2011. Cyclooxygenase- and lipoxygenase-mediated DNA 
damage. Cancer Metastasis Rev, 30, 437-47. 
ST-ARNAUD, R. 2008. The direct role of vitamin D on bone homeostasis. Arch 
Biochem Biophys, 473, 225-30. 
 160 
 
STAPLES, M., MARKS, R. & GILES, G. 1998. Trends in the incidence of non-
melanocytic skin cancer (NMSC) treated in Australia 1985-1995: are primary 
prevention programs starting to have an effect? Int J Cancer, 78, 144-8. 
STAPLES, M. P., ELWOOD, M., BURTON, R. C., WILLIAMS, J. L., MARKS, R. & GILES, G. 
G. 2006. Non-melanoma skin cancer in Australia: the 2002 national survey 
and trends since 1985. Med J Aust, 184, 6-10. 
STEIN, R. C. & WATERFIELD, M. D. 2000. PI3-kinase inhibition: a target for drug 
development? Mol Med Today, 6, 347-57. 
SUGIYAMA, Y., KAWAKISHI, S. & OSAWA, T. 1996. Involvement of the beta-diketone 
moiety in the antioxidative mechanism of tetrahydrocurcumin. Biochem 
Pharmacol, 52, 519-25. 
SURJANA, D., HALLIDAY, G. M. & DAMIAN, D. L. 2013. Nicotinamide enhances repair 
of ultraviolet radiation-induced DNA damage in human keratinocytes and ex 
vivo skin. Carcinogenesis, 34, 1144-9. 
TADOKORO, T., KOBAYASHI, N., ZMUDZKA, B. Z., ITO, S., WAKAMATSU, K., 
YAMAGUCHI, Y., KOROSSY, K. S., MILLER, S. A., BEER, J. Z. & HEARING, V. J. 
2003. UV-induced DNA damage and melanin content in human skin differing 
in racial/ethnic origin. FASEB J, 17, 1177-9. 
TEICHERT, A. E., ELALIEH, H., ELIAS, P. M., WELSH, J. & BIKLE, D. D. 2011. 
Overexpression of hedgehog signaling is associated with epidermal tumor 
formation in vitamin D receptor-null mice. J Invest Dermatol, 131, 2289-97. 
THOMAS-AHNER, J. M., WULFF, B. C., TOBER, K. L., KUSEWITT, D. F., RIGGENBACH, J. 
A. & OBERYSZYN, T. M. 2007. Gender differences in UVB-induced skin 
carcinogenesis, inflammation, and DNA damage. Cancer Res, 67, 3468-74. 
THOMPSON, B. C., SURJANA, D., HALLIDAY, G. M. & DAMIAN, D. L. 2014. 
Nicotinamide enhances repair of ultraviolet radiation-induced DNA damage 
in primary melanocytes. Exp Dermatol, 23, 509-11. 
THORNTON, M. J., TAYLOR, A. H., MULLIGAN, K., AL-AZZAWI, F., LYON, C. C., 
O'DRISCOLL, J. & MESSENGER, A. G. 2003a. The distribution of estrogen 
receptor beta is distinct to that of estrogen receptor alpha and the androgen 
receptor in human skin and the pilosebaceous unit. J Investig Dermatol Symp 
Proc, 8, 100-3. 
THORNTON, M. J., TAYLOR, A. H., MULLIGAN, K., AL-AZZAWI, F., LYON, C. C., 
O'DRISCOLL, J. & MESSENGER, A. G. 2003b. Oestrogen receptor beta is the 
predominant oestrogen receptor in human scalp skin. Exp Dermatol, 12, 
181-90. 
TOBIN, D. J. 2006. Biochemistry of human skin-our brain on the outside. Chemical 
Society Reviews, 35, 52-67. 
TONGKAO-ON, W. 2014. 
TONGKAO-ON, W., GORDON-THOMSON, C., RYAN, A., HALLIDAY, G. M., REEVE, V. E. 
& MASON, R. S. 2012. Photoimmune modulation by 1,25dihydroxyvitaminD 
is not specific to species or test protocol but may be regulated by gender. 
University of Sydney. 
TUCKEY, R. C., LI, W., ZJAWIONY, J. K., ZMIJEWSKI, M. A., NGUYEN, M. N., 
SWEATMAN, T., MILLER, D. & SLOMINSKI, A. 2008a. Pathways and products 
for the metabolism of vitamin D3 by cytochrome P450scc. FEBS J, 275, 2585-
96. 
 161 
 
TUCKEY, R. C., NGUYEN, M. N. & SLOMINSKI, A. 2008b. Kinetics of vitamin D3 
metabolism by cytochrome P450scc (CYP11A1) in phospholipid vesicles and 
cyclodextrin. Int J Biochem Cell Biol, 40, 2619-26. 
TUR, E. 1997. Physiology of the skin--differences between women and men. Clin 
Dermatol, 15, 5-16. 
VAN LAETHEM, A., CLAERHOUT, S., GARMYN, M. & AGOSTINIS, P. 2005. The 
sunburn cell: regulation of death and survival of the keratinocyte. Int J 
Biochem Cell Biol, 37, 1547-53. 
VAN LAETHEM, A., GARMYN, M. & AGOSTINIS, P. 2009. Starting and propagating 
apoptotic signals in UVB irradiated keratinocytes. Photochem Photobiol Sci, 
8, 299-308. 
VANTIEGHEM, K., DE HAES, P., BOUILLON, R. & SEGAERT, S. 2006. Dermal 
fibroblasts pretreated with a sterol Delta7-reductase inhibitor produce 25-
hydroxyvitamin D3 upon UVB irradiation. J Photochem Photobiol B, 85, 72-8. 
VERTINO, A. M., BULA, C. M., CHEN, J. R., ALMEIDA, M., HAN, L., BELLIDO, T., 
KOUSTENI, S., NORMAN, A. W. & MANOLAGAS, S. C. 2005. Nongenotropic, 
anti-apoptotic signaling of 1alpha,25(OH)2-vitamin D3 and analogs through 
the ligand binding domain of the vitamin D receptor in osteoblasts and 
osteocytes. Mediation by Src, phosphatidylinositol 3-, and JNK kinases. J Biol 
Chem, 280, 14130-7. 
VILLIOTOU, V. & DELICONSTANTINOS, G. 1995. Nitric oxide, peroxynitrite and 
nitroso-compounds formation by ultraviolet A (UVA) irradiated human 
squamous cell carcinoma: potential role of nitric oxide in cancer prognosis. 
Anticancer Res, 15, 931-42. 
WAN, Y. S., WANG, Z. Q., SHAO, Y., VOORHEES, J. J. & FISHER, G. J. 2001. Ultraviolet 
irradiation activates PI 3-kinase/AKT survival pathway via EGF receptors in 
human skin in vivo. Int J Oncol, 18, 461-6. 
WANG, H. Q., QUAN, T., HE, T., FRANKE, T. F., VOORHEES, J. J. & FISHER, G. J. 2003. 
Epidermal growth factor receptor-dependent, NF-kappaB-independent 
activation of the phosphatidylinositol 3-kinase/Akt pathway inhibits 
ultraviolet irradiation-induced caspases-3, -8, and -9 in human keratinocytes. 
J Biol Chem, 278, 45737-45. 
WANG, J., SLOMINSKI, A., TUCKEY, R. C., JANJETOVIC, Z., KULKARNI, A., CHEN, J., 
POSTLETHWAITE, A. E., MILLER, D. & LI, W. 2012a. 20-hydroxyvitamin D(3) 
inhibits proliferation of cancer cells with high efficacy while being non-toxic. 
Anticancer Res, 32, 739-46. 
WANG, W. H., LI, L. F., ZHANG, B. X. & LU, X. Y. 2004. Metallothionein-null mice 
exhibit reduced tolerance to ultraviolet B injury in vivo. Clin Exp Dermatol, 
29, 57-61. 
WANG, X., CHEN, W. R. & XING, D. 2012b. A pathway from JNK through decreased 
ERK and Akt activities for FOXO3a nuclear translocation in response to UV 
irradiation. J Cell Physiol, 227, 1168-78. 
WANG, Y., ZHU, J. & DELUCA, H. F. 2012c. Where is the vitamin D receptor? Arch 
Biochem Biophys, 523, 123-33. 
WARIN, A. P. 1978a. THE ULTRAVIOLET ERYTHEMAS IN MAN. British Journal of 
Dermatology, 98, 473-477. 
WARIN, A. P. 1978b. The ultraviolet erythemas in man. Br J Dermatol, 98, 473-7. 
 162 
 
WHITACRE, C. C., REINGOLD, S. C. & O'LOONEY, P. A. 1999. A gender gap in 
autoimmunity. Science, 283, 1277-8. 
WIDYARINI, S., DOMANSKI, D., PAINTER, N. & REEVE, V. E. 2006. Estrogen receptor 
signaling protects against immune suppression by UV radiation exposure. 
Proc Natl Acad Sci U S A, 103, 12837-42. 
WILGUS, T. A., BREZA, T. S., JR., TOBER, K. L. & OBERYSZYN, T. M. 2004. Treatment 
with 5-fluorouracil and celecoxib displays synergistic regression of ultraviolet 
light B-induced skin tumors. J Invest Dermatol, 122, 1488-94. 
WILGUS, T. A., ROSS, M. S., PARRETT, M. L. & OBERYSZYN, T. M. 2000. Topical 
application of a selective cyclooxygenase inhibitor suppresses UVB mediated 
cutaneous inflammation. Prostaglandins Other Lipid Mediat, 62, 367-84. 
WILLIAMS, C. S., MANN, M. & DUBOIS, R. N. 1999. The role of cyclooxygenases in 
inflammation, cancer, and development. Oncogene, 18, 7908-16. 
WILLIAMS, I. R. & KUPPER, T. S. 1996. Immunity at the surface: homeostatic 
mechanisms of the skin immune system. Life Sci, 58, 1485-507. 
WONG, G., GUPTA, R., DIXON, K. M., DEO, S. S., CHOONG, S. M., HALLIDAY, G. M., 
BISHOP, J. E., ISHIZUKA, S., NORMAN, A. W., POSNER, G. H. & MASON, R. S. 
2004. 1,25-Dihydroxyvitamin D and three low-calcemic analogs decrease UV-
induced DNA damage via the rapid response pathway. J Steroid Biochem Mol 
Biol, 89-90, 567-70. 
WOOD, A. W., CHANG, R. L., HUANG, M. T., USKOKOVIC, M. & CONNEY, A. H. 1983. 
1 alpha, 25-Dihydroxyvitamin D3 inhibits phorbol ester-dependent chemical 
carcinogenesis in mouse skin. Biochem Biophys Res Commun, 116, 605-11. 
WU, J. C., LAI, C. S., BADMAEV, V., NAGABHUSHANAM, K., HO, C. T. & PAN, M. H. 
2011. Tetrahydrocurcumin, a major metabolite of curcumin, induced 
autophagic cell death through coordinative modulation of PI3K/Akt-mTOR 
and MAPK signaling pathways in human leukemia HL-60 cells. Mol Nutr Food 
Res, 55, 1646-54. 
WU, J. C., TSAI, M. L., LAI, C. S., WANG, Y. J., HO, C. T. & PAN, M. H. 2013. 
Chemopreventative effects of tetrahydrocurcumin on human diseases. Food 
Funct, 5, 12-7. 
YOSHIZAWA, T., HANDA, Y., UEMATSU, Y., TAKEDA, S., SEKINE, K., YOSHIHARA, Y., 
KAWAKAMI, T., ARIOKA, K., SATO, H., UCHIYAMA, Y., MASUSHIGE, S., 
FUKAMIZU, A., MATSUMOTO, T. & KATO, S. 1997. Mice lacking the vitamin D 
receptor exhibit impaired bone formation, uterine hypoplasia and growth 
retardation after weaning. Nat Genet, 16, 391-6. 
YU, C., FEDORIC, B., ANDERSON, P. H., LOPEZ, A. F. & GRIMBALDESTON, M. A. 2011. 
Vitamin D(3) signalling to mast cells: A new regulatory axis. Int J Biochem Cell 
Biol, 43, 41-6. 
ZANELLO, L. P. & NORMAN, A. 2006. 1alpha,25(OH)2 vitamin D3 actions on ion 
channels in osteoblasts. Steroids, 71, 291-7. 
ZANELLO, L. P. & NORMAN, A. W. 1996. 1 alpha,25(OH)2 vitamin D3-mediated 
stimulation of outward anionic currents in osteoblast-like ROS 17/2.8 cells. 
Biochem Biophys Res Commun, 225, 551-6. 
ZANELLO, L. P. & NORMAN, A. W. 1997. Stimulation by 1alpha,25(OH)2-vitamin D3 
of whole cell chloride currents in osteoblastic ROS 17/2.8 cells. A structure-
function study. J Biol Chem, 272, 22617-22. 
 163 
 
ZANELLO, L. P. & NORMAN, A. W. 2003. Multiple molecular mechanisms of 1 
alpha,25(OH)2-vitamin D3 rapid modulation of three ion channel activities in 
osteoblasts. Bone, 33, 71-9. 
ZANELLO, L. P. & NORMAN, A. W. 2004a. Electrical responses to 1alpha,25(OH)2-
Vitamin D3 and their physiological significance in osteoblasts. Steroids, 69, 
561-5. 
ZANELLO, L. P. & NORMAN, A. W. 2004b. Rapid modulation of osteoblast ion 
channel responses by 1alpha,25(OH)2-vitamin D3 requires the presence of a 
functional vitamin D nuclear receptor. Proc Natl Acad Sci U S A, 101, 1589-
94. 
ZBYTEK, B., JANJETOVIC, Z., TUCKEY, R. C., ZMIJEWSKI, M. A., SWEATMAN, T. W., 
JONES, E., NGUYEN, M. N. & SLOMINSKI, A. T. 2008a. 20-Hydroxyvitamin D3, 
a Product of Vitamin D3 Hydroxylation by Cytochrome P450scc, Stimulates 
Keratinocyte Differentiation. J Invest Dermatol, 128, 2271-2280. 
ZBYTEK, B., JANJETOVIC, Z., TUCKEY, R. C., ZMIJEWSKI, M. A., SWEATMAN, T. W., 
JONES, E., NGUYEN, M. N. & SLOMINSKI, A. T. 2008b. 20-Hydroxyvitamin D3, 
a product of vitamin D3 hydroxylation by cytochrome P450scc, stimulates 
keratinocyte differentiation. J Invest Dermatol, 128, 2271-80. 
ZINSER, G. M., SUNDBERG, J. P. & WELSH, J. 2002. Vitamin D(3) receptor ablation 
sensitizes skin to chemically induced tumorigenesis. Carcinogenesis, 23, 
2103-9. 
 
